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Foreword
The explosion of knowledge that research on DNA 
has brought has been extraordinary. The recent, 
rapid development of gene sequencing and editing 
technologies has led to the creation of a new generation 
of tools. The technologies that allow humans to alter 
the genes of organisms to make them do things 
that humans want and that those organisms would 
not normally do -- for example, creating yeast that 
can make plastic or human medicine -- is called 
synthetic biology. There is an active international 
discussion on how best to define the field. 
 
Scientists now have tools available that in principle 
may allow them to make changes to the genetic 
makeup of nearly every species, including, but also 
extending well beyond, single gene manipulation. 
DNA can be copied into digital form, rearranged, 
turned back into organic form, then inserted back 
into living cells in an attempt to strengthen or create 
desirable characteristics or eliminate problematic 
ones. These new and rapidly evolving technologies 
create exciting opportunities in many fields, including 
new kinds of conservation, but they also raise 
serious questions and complex challenges. 
It was both deep concern and qualified excitement that 
led IUCN to commission a broad assessment of the 
current state of science and policy around synthetic 
biology techniques as they relate to biodiversity. The 
goal of this assessment is therefore to provide a clear 
understanding, based on the best available evidence, of 
the issues regarding synthetic biology that are relevant 
to and may have an impact – positive or negative – on 
the conservation and sustainable use of biological 
diversity. Produced by a global team of practitioners 
and researchers, this assessment responds in part 
to an IUCN Resolution adopted at the IUCN World 
Conservation Congress in 2016: “Development 
of IUCN policy on biodiversity conservation and 
synthetic biology” (WCC-2016-Res-086). 
Application of synthetic biology to conservation is in 
its earliest stage. That makes the requirement that this 
assessment use an evidence-based approach more 
challenging but even more vital. While policy debates 
necessarily engage values and preferences, claims in 
support of, or in opposition to, synthetic biology that 
draw primarily from these need to be distinguished 
from those grounded in evidence. This assessment 
thus aims to shed light on the state of the field, with 
the potential benefits and harms discernible to date. It 
cannot be, and does not aim to be, a comprehensive 
risk assessment. Rather, the goal of this assessment 
is to inform future deliberations and increase the 
understanding of the different ways that evidence 
regarding the potential impact of synthetic biology on 
conservation is generated, used, and interpreted.
This assessment is the beginning of a process that 
will lead to the development of an IUCN policy to 
guide the Union’s Director General, Commissions, 
and Members. The draft policy will be discussed 
in many fora before it is brought to vote at the 
World Conservation Congress in 2020. Far greater 
public attention to the topic of synthetic biology 
and biodiversity conservation is essential, given 
the potential impact of scientific discoveries and 
policy decisions that may be just over the horizon, 
and also given the need for broad partnerships to 
address the challenges that the conservation and 
synthetic biology communities will inevitably face. 
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Statement of principles of the IUCN Task 
Force on synthetic biology and biodiversity 
conservation
Recognising the complexity and large positive and negative potential impacts of the subject, both on and beyond 
the global conservation community, this assessment will draw on the values and proven processes of IUCN to 
provide a shared and trusted resource for subsequent deliberations.
In preparing the assessment on behalf of the IUCN membership, the Technical Subgroup has striven to adhere to 
the principles of:
Objectivity – assessing evidence and working to minimise and balance subjective bias;
Inclusivity – recognising and being considerate of the full diversity of views and interests;
Robustness – ensuring that all conclusions drawn are based on clear reasoning;
Humanity – interacting with all interested parties in a respectful and honest manner;
Transparency – ensuring that the process applied and all final outputs arising from it will be open access;
Consultation – giving meaningful opportunities for all interested parties to engage with the process, and 
responding to all formal submissions.
The work is all conducted under the umbrella of the IUCN Commission Code of Conduct and the IUCN Secretariat 
Code of Conduct.
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Glossary 
See Box 1.1 for standard introductory genetics terms.
Allele: a form of a gene at a particular 
position (locus) on a chromosome.
Autosome: chromosomes which are not sex 
chromosomes (such as X and Y in mammals).
Bioaugmentation: the addition of archaea 
or bacterial cultures required to speed up the 
rate of degradation of a contaminant.
Biodiversity: biological diversity, “the variability 
among living organisms from all sources including, 
inter alia, terrestrial, marine and other aquatic 
ecosystems and the ecological complexes of which 
they are part; this includes diversity within species, 
between species and of ecosystems” (CBD 1992).
Bottleneck (population): an ecological 
event that drastically reduces a population 
producing evolutionary impacts.
CITES: Convention on International Trade in 
Endangered Species of Wild Fauna and Flora. It is 
an international agreement between governments 
aimed at ensuring that international trade in 
specimens of wild animals and plants does not 
threaten their survival. It entered into force in 1975, 
and currently has a membership of 183 Parties.
CRISPR-Cas9 technology: biochemical 
method using clustered regularly interspaced 
short palindromic repeats (CRISPR) guide RNA 
in conjunction with Cas9 (CRISPR-associated 
9) nuclease to efficiently cut and edit DNA.
De-extinction (or species revival): the 
development of functional proxies for species 
which have previously become extinct.
Digital sequence information on genetic 
resources: contested term referring to certain types 
of genetic information derived from DNA sequencing.
DNA sequencing: detecting the sequence 
of the four bases (adenine, thymine, guanine, 
cytosine) as the code of genetic information. 
DNA synthesis: process of creating 
natural or artificial DNA molecules.
Functional genomic screening: a key discovery 
enabling the identification of gene and protein function.
Gene drive: A phenomenon of biased inheritance in 
which the ability of a genetic element to pass from a 
parent to its offspring through sexual reproduction 
is enhanced, leading to the preferential increase of 
a specific genotype that may determine a specific 
phenotype from one generation to the next, and 
potentially throughout a population. A gene drive 
element is a heritable element that can induce gene 
drive, such that the gene drive element is preferentially 
inherited. Gene drive elements may be referred to 
as gene drive systems or simply “gene drives.”
Gene flow: exchange of genetic material between 
populations, either through individuals, or mediated 
through pollen, spores, seeds or other gametes.
Genetic drift: random change of genetic 
variation from one generation to another.
Genetically modified organism (GMO): also known 
as “living modified organism” (LMO), an organism 
whose characteristics have been changed by genetic 
engineering (contrasting classical selection experiments 
or naturally by mating and/or recombination).
Genetic rescue: deliberate introduction of 
individuals or gametes as vehicles for the 
infusion of novel alleles (hence to increase 
gene flow, genetic diversity and fitness).
xii
Genome editing: making targeted changes to the 
genome of an organism, predominantly by using 
site-specific endonucleases such as CRISPR-Cas9.
Genotype: the genetic constitution 
of an individual organism.
Inbreeding depression: whereby the expression 
of deleterious recessive traits is more likely 
due to lower gene pool diversity, resulting 
in reduced fecundity and/or survival.
Invasive Alien Species: taxa that are introduced 
accidentally or deliberately into a natural environment 
where they are not normally found, with serious 
negative consequences for their new environment. 
Mendelian inheritance: form of inheritance 
proposed by Gregor Mendel with the following 
laws: law of segregation, law of independent 
assortment, law of dominance. Characteristics 
are inherited from parents to offspring individuals 
following those laws in predicted ratios.
Pathogen: a biological agent that causes 
disease or illness to its host.
Phenotype: the ensemble of observable 
characteristics displayed by an organism.
Risk: The likelihood and severity of a potential 
adverse effect. For example, if the likelihood of an 
adverse effect occurring is high, but the severity of 
the adverse effect is very low, the overall risk will be 
low. If, however, the severity of the adverse effect is 
extremely high, even a low probability of it occurring 
may still be considered a large risk. That is, even 
if there is only a 1% chance that an approaching 
asteroid will destroy the earth, this will likely be 
considered a high risk that needs to be addressed.
Risk assessment: the structured 
process for analysing risk.
Recombination: In the process of transferring 
genetic information from parents to offspring, 
new combinations of traits can occur, caused by 
recombination of chromosomes during meiosis.
Release of insects carrying a dominant lethal 
(RIDL): release into the wild of insects carrying 
a dominant lethal gene or genetic system.
Selection: Some individuals in a population have higher 
reproductive success, as they possess characteristics 
which make them more adapted to their environment. 
Squalene: a natural 30-carbon organic 
compound originally obtained for commercial 
purposes primarily from shark liver oil (hence 
its name, as Squalus is a genus of sharks).
SRY mice: Sry is a sex-determining gene that regulates 
testis differentiation; in SRY mice this gene is placed 
on an autosome and offspring are only male.
Sterile insect technique (SIT): a technique in which 
sterile individuals of a species are generated in the lab 
(e.g. through radiation) and then released into the wild.
Sterile male: Sterile males are released into 
nature such that, when mating with wild females, 
there are no offspring. Males are sterilised either 
through radiation or by genetic manipulation.
Symbiosis: any type of a close and longer-term 
biological interaction between two different biological 
organisms, be it mutualistic (benefits for both), 
commensalistic (benefits for one while no harm to 
the other) or parasitic (benefits for one while causing 
harm to the other). The organisms, each termed a 
symbiont, may be of the same or a different species.
Transgene: a gene or genetic material that 
has been transferred naturally, or by any of a 
number of genetic engineering techniques from 
one organism to the other. The introduction of a 
transgene (called “transgenesis”) has the potential 
to change the phenotype of an organism.
Vector: any agent that carries and transmits an 
infectious pathogen into another living organism. 
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1 .
What does synthetic 
biology and gene drive 
have to do with biodiversity 
conservation? 
Todd Kuiken, Edward Perello, Kevin Esvelt, Luke Alphey
Image by: SKHerb / Shutterstock.com
1.1 Introduction
The loss of Earth’s biodiversity is accelerating at an 
unprecedented rate and proceeding at all levels: 
ecosystems, species and genes. No corner of the 
Earth, no matter how remote, is today free from 
human influence, whether in the form of the altered 
atmosphere, expanding cities, ubiquitous pollution 
and invasive species, conversion of wildlands and 
loss of once fertile farmland, or expanding exploitation 
and trade of wild species. Governments have 
set ambitious targets for addressing biodiversity 
loss worldwide, such as the Aichi Targets of the 
Convention on Biological Diversity’s Strategic Plan 
2011–2020, and the Sustainable Development 
Goals (SDGs) agreed by the United Nations in 2015 
(UN, 2015). To date, however, both the targets 
and the institutional arrangements that support 
them are singularly failing (Tittensor et al., 2014). 
In recent years synthetic biology has emerged as a suite 
of techniques and technologies that enable humans to 
read, interpret, modify, design and manufacture DNA 
in order to rapidly influence the forms and functions of 
cells and organisms, with the potential to reach whole 
species and ecosystems. As synthetic biology continues 
to evolve, new tools emerge, novel applications are 
proposed, and basic research is applied; much remains 
to be learned about which genes influence which 
traits and how they may interact with each other and 
with environmental factors, including via epigenetic 
phenomena (for a description of epigenomics, see Box 
1.3). Much of synthetic biology innovation, especially in 
enabling technologies (Figure 1.1) is considered to be 
exponential, and it is considered a domain of the Fourth 
Industrial Revolution, blurring the lines between the 
physical, digital and biological spheres. The Industrial 
Revolution refers to the fourth major industrial revolution 
and is characterised by its “velocity, scope, and systems 
impact” and the combination of technologies from the 
physical, digital and biological realms (Schwab, 2016). 
The emerging capabilities, applied to the conservation 
of biodiversity, have great potential to reshape the 
conservation field in unforeseeable ways, both 
positive and negative and along unknown timelines. 
This assessment is one part of IUCN’s effort to provide 
recommendations and guidance regarding the potential 
positive and negative impacts of synthetic biology on 
biodiversity conservation. Past efforts and resolutions of 
IUCN have examined the impacts and potential uses of 
genetically modified organisms in relation to biodiversity 
(IUCN World Conservation Congress, 2000, 2004; 
Balakrishna, Dharmaji & Warner, 2003; Congress, 2004; 
Young, 2004). Taken together these will serve as an 
input to the development of policy recommendations to 
be debated and voted on by the IUCN membership at 
the 2020 World Conservation Congress in Marseilles.
Figure 1.1 The productivity of DNA synthesis and sequencing, measured as bases per person per day, using commercially available 
instruments, and compared to Moore’s Law, which is a proxy for IT productivity. Productivity in sequencing DNA has increased much 
faster than Moore’s Law in recent years. Productivity in synthesising DNA must certainly have increased substantially for privately 
developed and assembled synthesisers, but no new synthesis instruments, and no relevant performance figures, have been released 
since 2008. Adapted from Bioeconomy Capital, 2018.
2
1.2  Interaction of the 
synthetic biology and 
biodiversity conservation 
communities
The emergence of synthetic biology has led to tension 
within the global conservation community and a 
growing understanding of the utility of deeper and 
more meaningful interaction between contemporary 
conservation and synthetic biology communities 
(Piaggio et al., 2017). The governments of many 
developing countries, indigenous leaders and local 
communities have also voiced concerns over how 
synthetic biology may affect their cultures, rights and 
livelihoods. Both the hopes and fears surrounding 
the application of synthetic biology to conservation 
stem from the same troubling observation: the 
loss of biodiversity continues despite the growing 
sophistication of conservation activity and conservation 
science; and the understanding among governments 
at all levels as well as civil society that human well-
being depends on a thriving natural world. 
For some in the conservation community there 
is sentiment that while simply improving existing 
approaches might not be sufficient, those approaches 
— such as strengthening protected areas, improving 
policy regarding the use and protection of natural 
resources, working in robust partnership with 
communities who depend on nature for their survival 
— should always be the first option. At the same time, 
a growing minority of the conservation community 
is exploring new tools, such as those offered by 
synthetic biology, that could complement, and in 
some cases even reinforce, existing conservation 
techniques. Conservation is already an integrative 
discipline, and the incorporation of new tools into 
the kit should come as no surprise. However, the 
synthetic biology toolkit is not just a set of capabilities, 
but in many cases it modifies organisms to become 
tools in their own right. In this sense synthetic biology, 
especially gene drives, challenges agreed concepts 
of tools, organisms and conservation, and must 
be given special consideration by conservationists 
and biologists alike, to chart a path forward. 
Unfortunately the potential impact of synthetic biology 
on conservation is a “wicked problem,” with no clear 
route to a solution and no obvious stopping point 
((Rittel & Webber, 1973; Redford, Adams, & Mace, 
2013). The use of living modified organisms (LMOs), 
and their impact on biodiversity, remains a controversial 
but helpful precedent. The recent Convention on 
Biological Diversity Ad Hoc Technical Expert Group 
(AHTEG) Report (Ad Hoc Technical Expert Group 
on Synthetic Biology, 2017) noted that, beyond the 
experience gained from LMOs already released into 
the environment, there was limited direct empirical 
evidence to date on the benefits or adverse effects on 
biodiversity resulting from the organisms, components 
and products of synthetic biology. However, some 
have argued that in relation to gene drive there are 
crucial differences compared to LMOs and adapted 
risk assessments may be needed to evaluate their 
impacts (Simon, Otto & Engelhard, 2018).
For some, interest in synthetic biology represents 
a fascination with the new, a misplaced hope in a 
magic bullet technology that will solve heretofore 
intractable problems. In this view, where conservation 
has fallen short it has done so because the application 
of existing techniques was inadequate to address 
the nature or scale of the problems. Others in the 
conservation community believe that if the evidence 
for the utility of a new technique exists, then it should 
be used regardless of whether the potential for the 
old approach has been exhausted. In this view, 
while any new technology must be approached with 
caution, given the scale and pace of the biodiversity 
crisis, it makes sense to continue investigating new 
approaches, bearing in mind the precautionary principle 
(Harremoës et al., 2002; EEA, 2013), and using 
them as soon as they can be shown to be effective 
and safe and acceptable to local communities. 
To date, synthetic biology and conservation have 
proceeded largely in isolation from each other (Redford 
et al., 2014). The specialties and the scientists who 
practice them differ in obvious ways, such as training 
and scientific practice, but in subtler ways including 
world views, approaches to uncertainty and risk, and 
value systems. Despite these differences, there is an 
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Box 1.1
An introduction to the central dogma of genetics
Phil Leftwich
DNA to RNA to protein
The central dogma of biology has been a remarkably useful 
model for understanding DNA (Deoxyribonucleic acid), a 
complex molecule that carries all of the information necessary 
to build and maintain an organism. DNA can be read by 
cellular machinery to encode for RNA and protein, and the 
increasing sense that, over coming years, conservation 
and synthetic biology will converge or, as some 
people fear, collide. New ways to address seemingly 
intractable problems with scalable technology also 
present a host of new and unanticipated challenges. 
It is well noted that an established and continuous 
dialogue can minimise the potential harm from synthetic 
biology products that are being developed for multiple 
purposes, reduce mutual misunderstanding, and 
maximise their utility for nature conservation (Redford et 
al., 2014; Revive & Restore, 2015; Piaggio et al., 2017).
Recalling the blurred lines between synthetic biology 
and the digital sphere, debate about the use of digital 
sequence information (DSI) corresponding to the DNA 
of living organisms continues within the Convention on 
Biological Diversity (CBD), and its Subsidiary Body on 
Scientific, Technical and Technological Advice which 
has convened Ad Hoc Technical Expert Groups on both 
issues. On the one hand this represents an important 
mainstream interaction between conservation policy 
and synthetic biology; on the other, the Convention has 
not yet been able to decide whether synthetic biology 
should be classified as a new and emerging issue 
against the criteria set out in Decision IX/29 on Biosafety 
to the Convention on Biological Diversity (Sections 2.2.1 
&2.2.2), and whether or not digital sequence information 
would be covered by the existing framework of the 
Nagoya Protocol on Access to Genetic Resources 
and the Fair and Equitable Sharing of Benefits Arising 
from their Utilisation to the Convention on Biological 
Diversity (Sections 2.2.4 & 2.3.2). Such challenges 
perhaps reflect other societal concerns regarding the 
potential interactions between synthetic biology and 
conservation, as exemplified by the open letter “A call 
for conservation with a conscience: no place for gene 
drives in conservation” (Synbiowatch, 2016). However 
this does not represent the “public” as a whole, and 
there are limited studies that have examined the public’s 
understanding and views towards synthetic biology 
and gene drive (Schmidt et al., 2009; Eden, 2014). 
Synthetic biology and conservation indeed have the 
potential to interact in innumerable ways. Conservation 
may be improved by adapting the tools and processes 
of synthetic biology to further develop its own goals, 
much as conservationists did with classical genetics 
(DeSalle & Amato, 2004). Invasive species may be 
controlled with limiting gene drive (Case study 1). Oil 
spills could be remediated with microbes engineered 
to digest harmful compounds (Dvořák et al., 2017). 
Infectious and emerging diseases could be treated 
or prevented (Case study 4), and genetic diversity 
restored to where it has been lost (Case study 3). 
Across all such examples, the critical question asks 
how might such synthetic biology applications impact 
biological diversity, as measured not just against the 
current state of biodiversity but against a potential 
future in which business as usual is allowed to 
continue. Some applications of synthetic biology in 
conservation have been particularly controversial and 
have drawn a great deal of attention. For example, 
“de-extinction” – the process of creating an organism/
animal that is a member of an extinct species or 
serves as a proxy that may restore their extinct 
counterparts’ lost ecological value (IUCN SSC, 2016) 
– has been described as being “a fascinating but 
dumb idea” because it would divert resources away 
from saving endangered species and their habitats 
(Ehrlich & Ehrlich, 2014). On the other hand, certain 
conservation applications, for instance the engineering 
of microbes to biosynthesise products sourced from 
threatened species, such as a medically-valuable 
molecule found in the blood of horseshoe crabs, are 
already underway (Maloney, Phelan & Simmons, 2018; 
see Chapter 6 Case study 8 – Horseshoe Crab). 
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three classes of molecule can be considered interchangeable, 
and common to all life on Earth. Individuals may pass on 
this information from parents to offspring over generations, 
or directly to one another through horizontal gene transfer. 
Segments of DNA that encode the information for a 
specific protein are known as genes, and all organisms 
within a species share a common set of genes, many of 
which can differ slightly between individuals, the variations 
being known as alleles. The combined effect of all these 
allelic differences can have a major role in an organism’s 
suitability for its environment, and helps to define the 
biological traits of an individual and the species. 
DNA structure
The DNA molecule physically manifests as a double 
helix, composed of two long strands of polynucleotides 
that run in parallel while winding around each other to 
resemble a twisted ladder. Each strand is a long chain of 
smaller units called nucleotides, which may be one of four 
organic bases — adenine (A), guanine (G), cytosine (C) 
and thymine (T). The bases along these two strands link 
to each other in a specific manner – A will only pair with T 
on the opposing strand, and C will only pair with G. The 
double helix holds DNA in its linear structure allowing the 
storage of information via nucleotide ordering along two 
coding strands. The structure may also be unwound such 
that each strand serves as a template to form two new 
identical molecules when cells divide. Stored information 
sequences can be passed on to descendant molecules 
as the two halves separate, and can even be recombined 
between organisms during reproduction, providing the 
molecular basis for heredity and variation in offspring. 
Gene expression
A gene can be defined as a section of DNA that codes for 
a particular protein, with the order of nucleotides directing 
the ordered assembly of amino acids into a protein string. 
Protein strings fold into three-dimensional structures, which 
in turn determine the function of the folded protein. The 
process of directing protein synthesis is known as gene 
expression, and can occur at all times, or in response to 
particular environmental cues. Given the vital importance of 
genes in making all of the proteins that enable an organism 
to function they make up a surprisingly small proportion 
of the total genome. The human genome is made up of 
approximately 21,000 protein-coding genes – but this 
accounts for less than 2 per cent of the nucleotides in 
the total genome. Despite this, protein molecules form 
the basis of all living tissues and play central roles in 
all biological processes. Examples of proteins include 
antibodies, enzymes and structural proteins and hormones. 
Beyond the gene model
The central dogma and gene model serve as a useful 
basis for introducing concepts of genetics, but these 
simplifications hide the complexity of how genomes, genes, 
gene regulatory processes, trait manifestation and other 
complex genetic phenomena occur. For a more detailed 
primer on genetics, see Appendix 1 (www.iucn.org/synbio). 
1.3 What is synthetic biology? 
All living organisms contain shared fundamental 
components that serve as an instruction set to 
determine what organisms look like, what they do, and 
how they function (Box 1.1). While synthetic biology 
is evolving so rapidly that no commonly accepted 
definitions exist (Box 1.2), underlying all definitions is 
the concept that synthetic biology is the application 
of engineering principles to these fundamental 
components of biology. As the field grows, more and 
more disciplines are becoming aligned with it, making 
it even more difficult to find a single definition (Shapira, 
Kwon & Youtie, 2017). This assessment uses the 
operational definition considered by the CBD AHTEG as 
a useful starting point for discussions about synthetic 
biology: “a further development and new dimension 
of modern biotechnology that combines science, 
technology and engineering to facilitate and accelerate 
the understanding, design, redesign, manufacture 
and/or modification of genetic materials, living 
organisms and biological systems” (UN CBD, 2017). 
Humans have been altering the genetic code of plants 
and animals for millennia, by selectively breeding 
individuals with desirable features to reassert and 
accentuate traits in populations over time and in 
environments formed by husbandry practices, 
social systems and ecological drivers. The advent 
of biotechnology allowed humans to more precisely 
read and edit the code that governs genetics, 
allowing genetic information and traits to be usefully 
modified. This is the basis of genetic engineering, and 
has allowed researchers to speed up the process 
of developing new breeds of plants and animals 
relevant to agriculture and medical research.
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More recent advances at the intersection of 
biotechnology, modern engineering, computation 
and chemistry have enabled scientists to design and 
synthesise new sequences of DNA from scratch, 
supporting the design of cells and organisms that 
do new things — such as produce biofuels, secrete 
the precursors of clinical drugs or act as biosensors. 
Many believe that designing novel DNA to obtain 
specific functions is the essence of synthetic biology.
Synthetic biology has been enabled and driven by 
the ability to convert and represent DNA base pairs, 
codons, amino acids, genes and regulatory elements 
in a digital form (National Academies of Sciences, 
Engineering, and Medicine, 2017). Digital sequence 
information not only enables researchers to view 
and understand the blueprints of an organism in a 
computational environment, but opens the door to 
designing, editing and modelling biological components 
prior to physically producing and inserting them 
into a cell or organism. The simulation and testing 
of biological designs using computer software is an 
emerging opportunity to evaluate biological interactions 
across organisms, and potentially even ecosystems, 
prior to the release of a modified organism, but 
there remain challenges in accurate modelling of 
complex systems. More generally, increasing access 
to public digital sequence information, collections of 
biological components and computer automation 
has substantially reduced the time it takes to design 
new biological components and enabled new actors 
to participate in synthetic biology (Section 6.6).
The early concepts underpinning synthetic biology 
surfaced over a century ago (Leduc, 1912), more 
recently being formalised as the fusion of molecular 
biology and engineering principles. Today, synthetic 
biology exists as, and is embodied in, a broad set 
of tools, processes and disciplines. The tools may 
include CRISPR-Cas9 reagents that are used to cut 
and splice DNA, as well as DNA sequencers and 
DNA design software packages. Significant synthetic 
biology processes include genome editing, whole 
genome sequencing and functional screening. The 
disciplines associated with synthetic biology include 
systems biology, bioinformatics, molecular biology, 
microbial ecology and plant virology (Figure 1.2). A 
feature of synthetic biology is that this diversity of 
fields, and the borrowing of tools from non-synthetic 
biology domains, makes the taxonomy of synthetic 
biology challenging. Specific tools or processes can 
rarely be said to be uniquely tied to synthetic biology; 
CRISPR-Cas9 may be used in multiple non-synthetic 
biology contexts, for example, and the products 
resulting from the use of a tool or process are not 
always the intrinsic products of synthetic biology.
Synthetic biology is a convergent branch of biology 
and engineering that is perhaps better articulated not 
as a list of tools, processes and fields, but rather the 
use cases for which they are developed and deployed. 
These use cases are expanding as interactions between 
nanotechnology, artificial intelligence, robotics and a 
myriad of biological innovations yield breakthroughs in 
smart materials, material structures, energy generation, 
pollution remediation and more. Synthetic biology is 
only one of a set of new technologies that is being 
developed and deployed. There is a constant, fluid, and 
potentially extremely broad interaction and innovation 
frontier between this “Fourth Industrial Revolution” 
and biodiversity (World Economic Forum’s System 
Initiative on Shaping the Future of Environment and 
Natural Resource Security, 2018). The Fourth Industrial 
Revolution refers to the fourth major industrial revolution 
and is characterised by its “velocity, scope, and systems 
impact” and the combination of technologies from the 
physical, digital and biological realms (Schwab, 2016).
When applied to conservation, each application, tool 
and process derived from the various disciplines of 
the synthetic biology field should be evaluated on the 
evidence for the positive and/or negative impacts they 
are likely to have on any given conservation objective. 
In all cases, assessments must widely investigate how 
a synthetic biology approach will influence the entire 
plurality of conservation objectives for all biodiversity 
impacted. Only then can informed decisions be 
made. Such assessments would assemble a body of 
knowledge to guide future decision makers through 
the broad spectrum of synthetic biology applications, 
and the considerations that should be made in 
light of their impact on biodiversity conservation.
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Figure 1.2 What is synthetic biology? Synthetic biology is both a platform technology (building a systematic basis for design—combining 
biological, engineering, and computational capabilities) and a translational technology (providing the link between a wide range of 
underpinning disciplines—ranging from biochemistry to systems theory—and practical applications in a wide range of market sectors). 
Adapted from a figure by the UK Synthetic Biology Roadmap Coordination Group.
Box 1.2
Example definitions of synthetic biology
• A further development and new dimension of modern 
biotechnology that combines science, technology 
and engineering to facilitate and accelerate the 
understanding, design, redesign, manufacture and/
or modification of genetic materials, living organisms 
and biological systems (UN CBD, 2017).
• The application of science, technology and 
engineering to facilitate and accelerate the design, 
manufacture and/or modification of genetic materials 
in living organisms (SCENIHR, SCCS, 2014).
• The deliberate design of biological systems 
and living organisms using engineering 
principles (Balmer & Martin, 2008).
• The design and construction of novel artificial 
biological pathways, organisms and devices or 
the redesign of existing natural biological systems 
(The Royal Synthetic Biology Society, 2017).
• The use of computer-assisted, biological engineering 
to design and construct new synthetic biological 
parts, devices and systems that do not exist in nature 
and the redesign of existing biological organisms, 
particularly from modular parts (International Civil 
Society Working Group on Synthetic Biology, 2011).
• A new research field within which scientists and 
engineers seek to modify existing organisms by 
designing and synthesising artificial genes or proteins, 
metabolic or developmental pathways and complete 
biological systems in order to understand the basic 
molecular mechanisms of biological organisms 
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and to perform new and useful functions (The 
European Group on Ethics in Science and New 
Technologies to the European Commission, 2009).
• A new field defined by the application of 
engineering principles to living systems for 
useful applications in health, agriculture, 
industry and energy (UK BBSRC, 2017).
• A platform technology that enables the design and 
engineering of biologically-based systems. As a field of 
science, it encompasses both the biological aspect of 
designing systems to help understand them, and the 
engineering aspect of designing systems with the aim 
of achieving a set endpoint. Thus, overall it involves the 
design of new living systems that can carry out specific 
functions or produce products (Parks et al., 2017).
• A new field of research in biotechnology that draws 
on engineering principles to manipulate DNA in 
organisms. It allows for the design and construction 
of new biological parts and the re-design of natural 
biological systems for useful purposes (OECD, 2016).
• The molecular-biological modification of known 
organisms which are mostly application-oriented 
and increasingly based on digital information. 
These approaches aim at producing chemicals by 
means of new ways of bio-synthesis or at designing 
genetic circuits for new sensory and regulatory cell 
functions in existing organisms. Synthetic biology in 
the broad sense goes beyond simple approaches 
for genetically modifying metabolic pathways of 
organisms (so-called metabolic engineering). For this, 
computer-assisted design and modelling processes 
are used increasingly (Sauter et al., 2015).
• An emerging discipline that combines both 
scientific and engineering approaches to the study 
and manipulation of biology (NRC, 2013).
1.4 What is gene drive? 
In addition to focusing on synthetic biology, IUCN 
Resolution WCC-2016-Res-086 called for an 
examination of gene drive systems and biodiversity 
conservation. Gene drive is a ubiquitous natural 
phenomenon in which a genetic element improves the 
chance that it will be inherited at a frequency above 
the usual 50 per cent by copying itself or selectively 
eliminating competing elements (Figure 1.3) (Burt and 
Trivers, 2006; NASEM, 2016a). This potentially allows 
gene drive elements to spread through populations 
even without providing a fitness advantage to the 
individuals carrying the elements, though a fitness 
disadvantage will slow and perhaps prevent spread. 
Such spread can be rapid relative to ‘normal’ gene 
changes, but still slow relative to genetic elements that 
can readily transfer between individuals (“horizontal 
gene transfer”) such as viruses or plasmids. Nearly 
every organism whose genome has been sequenced 
carries active or broken gene drive elements, which 
in some species can comprise most of their DNA 
(Feschotte & Pritham, 2007; de Koning et al., 2011).
 
Scientists are working to harness gene drive, either 
repurposing naturally occurring systems or building 
synthetic versions – engineered gene drives – that might 
be used to spread engineered changes through wild 
populations over many generations. Some methods 
may allow populations to be suppressed by distorting 
the sex ratio or impairing the fertility of organisms that 
inherit two copies, which may be relevant for invasive 
species control. Mathematical models incorporating 
spatial spread of engineered population suppression 
gene drives in species such as mosquitoes predict that 
suppression should not result in extinction absent other 
ecological pressures (Eckhoff et al., 2017). Many types 
of gene drive are found in nature; crucially, different 
mechanisms give rise to different behaviours. Some 
gene drive elements, including many found in nature 
and some engineered ones, are predicted to keep 
spreading to most populations of the target species 
(Marshall, 2009; Noble et al., 2018). Other types of 
drive systems are inherently localised due to some 
form of frequency-dependence; like non-driving genes, 
engineered local drive systems are not predicted to 
spread far beyond the populations in which they are 
introduced (Hoffmann et al., 2011; Marshall & Hay, 
2012). For more detailed information on gene drive 
systems see Appendix 2 (www.iucn.org/synbio). 
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Box 1.3
Modifying epigenomes using synthetic biology
Johanna E. Elsensohn
Epigenetics is a field of study that looks at how environmental 
(i.e. non-genetic) factors can affect how, whether and 
when genes are expressed. Epigenetic changes can be 
transient, present throughout the organism’s life cycle, or, 
in some cases, passed on to subsequent generations. 
This last possibility, called transgenerational epigenetic 
inheritance (TEI), is well established in plants, microbes, 
yeast and nematodes, among other organisms (Rusche, 
Kirchmaier & Rine, 2003; Casadesús & Low, 2006; 
Quadrana & Colot, 2016; Minkina & Hunter, 2017). As 
Figure 1.3 What is gene drive? Gene drive systems distort inheritance in their favour, enabling them to spread vertically through 
populations over generations (a). Some types of engineered gene drive systems can suppress populations, either by ensuring that 
organisms that inherit one copy from each parent are nonviable or sterile, or by ensuring that organisms inheriting a copy develop 
exclusively as one sex, e.g. all male (b). Self-propagating gene drive systems are predicted to invade most or all susceptible populations 
connected by gene flow, whereas the geographic spread of local drive systems is limited by their dependence on the frequency of other 
genetic elements, reducing their ability to spread or invade populations distant from the release sites (c).
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epigenetic modifications can target the expression pattern 
of a specific gene at a specific time, the implications for 
its use in synthetic biology and engineered gene drive 
systems could be significant (Jurkowski, Ravichandran & 
Stepper, 2015; Keung et al., 2015). However, synthetic 
biologists are only beginning to explore the implications 
of this research (Rodriguez-Escamilla, Martínez-Núñez 
& Merino, 2016; Maier, Möhrle & Jeltsch, 2017).
The existence of TEI in mammals remains unclear. First, 
no mechanisms have been identified, with specific 
exceptions (e.g. researchers have silenced but not altered 
the sequences of certain genes of newborn agouti mice 
by feeding their mothers extra vitamins during pregnancy). 
Second, mammalian germ cells (that is, eggs and sperm) 
develop dynamically, which can eliminate epigenetic 
changes (Feil & Fraga, 2012; Skvortsova, Iovino & 
Bogdanović, 2018). Challenges to the use of epigenetic 
modification for conservation or other purposes are 
similar to those for gene editing, and include a lack of 
clarity on the stability of engineered epigenetic alterations 
within and across generations, and the regulations 
that would apply to the engineered organisms. 
Some researchers are exploring the possibility that 
epigenome therapy may be able to help prime certain 
genes of threatened species against specific stressors. 
Epigenome editing has mostly been explored in humans 
(Kungulovski & Jeltsch, 2016; Holtzman & Gersbach, 
2018), but has broader potential (Keung et al., 2015; 
Sharakhov & Sharakhova, 2015). Such changes would 
not be passed onto future generations and would not 
address the underlying problems many species face, 
but epigenetics may offer a stopgap aid during periods 
of acute stress, such as drought or increased salinity.
1.5 Values in synthetic biology 
and biodiversity conservation 
Values shape how we individually and collectively 
assess technologies. Synthetic biology is in that sense 
no different than other transformational scientific 
discoveries. Values can be understood as motivational 
goals deeply embedded in material culture, collective 
behaviours, traditions and social institutions. They 
often serve to define and bind groups, organisations 
and societies (Manfredo et al., 2017). As such, values 
shape how humans individually and collectively assess 
new technologies such as synthetic biology. The 
values underlying public discussion about the use of 
synthetic biology products are raising a mix of moral, 
metaphysical, socio-political and ethical questions. 
One of the recurring concerns is that synthetic biology 
interventions are tantamount to “playing God” (Dabrock, 
2009; Akin et al., 2017), constituting acts that should 
not be pursued either because of one’s faith-based 
values, or due to risk of irrevocably perturbing complex 
natural systems seen to be outside of humanity’s control 
at present. Such values are most apparent, perhaps, 
regarding issues of species extinction (Sandler, 2012). 
For synthetic biology and biodiversity conservation, this 
is particularly relevant for questions regarding creation 
of proxies for extinct species (IUCN, 2016a; see Section 
5.3.2) and the rescue of species facing otherwise 
intransigent threats (see Sections 5.2 and 5.3.1). 
In pursuit of improving human health, a case has been 
made for putting into place methods that would cause 
deliberate species extinction – a subject that raises 
concerns among conservation biologists (Sandler, 
2012). Extinction of Anopheles gambiae could in 
theory be seen as a logical endpoint if gene drive 
approaches for malaria control prove effective (Case 
study 6). Such deliberate extinction would, however, 
be unprecedented; despite initial enthusiasm regarding 
destruction of laboratory stocks of Variola smallpox 
(Arita, 1980), many specialists now concur that retention 
of these is appropriate (Koplow, 2004; Weinstein, 
2011). However, no agency has stated extinction of 
Anopheles gambiae as a goal of suppression gene drive 
approaches for malaria control (Case study 6), and this 
would in any case be highly unlikely in the wild (Eckhoff 
et al., 2017) or in ex situ settings, given the number 
of populations maintained in laboratories around the 
world (https://www.beiresources.org/MR4Home.aspx).
On the other hand, some researchers and ethicists 
propose a utilitarian perspective on synthetic biology 
(Smith, 2013), in which ethical issues surrounding the 
application of synthetic biology are considered in the 
light of the potential beneficial outcomes for humanity. 
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For example, concerning the use of an engineered 
gene drive to control malaria (Case study 6), ethicists 
have weighed the moral arguments against modifying 
a mosquito species with the moral arguments for 
developing a new tool that could positively impact 
the caseload of clinical malarial disease (Pugh, 2016; 
Zoloth, 2016). These utilitarian perspectives also 
inform concerns about a “slippery slope;” that is, 
once a certain technology is accepted it may lead 
to new technologies or new options that would 
not have been acceptable had they been foreseen 
at the time of the initial decision (Smith, 2013). 
1.6 Size and expansion 
of synthetic biology 
funding and markets
Synthetic biology is attracting significant funding from 
both the public and private sectors. Several reports 
have tracked investment in synthetic biology. A 2015 
report from the Woodrow Wilson Center estimated that 
US research agencies have invested ~US$ 820 million 
in public funding (WWC, 2015). Less than 1 per cent of 
the total US funding was focused on risk research and 
approximately 1 per cent addresses ethical, legal and 
social issues (WWC, 2015). Since 2012, the majority of 
US funding has come from its military funding agencies, 
which have created multiple programmes around 
synthetic biology that could have research impacts 
for conservation (WWC, 2015). For example, the US 
Defense Advanced Research Projects Agency (DARPA) 
has developed programmes such as Living Foundries 
(DARPA, 2018c), Biological Robustness in Complex 
Settings (DARPA, 2018a), Safe Genes (DARPA, 2018d), 
Insect Allies (DARPA, 2018b), and in late 2016, issued 
a call for proposals to develop ecological niche-
preference engineering technologies, which would 
“enable the genetic engineering of an organism’s 
preference for a niche (e.g., temperature, range, food 
source, and habitat)” in order to lessen their “economic, 
health, and resource burdens” (DARPA, 2016). 
Total European public research funding was estimated 
at €450 million between 2007–2014 (ERASynBio, 
2014). While exact funding amounts are difficult to 
estimate, China began to invest in public research in 
synthetic biology through its Ministry of Science and 
Technology, with additional funding from the National 
Natural Science Foundation of China and other 
governmental research and technology programmes 
starting towards the end of the 2000s (Shapira, Kwon & 
Youtie, 2017). In 2018 Singapore launched a synthetic 
biology research and development programme (Ong, 
2018). A recent analysis of global markets by BCC 
Figure 1.4 Growth in funding for synthetic biology companies. Adapted from Synbiobeta, 2018.
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Figure 1.5 Increase in synthetic biology publications. Adapted from Shapira et al., 2017.
Figure 1.6 2018 iGEM Team Map (iGEM, 2018). The iGEM competition brings together students from universities, high schools and 
community biotech labs to give them the opportunity to explore synthetic biology. Each dot represents a team or cluster of teams. 
Multidisciplinary groups work together to design, build, test and measure a system of their own design using interchangeable biological 
parts and standard molecular biology techniques. Every year nearly 6,000 people participate in iGEM and then come together in the fall to 
present their work and compete at the annual Jamboree. 
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Research suggests that in 2017 the global synthetic 
biology market was valued at US$ 4.4 billion and is 
expected to grow to US$ 13.9 billion by 2022 (Globe 
Newswire, 2018). Private investment appears to be 
growing rapidly. In 2016 over US$ 1 billion was invested 
in synthetic biology companies, fuelling their rapid 
growth (Figure 1.4). Figure 1.5 shows the rapid increase 
in the funding for synthetic biology publications over 
recent years, and Figure 1.6 shows that the interest 
in synthetic biology is becoming globally distributed. 
No data have been traced on the volume of funding 
for synthetic biology from civil society, including from 
conservation NGOs, but it is likely relatively small 
compared to government and industry investment.
1.7 Reports on
synthetic biology
Given the funding in synthetic biology it is no surprise 
that there has been a large number of reports 
that examine the impacts of synthetic biology and 
engineered gene drive systems produced by various 
governments’ agencies, think tanks and NGOs (Haseloff 
Lab, 2018). A sampling of those reports can be found 
in Table 1.1. These reports represent a broad set of 
governmental and non-governmental interests and 
approaches to the field and indicate the extensive 
consideration that synthetic biology has generated.
Table 1.1 Sample reports examining the impacts of synthetic biology and gene drive systems. For a comprehensive list see Haseloff
Lab (2018).  
Organisation
Friends of the Earth, 
Centre for Technology 
Assessment and ETC Group
Wildlife Conservation Society
European Commission 
- GEST
UN Secretariat of 
the Convention on 
Biological Diversity
German Office of 
Technology Assessment
UN Secretariat of 
the Convention on 
Biological Diversity
Dutch National 
Institution for Health and 
Environment (RIVM)
German Committee of 
Biological Safety
2012
2013
2014
2015
2015
2015, 2018
2016
2016
Principles for the oversight 
of Synthetic Biology
How will Synthetic Biology and 
conservation shape the future of nature?
Ethics Debates on Synthetic 
Biology in the Three Regions
Synthetic Biology - CBD 
Technical Series No. 82
Synthetic Biology - the next phase of 
biotechnology and genetic engineering
Report of the Ad Hoc Technical 
Expert Group on Synthetic Biology
Gene drives: Policy Report
“Position statement of the ZKBS on 
the classification of genetic engineering 
operations for the production and 
use of higher organisms using 
recombinant gene drive systems”
Date released Topics
Governance, risk 
assessment
Synbio and 
conservation
Ethics
Risk/benefits
Risk assessment
Risks/benefits
Gene drive 
systems
Gene drive 
systems
Hoffman, Hanson & 
Thomas, 2012)
(Redford et al., 2013)
(Stemerding et al., 
2014)
(Scott et al., 2015)
(Sauter et al., 2015)
(Ad Hoc Technical 
Expert Groups on 
Synthetic Biology, 
2015, 2018)
(Westra et al., 2016)
(GCCBS, 2016)
Title Reference
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Organisation
Organisation for 
Economic Co-operation 
and Development
US National Academies 
of Sciences, Engineering, 
and Medicine
Australian Academy 
of Science
European Academies of 
Science Advisory Council
US Environmental 
Protection Agency
US National Academies 
of Sciences, Engineering, 
and Medicine
UN International Treaty on 
Plant Genetic Resources 
for Food and Agriculture
BBSRC-GCRF OpenPlant-
Earlham Foundry
African Union
OECD Working Party 
on Biotechnology, 
Nanotechnology 
and Converging 
Technologies (BNCT)
US National Academies 
of Sciences, Engineering, 
and Medicine
2016
2016
2017
2017
2017
2017
2017
2017
2018
2018
2018
OECD Science, Technology 
and Innovation Outlook
Gene Drives on the Horizon: Advancing 
Science, Navigating Uncertainty, and 
Aligning Research with Public Values
Synthetic Gene Drives in Australia: 
Implications of Emerging Technologies
Genome Editing: Scientific 
opportunities, public interests and 
policy options in the European Union
2017 Update to the Coordinated 
Framework for the Regulation 
of Biotechnology
Preparing for Future Products 
of Biotechnology
Potential implications of new synthetic 
biology and genomic research 
trajectories on the International Treaty 
for Plant Genetic Resources for Food 
and Agriculture (ITPGRFA or “Treaty”)
Capacity Building for the 
Bioeconomy in Africa
Gene Drives for Malaria Control 
and Elimination in Africa
Gene editing in an international 
context: Scientific, economic and 
social issues across sectors
Biodefense in the Age of 
Synthetic Biology
Date released Topics
Research 
trajectories, 
investment
Risk assessment 
of gene drive 
systems
Risk assessment 
of gene drive 
systems
Genome editing
Governance
Governance, 
products, horizon 
scanning
Digital sequence 
information
Capacity 
building, 
technology 
transfer, access
Gene drive 
systems
Gene editing
Biosecurity
(OECD, 2016)
(NASEM, 2016a)
(AAS, 2017)
(EASAC, 2017)
(US EPA, 2017)
(NASEM, 2017b)
(Welch et al., 2017)
(UK BBSRC, 2017)
(NEPAD, 2018)
(Shukla-Jones, 
Friedrichs & 
Winickoff, 2018)
(NASEM, 2018)
Title Reference
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1.8 International deliberations 
It is not just reports that have examined the field. 
Various international treaties and organisations 
are currently examining the impacts of synthetic 
biology and engineered gene drive systems on 
their respective agreements. Table 2.1 presents 
these in detail, but in summary they are: 
• Convention on Biological Diversity (CBD). Since 
2010, the CBD has discussed whether synthetic 
biology should be classified as a new and emerging 
issue. An assessment of synthetic biology against 
the CBD’s new and emerging criteria was carried 
out; however, no definite conclusion was reached. 
Both the twelfth Conference of the Parties (COP12) 
and COP13 produced decisions seeking a more 
robust assessment of synthetic biology against 
the Convention’s new and emerging criteria but 
this assessment has yet to be completed. Defining 
synthetic biology as such would officially state that 
it “needs urgent attention by the Subsidiary Body 
on Scientific, Technical and Technological Advice” 
[IX/29 2003], potentially developing new guidance 
and risk assessments on how synthetic biology 
and its applications (separate from LMOs) could be 
utilised in the future by a member state. Decision 
XII/24 (Secretariat of the Convention on Biological 
Diversity, 2015) established an Ad Hoc Technical 
Expert Group on Synthetic Biology that has 
produced multiple reports and recommendations 
but which has not yet undertaken the robust 
assessment against the new and emerging criteria 
as mandated by the COP (Ad Hoc Technical 
Expert Groups on Synthetic Biology, 2015, 
2018). Current deliberations are also considering 
whether or not synthetic biology, including 
engineered gene drive, would fall under the 
definitions of Living Modified Organisms and thus 
be subject to the risk assessment requirements 
of the Cartagena Protocol CBD/SYNBIO/
AHTEG/2017/1/3. These deliberations continue. 
• Nagoya Protocol. In 2017 the Secretariat of 
the CBD commissioned a report examining the 
impacts of digital sequence information as it 
relates to the Nagoya Protocol on Access to 
Genetic Resources and the Fair and Equitable 
Sharing of Benefits Arising from their Utilization 
(ABS) to the Convention on Biological Diversity 
(Wynberg and Laird, 2018). An Ad Hoc Technical 
Expert Group was also established to provide 
recommendations for member states on those 
impacts and a draft decision was submitted 
with vast disagreements (CBD/SBSTTA/22/
CRP.10, 2018). These deliberations continue. 
• Food and Agricultural Organization of the United 
Nations (FAO). In 2017 the International Treaty 
on Plant Genetic Resources for Food and 
Agriculture commissioned a report to examine 
the impacts of synthetic biology and digital 
sequence information on the Plant Treaty (Welch 
et al., 2017). These deliberations continue.
• Convention on International Trade in Endangered 
Species of Wild Fauna and Flora (CITES). CITES 
has engaged in a discussion on the question 
of synthetic products that are indistinguishable 
from products from listed specimens and the 
status of modified organisms and products 
under the convention [Decisions 17.89 to 
17.91, 2016; SC69 Doc. 35, 2017].
Similar deliberations have been underway in IUCN, 
which, through this assessment, has commissioned 
a broad assessment of the current state of science 
and policy related to these questions and to identify 
applications and products that might positively and 
negatively impact conservation and the sustainable 
use of biological diversity. As such, this assessment 
addresses mandates established at the 2016 IUCN 
World Conservation Congress: “Development of IUCN 
policy on biodiversity conservation and synthetic 
biology” (WCC-2016-Res-086), which calls on the 
Director General and IUCN Commissions to:
examine the organisms, components and products 
resulting from synthetic biology techniques 
and the impacts of their production and use, 
which may be beneficial or detrimental to the 
conservation and sustainable use of biological 
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diversity and associated social, economic, 
cultural and ethical considerations; and to
assess the implications of Gene Drives and 
related techniques and their potential impacts 
on the conservation and sustainable use of 
biological diversity as well as equitable sharing 
of benefits arising from genetic resources;
Figure 1.7 situates these mandates within the 
broader context of IUCN. The Union’s membership of 
governments and non-governmental and indigenous 
peoples’ organisations approved the Resolution, 
triggering this assessment process. The delivery of 
the first four operative paragraphs of the Resolution 
falls under the mandate of the IUCN Commissions 
and Director General. This report seeks to deliver 
the assessment elements of the first two operative 
paragraphs; it has been supported by resource 
mobilisation (Acknowledgements), and will be 
finalised based on peer review (Section 3.4.6). Further 
to the completion of the assessment, the other 
mandates from the Resolution will be addressed 
through the development of a draft IUCN policy 
on synthetic biology and biodiversity conservation, 
under the mandate of the IUCN Council (Section 
7.2). Ultimately, the success of the process should 
be measured by the uptake of both the assessment 
and resulting policy across society at large.
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Figure 1.7 IUCN process for developing a policy on synthetic biology and biodiversity conservation.
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Understanding the potential implications of 
synthetic biology for conservation and sustainable 
use of biological diversity entails examination of 
the existing governance frameworks applicable 
to this area, as well as the special governance 
challenges raised by synthetic biology, 
including engineered gene drive systems.
This chapter first describes principles relevant to 
governance of synthetic biology. It then assesses 
existing governance frameworks and tools applicable 
to synthetic biology, including international and 
national law, indigenous, customary and religious 
governance, and governance by industry and 
communities of practice. Finally, it discusses challenges 
raised by synthetic biology, including challenges 
associated with synthetic biology techniques 
and practices as well as challenges in engaging 
with different communities and perspectives.  
2.1 Principles
This section highlights principles relevant to the 
governance of synthetic biology that have featured 
in the discourse: the precautionary principle; the 
principle of state sovereignty and state responsibility; 
principles of access to information, participation 
and access to justice in decision making; principles 
associated with indigenous peoples’ rights to self-
determination and free prior informed consent; and 
principles of inclusivity and non-discrimination. This 
is not an exhaustive list of principles, but a selection 
of principles that appear frequently in ongoing 
governance discussions on synthetic biology.
2.1.1 Precautionary principle/approach 
Scientific uncertainty is a persistent characteristic 
of environmental governance. The precautionary 
principle or approach provides a tool for addressing 
uncertainty in decision making (Wiener & Rogers, 2002; 
Peterson, 2006). As formulated in the Rio Declaration 
on Environment and Development, it states:
 Where there are threats of serious or irreversible 
damage, lack of full scientific certainty shall 
not be used as a reason for postponing cost-
effective measures to prevent environmental 
degradation  [Rio Declaration, Principle 15].
This has been reformulated in the preamble of the 
Convention on Biological Diversity, which reads:
Where there is a threat of significant reduction or loss 
of biological diversity, lack of full scientific certainty 
should not be used as a reason for postponing 
measures to avoid or minimize such a threat.
The CBD has been ratified by 196 states, with the 
exception of the United States (Table 2.1). Precaution 
has been referenced in the preamble of the Cartagena 
Protocol and applied in the articles relating to decision-
making procedures. CBD COP Decision XI/11 explicitly 
applies the approach to synthetic biology, stating:
Recognizing the development of technologies 
associated with synthetic life, cells or genomes, and 
the scientific uncertainties of their potential impact 
on the conservation and sustainable use of biological 
diversity, urges Parties and invites other Governments 
to take a precautionary approach, in accordance with 
the preamble of the Convention and with Article 14, 
when addressing threats of significant reduction or loss 
of biological diversity posed by organisms, components 
and products resulting from synthetic biology, in 
accordance with domestic legislation and other relevant 
international obligations [CBD Decision XI/11 para. 4].
In November 2018, the CBD COP further called 
upon Parties to apply a precautionary approach with 
regard to engineered gene drives [COP/14/L.31].
Precaution as a legal requirement is multiform 
and controversial (Marchant, 2003). It has been 
incorporated into international instruments as well 
as national constitutions and laws (Fisher, Jones 
and von Schomberg, 2006; Hanson, 2014). The 
European Union (EU), for example, has elaborated 
guidelines on application of the precautionary 
principle which include a preliminary evaluation 
of risks and uncertainties to determine when the 
principle is triggered [EU, 2000]. Other countries, like 
the United States, have not explicitly included the 
precautionary principle in their legal system and have 
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resisted codification of the principle in international 
treaties, though in practice they may still have 
adopted measures to manage risk in the context of 
uncertainty (Hammitt et al., 2005; Hanson, 2014).
While the principle has not yet achieved the status 
of an international customary rule, it is accepted 
as an “approach” that guides the interpretation 
of existing treaty or customary rules (Birnie, 
Boyle & Redgwell, 2009, p. 163). Whether as 
a binding principle or approach, there is wide 
agreement that precaution includes the following 
core elements (Wiener, 2018, p. 179):
1. a threat of serious or irreversible or 
catastrophic risk or damage; 
2. a stance on knowledge, providing that 
scientific uncertainty about such risks 
does not preclude policy measures; 
3. a stance on timing, favouring earlier measures 
to anticipate and prevent the risk; 
4. a stance on stringency, favouring greater 
protection (such as prevention or burden-
shifting that prohibits risky activities until they 
are shown to be safe or acceptable); and 
5. a qualifying stance on the impacts of the 
precautionary measures themselves, calling for 
them to be cost-effective or weigh costs and 
benefits, and to be provisional and hence involve 
reassessment and improvement over time as 
knowledge is gained (Wiener, 2018, p. 179).
As detailed in Chapters 5 and 6, applications of 
synthetic biology carry risk that is uncertain and 
potentially irreversible, making the precautionary 
principle or approach applicable. There is no consensus 
on what this means in terms of regulatory measures. 
Some proponents of synthetic biology claim that some 
or all of the new techniques should be exempted 
from current genetically modified organism (GMO) 
regulation, while others insist that all techniques 
should be covered by administrative oversight, which 
may allow for some simplified procedures (ENSSER, 
2017). Some civil society and scientific organisations 
have argued that the precautionary principle or 
approach necessitates a “moratorium on the release 
and commercial use of synthetic organisms, cells, or 
genomes until government bodies, with full participation 
of the public” have conducted assessments and 
developed international oversight mechanisms (Friends 
of Earth (FOE), 2012; https://genedrivenetwork.
org/open-letter; http://www.etcgroup.org/content/
over-200-global-food-movement-leaders-and-
organizations-reject-gene-driveshttp://www.etcgroup.
org/content/over-200-global-food-movement-leaders-
and-organizations-reject-gene-drives). Others claim 
that a moratorium on synthetic biology could cripple 
the field and block potentially beneficial advances, 
while a more nuanced interpretation of the principle 
that allows for some, well-regulated risk, could help 
manage the tension between a desire for caution 
regarding the risk of intervention and worry about the 
risks of non-intervention (Wareham & Nardini, 2015). 
2.1.2 State sovereignty and state 
responsibility for international harm 
A basic principle of international law is that states have 
sovereignty over natural resources in their territory as 
well as responsibility for activities within their jurisdiction 
or control that cause damage to the environment of 
other states or areas beyond the limits of national 
jurisdiction [Stockholm Declaration 1972, Principle 
21]. State sovereignty provides the basis for states 
to make decisions regarding genetic resources and 
biological diversity within their territory. This includes 
decisions regarding access to genetic resources that 
states may subject to requirements for permits and 
benefit-sharing contracts or make freely available for 
access and utilisation (Section 2.2.4). State sovereignty 
also includes decisions relating to activities affecting 
natural resources in their territory, including decisions on 
introduction of modified organisms into the environment 
(Section 2.2.1). Many fora are working on regional and 
even global harmonisation of state-based standards for 
risk assessment and management (Tung, 2014).It has 
been argued, though, that a plurality of approaches may 
be more realistic and even preferable (Winter, 2016a).
States also have responsibility for transboundary harm. 
There is an international customary rule that a state 
must prevent and provide compensation for damage 
wrongfully caused from its territory to other states [ICJ 
Pulp Mills 2010]. The International Law Commission has 
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concretised the general rule by developing Draft Articles 
on Responsibility of States for Internationally Wrongful 
Acts, which provide an obligation to make reparation 
for “any damage, whether material or moral, caused 
by the internationally wrongful act of a State”[ILC 
Draft Articles 2001, art. 31].The obligation has been 
partly applied to biosafety issues by the Nagoya-
Kuala Lumpur Supplementary Protocol on Liability 
and Redress, which had only 42 Parties as of 2018.
In addition to the “ex post” liability approach, the 
principle of state responsibility for transboundary 
harm implicates an “ex ante” approach in the form 
of a responsibility to conduct environmental impact 
assessments where there is potential for significant 
transboundary adverse impact [ICJ Pulp Mills 2010; 
UNCLOS art. 206]. Depending on scope, this could 
apply in cases where synthetic biology or engineered 
gene drives cross boundaries. The Cartagena Protocol 
further stipulates that export of GMOs requires prior 
informed consent of the importing state. However, as of 
2018, some of the most active states in biotechnology 
are not among the 171 Contracting Parties of the 
Protocol, including the United States, Australia, Canada, 
Russia, Israel and Chile. Failure to comply with prior 
informed consent and EIA obligations would possibly 
qualify as a wrongful act in the sense of the international 
customary rule and Draft Articles described above.
Recognising the potential for harm in the absence of 
wrongful activities, the International Law Commission 
of the United Nations developed Draft Principles on 
the Allocation of Loss in the Case of Transboundary 
Harm Arising out of Hazardous Activities [2006], 
which would require states to impose strict liability 
on operators of hazardous activities, and require 
operators to have financial security, such as insurance, 
to cover compensation claims [ILC Draft Principles 
2006]. It is however open to debate whether synthetic 
biology could be considered a “hazardous activity” as 
understood by the Draft Principles (see Section 2.2).
2.1.3 Access to information, public 
participation and access to justice 
in environmental matters 
Procedural norms of good governance apply to 
decision making on activities related to or potentially 
impacting biodiversity and the natural environment. 
These include three key components: access to 
information; public participation in decision-making 
processes; and access to justice [SDG 16; Rio 
Declaration Principle 10]. These components have 
a long tradition in several legal systems, including 
the United States (Stewart, 2003). They were further 
elaborated in the Aarhus Convention on Access to 
Information, Public Participation in Decision-making 
and Access to Justice in Environmental Matters 
[1998]. The Aarhus Convention, while European in 
scope, provides guidance on interpretation of the three 
aspects, that have been recognised as globally relevant 
(Morgera, 2005). According to the Aarhus Convention, 
the principle of access to information requires that 
any person has the right of access to environmental 
information held by public authorities, including private 
actors with public functions, notwithstanding exceptions 
concerning the protection of privacy, trade secrets and 
certain public interests [Aarhus art. 4].The principle of 
public participation provides for a right of the public at 
large and particularly concerned persons to participate 
early in decision-making processes in relation to certain 
hazardous activities or environment-related plans, 
programmes and executive regulations [Aarhus arts. 
6-8]. The principle of access to justice in environmental 
matters states that any person – which includes any 
environmental organisation – who considers their rights 
violated or interests affected by an environmental 
decision has access to a court or other independent 
and impartial review procedure to challenge the 
substantive and procedural legality of the decision 
[Aarhus art. 9]. The Aarhus Convention explicitly 
applies these principles to matters related to genetically 
modified organisms [Aarhus art. 2(3)(a), art. 6(11)]. 
2.1.4 Peoples’ rights to self-
determination and free prior 
and informed consent 
Synthetic biology decision making can implicate rights 
of indigenous peoples and local communities in relation 
to natural resources and culture. The principle of self-
determination of peoples, recognised in the Charter 
of the United Nations, the International Covenant on 
Civil and Political Rights, the International Covenant 
on Economic, Social and Cultural Rights, entails a 
right to control over natural wealth and resources [UN 
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Charter art. 55; ICCPR art. 1; ICESCR art. 1]. The UN 
Declaration on the Rights of Indigenous Peoples and 
International Labour Organization (ILO) Convention 169 
elaborate the rights of indigenous and tribal peoples to 
participate in the use, management and conservation 
of resources pertaining to their lands. ILO Convention 
169 requires governments to “respect the special 
importance for the cultures and spiritual values of the 
peoples concerned of their relationship with the lands or 
territories, or both as applicable, which they occupy or 
otherwise use...” [ILO Convention 169 art. 14]. A series 
of international human rights cases have highlighted 
the special relationship between indigenous peoples 
and their traditional territory and resources and found 
that interference with rights of communities related 
to their natural resources can implicate the human 
right to culture [e.g. HRC “Lubicon Lake Band” 1984; 
IACHR “Awas Tingni” 2001; ACHPR “Endorois” 2009].
In practice, these rights are realised through procedural 
requirements for involvement of communities in decision 
making. The UN Declaration on Rights of Indigenous 
Peoples provides that indigenous peoples shall not 
be relocated from their lands or territories without 
their free, prior and informed consent [art. 10]. The 
concept of free prior and informed consent (FPIC) 
has been extended to apply to any decision making 
related to activities affecting the territory or natural 
resources of indigenous peoples or communities. For 
instance, financial institutions have included FPIC in the 
Equator Principles, a risk management framework for 
determining, assessing and managing environmental 
and social risk in projects (Amalric, 2005). Human 
Rights Tribunals have found that FPIC entails good 
faith and culturally appropriate consultation, sufficient 
sharing of information including environmental and 
social impact studies in advance of decisions, and 
appropriate monitoring [IACHR “Saramaka” 2007; 
ACHPR “Ogoni” 2001; IACHR “Maya” 2004].
Free, prior and informed consent has been largely 
discussed in the context of conservation for decisions 
impacting indigenous peoples and local communities. 
In its recent report, the CBD’s Ad Hoc Technical 
Expert Group on Synthetic Biology noted that “free, 
prior and informed consent of indigenous peoples 
and local communities, might be warranted in the 
development and release of organisms containing 
engineered gene drives” (Ad Hoc Technical Expert 
Group on Synthetic Biology, 2017, para. 25). The 
AHTEG also stated that the development of synthetic 
biology technologies “should be accompanied by the 
full and effective participation of indigenous peoples 
and local communities” (para. 26). In 2018, the CBD 
COP called upon Parties and other Governments 
to obtain, as appropriate, free, prior and informed 
consent or approval and involvement of potentially 
affected indigenous peoples and local communities 
as a prerequisite to introducing engineered gene 
drives into the environment, in accordance with 
national circumstances and legislation [COP/14/L.31
para. 9, 11].
2.1.5 Inter-generational equity 
and sustainable development 
Synthetic biology has potential benefits and adverse 
effects that could affect resource management 
and economic development now and for future 
generations. The concept of sustainable development 
is defined as development that “meets the needs 
of the present without compromising the ability of 
future generations to meet their own needs” (World 
Commission on Environment and Development, 1987). 
It recognises that economic and social development 
and environmental conservation are interdependent 
[Rio Declaration, Principle 4]. It is linked to the principles 
of intergenerational equity, which entails an obligation 
of stewardship of the natural environment for future 
generations, and intragenerational equity which 
emphasises the need to meet the basic needs of 
current generations across circumstances and regions 
(Brown Weiss, 1993; [ICJ Nuclear Test Case, 1995, 
Weeramantry dissenting; ICJ Gabcikovo-Nagymaros, 
1997, Weeramantry concurring; Minors Oposa, 1993]).
The Sustainable Development Goals (SDGs) adopted 
in 2015 provide globally agreed upon targets for 
alleviating poverty, ensuring food security, combating 
climate change and conserving biological diversity. 
Certain applications of synthetic biology are intended to 
provide a means for realising sustainable development 
goals. For example, applications to address invasive 
species could contribute to goals related to terrestrial 
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and marine conservation [SDGs 14 and 15], while 
applications addressing human disease vectors 
such as mosquitos support achievement of goals on 
human health and well-being as well as alleviation of 
poverty [SDGs 1 and 3]. At the same time, some of 
the risks associated with synthetic biology could affect 
attainment of these goals in a different way (see Section 
2.2). The potential benefits and risks of synthetic biology 
are discussed in more detail in Chapters 5 and 6.
2.2 Governance frameworks 
relevant to synthetic biology 
impacts on biodiversity
Synthetic biology engages existing normative 
systems, including legal, customary and industry 
systems, at the international, regional, national 
and subnational levels. These include frameworks 
governing risk assessment and management, 
liability for harm, intellectual property and ownership, 
and sharing of benefits. Table 2.1 provides a 
summary of relevant international legal regimes.
Many of the existing governance frameworks 
were developed in the context of “traditional” 
genetic engineering and may have to be revised in 
order to cope with challenges raised by synthetic 
biology (Wynberg & Laird, 2018). These challenges 
are addressed in depth in Section 2.3.
This section first explores international and national 
legal instruments and approaches in relation to risk 
assessment, liability, intellectual property, and access 
and benefit sharing. It then briefly discusses indigenous, 
customary and religious governance, followed by 
governance by industry and communities of practice. 
Table 2.1 International legal frameworks.
Instrument
Convention on Biological Diversity (CBD)
Adopted: 1992
Entered into force: 1993
Parties: 196
Cartagena Protocol on Biosafety to 
the Convention on Biological Diversity 
(Cartagena Protocol)
Adopted: 2000
Entered into force: 2003
Parties:171
Nagoya-Kuala Lumpur Supplementary 
Protocol on Liability and Redress to 
the Cartagena Protocol on Biosafety 
(Supplementary Protocol)
Adopted: 2010
Entered into force: 2018
Parties: 42
Nagoya Protocol on Access to Genetic 
Resources and the Fair and Equitable 
Sharing of Benefits Arising from their 
Utilization to the Convention on Biological 
Diversity (Nagoya Protocol)
Adopted: 2010
Global legal framework addressing 
conservation, sustainable use and 
sharing of benefits of biodiversity
Protocol to CBD intended to ensure 
the “safe transfer, handling and 
use of living modified organisms 
resulting from modern biotechnology 
that may have adverse effects on 
biological diversity...” (art. 1)
Supplementary Protocol to 
Cartagena Protocol intended to 
provide rules and procedures 
for liability and redress relating 
to living modified organisms
Protocol to CBD providing 
international framework for access 
to genetic resources and sharing of 
benefits arising from their utilisation
Relevance for synthetic biology
Creates obligations for each Party to 
manage risks associated with living modified 
organisms that could have a negative 
impact on biological diversity (art. 8(g)) and 
framework for access and benefit sharing 
relating to genetic resources (art. 15).
Requires sharing of risk related information 
between exporting and importing Parties 
and provides guidelines on methodology 
for environmental risk assessments and 
considerations in decision-making.
Provides for national frameworks requiring 
response measures and assigning civil 
liability in event of damage resulting from 
living modified organisms which find their 
origin in transboundary movement.
Applies to genetic resources that serve 
as source material for synthetic biology 
research. Creates ABS framework 
based on traceability and transfer of 
material that could be undermined by 
use of digital sequence information.
Description
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Entered into force: 2014
Parties: 105
International Treaty for Plant Genetic 
Resources for Food and Agriculture 
(ITPGRFA)
Adopted: 2001
Entered into force: 2004
Parties: 144
Agreement on Trade-related Aspects of 
Intellectual Property Rights (TRIPS)
Adopted: 1994
Entered into force: 1995 
Parties: 164
Convention on International Trade in 
Endangered Species of Wild Fauna and 
Flora (CITES)
Adopted: 1973
Entered into force: 1975
Parties: 183
UN Convention on the Law of the Sea
Adopted: 1982
Entered into force: 1994
Parties: 168
Convention on the Prohibition of Military 
or Any Other Hostile Use of Environmental 
Modification Techniques (ENMOD)
Adopted: 1976
Entered into force: 1978
Parties: 78
International regime recognising 
sovereign rights over plant genetic 
resources for food and agriculture, 
and establishing multilateral system 
to facilitate access to and sharing 
of benefits from listed plants
WTO Agreement defining 
obligations to grant and respect 
patents, including exceptions 
for patenting of plants, animals 
and biological processes
Multilateral Environmental 
Agreement establishing regulations 
and permitting system covering 
trade in listed species
Codification of law of the sea 
including activities and resources in 
areas beyond national jurisdiction
Multilateral instrument prohibiting 
use of military or hostile 
environmental modification 
techniques having widespread, 
long-lasting or severe effects
Creates ABS system that could be 
undermined by new techniques using 
digital sequence information that enable 
development of new plant varieties without 
access to the original genetic material.
Provides forum for ongoing discussions 
on patentability of genetic resources.
Hosts discussions related to 1) synthetic 
products that substitute or resemble products 
from a CITES listed species in international 
trade; and 2) status of genetically modified 
species and “de-extinction” under CITES.
Provides basis for ongoing negotiation 
of international agreement on marine 
biodiversity in areas beyond national 
jurisdiction, including sharing of benefits 
from marine genetic resources.
Potentially applies to military use of 
synthetic biology techniques with potential 
to significantly modify ecosystems.
Instrument Relevance for synthetic biologyDescription
2.2.1 Risk assessment and regulation
Most countries have national regulatory frameworks 
for risk assessment and management in relation 
to genetically modified organisms. The Cartagena 
Protocol requires Parties to “establish and maintain 
appropriate mechanisms, measures and strategies to 
regulate, manage and control risks” connected with the 
use, handling and transboundary movement of living 
modified organisms (LMOs), including “possible adverse 
effects of living modified organisms on the conservation 
and sustainable use of biological diversity” [Arts. 15, 
16]. Where LMOs are intended for introduction into 
the environment, the decision to allow import must 
be based on a risk assessment and apply precaution 
[Arts. 7, 10(6), 15]. Annex III of the Protocol outlines the 
methodology of risk assessment, including identification 
of potential adverse effects, evaluation of the likelihood 
of the effects, evaluation of the consequences of 
the effects and estimation of overall risk. It also lists 
points to consider, including the characteristics of the 
recipient or parental organism, the donor organism, 
the vector and the insert or modification, as well as 
a comparison of the unmodified with the modified 
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recipient or parental organism. National biosafety 
regulation may provide that certain activities require 
prior authorisation or notification, containment 
procedures or other forms of administrative oversight.
The Cartagena Protocol has 171 Parties, but was not 
ratified by several countries active in biotechnology, 
as discussed above. Nonetheless, many countries 
have biosafety legislation in place that fully or partly 
follows the risk assessment framework outlined in 
the Protocol. A search of the CBD Biosafety Clearing 
House and the ECOLEX legal database found 131 
countries with national laws on risk assessment 
and management (Figure 2.1). This includes 
countries such as the United States, Canada and 
Argentina that are not Parties to the Protocol.
National risk management legislation applicable 
to synthetic biology may include a range of legal 
instruments addressing different sectors and products. 
In addition to specific biosafety regulations, this may 
include legislation covering plant-breeding, food and 
drug safety, pesticides, toxic substances, sanitary and 
phytosanitary measures, and environmental protection. 
Some countries may have multiple laws that potentially 
cover synthetic biology products, as discussed below.
2.2.1.1 Scope of application 
of regulatory oversight
At COP13 in Mexico in 2016, the CBD Parties noted 
that it is not clear whether or not some organisms 
of synthetic biology would fall under the definition of 
LMO under the Cartagena Protocol [COP13 Decision 
17, para. 7]. They stated that the Cartagena Protocol 
and existing biosafety frameworks provide a starting 
point for addressing synthetic biology but may need 
to be updated and adapted for current and future 
developments and applications, and directed the 
Synthetic Biology AHTEG to continue deliberating on 
the matter [COP13 Decision 17, para. 6]. In 2017, the 
AHTEG concluded that “most living organisms already 
developed or currently under research and development 
through techniques of synthetic biology, including 
Figure 2.1 Countries with national laws on risk assessment and management related to genetically modified organisms. This map shows 
only those countries whose laws show up in the CBD Biosafety Clearing House or ECOLEX legal database. Lack of inclusion on this map 
does not mean that the country has no biosafety regulation. Adapted from CBD Biosafety Clearing House; ECOLEX.
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organisms containing engineered gene drives, fell under 
the definition of LMOs as per the Cartagena Protocol” 
(Ad Hoc Technical Expert Group on Synthetic Biology, 
2017, para. 28). In November 2018, CBD COP14 
extended the AHTEG, and emphasised the need for 
case-by-case risk assessments before organisms 
containing engineered gene drives are considered 
for release into the environment and recognised 
that specific guidance on such risk assessment 
could be useful [COP/14/L.31 para 9(a), 10].
National regulatory regimes take different approaches 
in addressing scope of applicability. These are 
often discussed in terms of “product” or “process” 
approaches. A “product” approach means that 
oversight is triggered by certain characteristics of 
products that are considered to pose a risk, no matter 
by what processes the product was generated, where 
a “process” approach means that the product that is 
subject to oversight is defined by the process of its 
generation. The United States, Argentina, Canada, the 
Philippines and Bangladesh have been categorised as 
having product-based approaches, while Brazil, India, 
China, Bolivia, Australia, Burkina Faso, the EU and New 
Zealand have been counted as process-based (Ishii & 
Araki, 2017). In reality, product-based approaches to 
regulation often rely upon process-based distinctions, 
and process-based approaches often consider a 
combination of product and process-based factors. 
The usefulness of the product/process dichotomy 
has therefore been questioned (Kuzma, 2016).
The United States applies what is frequently considered 
a product approach under the Plant Protection Act 
(PPA), Federal Insecticide, Fungicide and Rodenticide 
Act, the Federal Food, Drug and Cosmetics Act, 
and the Toxic Substances Control Act (Bergeson 
et al., 2015). However, in some cases agencies 
may consider process in their decision making. For 
example, applications for permits for introduction of 
genetically modified plant pests require a “detailed 
description of the molecular biology of the system 
(e.g., donor-recipient-vector) which is or will be used 
to produce the regulated article” [US 7 CFR 340.4] 
(Kuzma, 2016). The Toxic Substances Control Act 
applies to genetically modified micro-organisms defined 
as “intergeneric” but not physically or chemically 
mutagenised micro-organisms (Wozniak et al., 2013). 
Likewise, the Food and Drug Administration (FDA) 
regulates genetically engineered animals under the 
“new animal drug” provisions of the Federal Food, 
Drug and Cosmetics Act, considering manufacturing 
methods and facilities in its review process (FDA, 
2017b). There have been claims that the combination 
of product and process approaches can open the door 
for industry to lobby for whichever approach suits their 
interest. According to Kuzma, “[i]ronically the same 
GE developers who once claimed that the process of 
GE does not matter for regulatory purposes are now 
arguing that changes to the engineering process justify 
looser regulatory scrutiny” (Kuzma, 2016, p. 166).
Canada likewise bases its regulatory approach on 
the characteristics of genetically modified products, 
embedded within its overall framework for regulating 
“novel products.” The trigger for regulatory review of 
products intended for introduction into the environment 
is “novelty,” whether it derives from genetic modification 
or other techniques, though the determination of 
“novelty” may entail process considerations (Montpetit, 
2005; McHughen, 2016). For example, the Food 
and Drug Regulations define “novel food” to include 
“a food that is derived from a plant, animal or micro-
organism that has been genetically modified such that 
… one or more characteristics of the plant, animal or 
microorganism no longer fall within the anticipated 
range for that plant, animal or microorganism” [Canada 
Food and Drug Regulations B.28.001]. The Seeds 
Regulations define “Novel Trait” as one that “is not 
substantially equivalent, in terms of its specific use 
and safety both for the environment and for human 
health, to any characteristic of a distinct, stable 
population of cultivated seed of the same species in 
Canada” [Seeds Regulations 107(1)].The “substantial 
equivalence” test has raised criticisms of ambiguity 
and susceptibility to regulatory capture (Moran, Ries 
and Castle, 2009). Others have lauded the “novelty” 
trigger as more practical and scientifically sound than 
other regulatory approaches (McHughen, 2016).
In contrast, the EU applies what is considered a 
process approach, under which the process of genetic 
modification of an organism is the main trigger for 
oversight. A genetically modified organism (GMO) is 
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defined as an organism “in which the genetic material 
has been altered in a way that does not occur naturally 
by mating and/or natural recombination” (2001/18/
EC Art. 2(2)). This definition implies that the application 
of the recombination technique must result in a 
changed organism, and hence in a modified product 
(Callebaut, 2015). Certain techniques are listed as 
being – among others – genetic modification. They 
are considered to include not only the transfer of 
genes between species (transgenesis) but also the 
reorganisation of genes within a species (cisgenesis) 
[ECJ Case 528/16, 2018, paras 27–38].
2.2.1.2 Regulatory stages and requirements
Most regulatory systems require prior authorisation 
for certain types of genetic engineering or release of 
GMOs into the environment. For activities considered 
to be low or negligible risk, notification or reporting 
obligations are used as a form of more lenient oversight. 
Synthetic biology applications are often subject to 
step-by-step or staged regulation and monitoring at 
different levels, from the laboratory to full deployment/
release of the organism through potentially other 
stages such as confined field trials (Figure 2.2). For 
example, EU Directive 2001/18 sets out a step-by-
step approach for introduction of a GMO into the 
environment, with evaluation of impacts on human 
health and the environment required at each step. Its 
preambular consideration 24 explains this as follows:
The introduction of GMOs into the environment 
should be carried out according to the ‘step by step’ 
principle. This means that the containment of GMOs is 
reduced and the scale of release increased gradually, 
step by step, but only if evaluation of the earlier 
steps in terms of protection of human health and the 
environment indicates that the next step can be taken.
Likewise, in Canada, plants with novel traits, including 
genetically modified plants, must go through multiple 
regulatory stages to be approved for environmental 
release. Stages include, as applicable: import 
(subject to permit); contained use in a laboratory or 
greenhouse (subject to biosafety guidelines); confined 
environmental release (subject to risk management 
conditions); unconfined environmental release (subject 
to risk assessment and management and monitoring); 
variety registration; and commercialisation ([http://
www.inspection.gc.ca/plants/plants-with-novel-
traits/eng/1300137887237/1300137939635]). 
Oversight tools typically distinguish between GMOs 
made or used in containment and GMOs released to 
the environment (Prabhu, 2009). For example, Japanese 
legislation distinguishes between “Type 1 Use” and 
“Type 2 Use” where “Type 2 Use” describes use where 
measures are taken to prevent release outside the 
facility, and “Type 1 Use” refers to all other use where 
such measures are not taken. Type 1 Use requires 
ministerial determination that the use will result in no 
adverse effect if the approved procedures are followed, 
while Type 2 Use requires confirmation of measures for 
containment [Japan, Act no. 97 of 2003, arts. 4–15].
In some cases, the areas where the GMO may be 
released are restricted. In the EU, even if a genetically 
modified plant was authorised for the EU market, 
the member states have powers to “opt out” and 
close areas and even the whole country to its release 
(Winter, 2016a) [2001/18/EC Art. 26b]. In addition, 
nature protection, seed protection and other laws may 
prevent the release of GMOs for specified areas. For 
instance, in an area under special nature protection the 
introduction of GMOs may be categorically excluded 
for reasons of maintaining GM free reference sites, 
or of preserving the pristine nature. In Germany and 
Figure 2.2 Typical stages in risk regulation applicable to synthetic biology.
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other states, farmers have agreed to declare regions 
as to be held GMO-free (GMO Free Europe, 2016).
2.2.1.3 Factors in assessing risks
In assessing risk, national decision makers may be 
legally required or allowed to take different factors 
into consideration. Many countries’ laws institute 
administrative bodies and provide them with broadly 
discretionary powers of oversight [see, e.g. (Saegusa, 
1999); Nordrhein-Westfalen Nature Protection Law s. 
54]. Other countries’ laws set out material yardsticks 
for oversight in an endeavour to bind administrative 
decision makers and provide legal certainty for 
operators [see, e.g. EU Directive 2001/18/EC, 
Article 4; German Genetic Engineering Act sec. 16]. 
Commonly, laws provide that impacts on human 
health and the environment are to be considered. 
In addition, some countries include socio-economic 
concerns as well as impacts on indigenous and local 
communities. Art. 26 of the Cartagena Protocol states:
The Parties, in reaching a decision on import under this 
Protocol or under its domestic measures implementing 
the Protocol, may take into account, consistent 
with their international obligations, socio-economic 
considerations arising from the impact of living modified 
organisms on the conservation and sustainable use of 
biological diversity, especially with regard to the value of 
biological diversity to indigenous and local communities.
There are many possible socio-economic considerations 
that could be relevant to biotechnology regulation, 
and the ways in which they are taken into account 
vary across countries (Ludlow, Smyth & Falck-Zepeda, 
2014). For example, there are arguments that use of 
biotechnology can drive change in agricultural practices, 
and even influence the change of whole regions 
from sustainable peasant agriculture to industrialised 
agriculture, as has been observed in Argentina and 
other countries (Robin, 2010). This type of socio-
economic impact could potentially be captured in 
systems like the EU, which considers impacts on 
cultivation, management and harvesting techniques.
In some countries, moral values are also considered 
in risk regulation. Poland, for instance, referred to 
religious beliefs of its population when prohibiting 
the cultivation of genetically modified plants, though 
bringing such plants onto the market was previously 
authorised by the Commission. The European 
Court of Justice found the reason not sufficiently 
substantiated [ECJ Case C-165/08, paras 57–59].
2.2.1.4 Weighing risks against benefits
Many risk assessment frameworks do not allow for 
analysis of benefits. Some legal systems, including 
that of the EU, have separate systems for risk 
assessment – which does not consider costs – and 
risk management – which can consider regulatory 
costs and other concerns, depending on the 
wording of the applicable law (Winter, 2016b).
 
The United States applies cost-benefit analysis in 
many, but not all, processes of environmental decision 
making. In reviewing pesticides, the US Environmental 
Protection Agency (EPA) considers economic, social 
and environmental costs to determine whether any 
adverse effects on the environment are “unreasonable” 
(NASEM, 2016b). Conversely, in determining safety 
of food additives, the FDA can only consider whether 
there is a “reasonable certainty of no harm,” and 
may not take into account other factors (NASEM, 
2016b). Cost-benefit analysis has been proposed 
as an alternative to the precautionary principle as 
a means for guiding decision makers and ensuring 
the best outcomes, taking into consideration all 
possible benefits and risks (Sunstein, 2005).
There are different methodologies for weighing 
risks and benefits. One example can be found in 
the EU chemicals regulation [1907/06 “REACH”]. 
According to Art. 60, an authorisation of marketing 
of a substance is possible, even if the substance is 
highly dangerous or considered not to be adequately 
controlled, “if it is shown that socio-economic 
benefits outweigh the risk to human health or the 
environment arising from the use of the substance 
and if there are no suitable alternative substances or 
technologies.” This is a type of risk-inclined approach, 
which allows benefits to outweigh any risk, even a 
serious one. Other systems are risk-averse, allowing 
only residual risks to be outweighed by benefits
(Winter, 2016b). 
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Those states that allow for the weighing of risks 
and benefits of products for synthetic biology must 
consider how to define benefits. The EU chemicals 
regulation suggests a broad range of concerns 
including economic interests of suppliers, employment, 
consumer demand, benefits for human health and the 
environment, etc. [Annex XVI of the REACH Regulation]. 
Other approaches would limit benefits to justifiable use 
values that are expressed in qualitative terms rather 
than through market prices or survey-based pricing 
(Ackerman & Heinzerling, 2004; Winter, 2018). 
The CBD COP in 2016 invited parties “in accordance 
with their applicable domestic legislation or national 
circumstances, to take into account, as appropriate, 
socio-economic, cultural and ethical considerations 
when identifying the potential benefits and potential 
adverse effects of organisms, components and 
products resulting from synthetic biology techniques in 
the context of the three objectives of the Convention” 
[CBD COP13 Decision 7, 2016]. The present study 
describes certain ways that synthetic biology can be 
intended to create benefits for biodiversity conservation 
and sustainable use (Chapter 5) and socio-economic 
benefits and benefits for human health (Chapter 6), 
as well as potential negative impacts. For example, 
the effect of a new product (such as “natural” vanillin 
produced through synthetic biology) on existing supply 
chains (such as vanilla supply chains in Madagascar) 
may have to be weighed against socio-economic 
benefits of synthetic production (Chapter 6).
Another component of risk-benefit weighing is the 
testing of alternatives, to determine which could achieve 
the intended benefit with lowest environmental risks. 
For example, in evaluating a proposal for modification 
of a mosquito to eradicate human malaria, decision 
makers would need to consider alternatives such 
as vaccination and use of pesticides. Under this 
concept, it would not be necessary to assess the 
value of human lives saved and compare them with 
the loss of biodiversity. It may suffice to examine which 
of the alternatives – the synthetic biology technique 
and the application of chemicals – have less harmful 
impacts on the environment (Winter, 2018).
2.2.1.5 Risk assessment methodologies
The methodology of risk assessment has a common 
structure throughout national systems, but differs 
somewhat in terms of depth and width of analysis 
(Paoletti et al., 2008). One of the most detailed 
examples is the EU Environmental Risk Assessment 
methodology (Box 2.1). Most risk assessment 
methodologies are based on two main components: 
(1) evaluation of intended and unintended effects, 
including probability and potential significance of the 
effects; and (2) comparison of the modified product 
with existing counterparts (Paoletti et al., 2008). In 
evaluating potential effects, decision makers can 
consider information relating to, inter alia, toxicity, 
persistence and gene transfer, and evaluate potential 
intended and unintended impacts on target and non-
target populations as well as associated social and 
cultural effects. The comparison of the modified product 
with counterparts is at the heart of risk assessment. 
Many countries exempt products from risk assessment 
where they have a history of safe use. Traditionally the 
comparison has been between modified and “natural” 
products, but as genetic modification becomes 
more common, the definition of “conventional” may 
change (Paoletti et al., 2008; Pauwels et al., 2013). 
Box 2.1
Environmental risk assessment in the EU
The environmental risk assessment (ERA) required by the 
EU Directive on deliberate release into the environment 
of genetically modified organisms is defined as “the 
evaluation of risks to human health and the environment, 
whether direct or indirect, immediate or delayed, which 
the deliberate release or the placing on the market of 
GMOs may pose and carried out in accordance with 
Annex II” [EU Directive 2001/18/EC, arts. 2(8), 4(2)]. In 
relation to agricultural plants a Guidance Paper of the 
European Food Safety Authority (EFSA) distinguishes 
between seven paths of possible impact (EFSA, 2010):
• Persistence and invasiveness of the GM 
plant, or its compatible relatives, including 
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plant-to-plant gene transfer
• Plant-to-microorganism gene transfer
• Interaction of the GM plant with target organisms
• Interaction of the GM plant with non-target organisms
• Impact of the specific cultivation, management 
and harvesting techniques2 
Under the EU regulations, different types of information are to 
be submitted and considered in risk assessment, including 
information on the molecular and cellular level, the organism 
and population level, and the ecosystem level, as well as 
• Effects on biogeochemical processes
• Effects on human and animal health
Each specific path must be examined following six steps 
of ERA [EU Directive 2001/18/EC Annex II sec. C.2].
technical information. The information must reveal how the 
donor organism differs from the recipient organism in terms 
of functions, reproduction, dissemination, survivability, etc. 
[EU Directive 2001/18/EC, Annex III]. 
Figure 2.3 Six steps in the EU environmental risk assessment. Adapted from Directive 2001/18/EC.
2.2.1.6 Monitoring
Legislation may provide for monitoring of regulated 
activities. The United States provides post-market 
oversight authority to multiple agencies in relation to 
biotechnology products. The FDA requires reporting 
from manufacturers and conducts post-market 
risk assessment and safety inspections in relation 
to animal drugs, foods and other biotechnology 
products (NASEM, 2017b). The EPA is required to 
re-evaluate pesticide products every 15 years, though 
in practice it has been re-evaluating biotechnology 
products every 5–6 years. In contrast, genetically 
engineered organisms that could act as plant-pest 
can be deregulated upon evidence that they are 
unlikely to pose a risk, in which case there is little 
follow-up monitoring or oversight (NASEM, 2017b).
Under EU law, monitoring requirements are different 
depending on whether a GMO is experimentally 
released into the environment, or if it is brought to the 
market with subsequent general release. In the latter 
case, for instance, the operator is obliged to comply 
with the authorisation conditions, and in particular with 
regard to the monitoring scheme, and to continuously 
report to the competent authority about unexpected 
2 An example for such effects on cultivation practices would include the change of whole regions from sustainable peasant to industrialised agriculture, as has 
for example been observed in Argentina (Robin, 2010). 
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incidents during the market placement or release into 
the environment, be it through case specific or general 
observations. Likewise, the competent authority is 
obliged to supervise the monitoring and intervene in 
case of emergencies [EU Directive 2001/18/EC Article 
20]. It has however been found that the monitoring 
requirements are not well implemented in practice 
and need to be revised in order to produce more 
scientifically usable information (Züghart et al., 2011).
2.2.2 Liability
National and international legal systems may provide 
for liability for environmental damage attributable to 
synthetic biology. As described in Section 2.1.2, there is 
an international legal principle of state responsibility for 
international harm. However, there are few international 
frameworks that explicitly provide for liability – either 
on the part of states or on the part of operators – in 
the context of biosafety. The Nagoya-Kuala Lumpur 
Supplementary Protocol on Liability and Redress 
[Supplementary Protocol] to the Cartagena Protocol 
provides for states to establish national frameworks 
for liability in cases of environmental harm caused by 
living modified organisms. Under the Supplementary 
Protocol, Parties should require operators to take 
certain actions in the event of damage, including 
informing the competent authority, evaluating the 
damage, and taking reasonable actions to restore 
affected biodiversity [art. 2, 5]. Where the operator fails 
to take appropriate response measures, the competent 
authority may implement such measures and recover 
from the operator the associated costs. States should 
also provide for rules and procedures that address 
damage, including as appropriate, civil liability. Parties 
may apply existing general rules and procedures on 
civil liability and/or develop specific civil liability rules 
and procedures. In either case, under the Protocol they 
shall, as appropriate address (a) damage; (b) standard 
of liability (strict or fault-based); (c) channelling of liability; 
and (d) the right to bring claims. The Supplementary 
Protocol provides little in the way of binding obligations 
for civil liability, and has only 42 Parties to date.
European legal instruments apply a principle of 
strict liability, or no-fault liability, for damage to the 
environment resulting from certain dangerous activities. 
The European Convention on Civil Liability for Damage 
Resulting from Activities Dangerous to the Environment 
[Lugano Convention] imposes liability on the operator 
of a dangerous activity for any damage caused by the 
activity, regardless of fault [art. 6]. Dangerous activities 
are those which create significant risk for man, the 
environment or property, and include the production, 
storage, use disposal or release of genetically modified 
organisms [art. 2]. The EU Liability Directive applies 
strict liability to environmental damage caused by a 
set of listed activities “in order to induce operators to 
adopt measures and develop practices to minimise the 
risks of environmental damage so that their exposure 
to financial liabilities is reduced” [preambular para 2, 
art. 3(1)(a)]. Listed activities include: “Any contained 
use, including transport, involving genetically modified 
micro-organisms” and “Any deliberate release into the 
environment, transport and placing on the market of 
genetically modified organisms” [Annex III (10 and 11)]. 
In Tanzania, the 2009 Biosafety Regulations provide 
for strict liability in relation to GMOs, including 
synthetic organisms [§ 3]. The Regulations state:
Any person or his agent who imports, transits, 
makes contained or confined use of, releases, carries 
out any activity in relation to GMOs or products 
thereof or places on the market a GMO shall be 
strictly liable for any harm, injury or loss caused 
directly or indirectly by such GMOs or their products 
or any activity in relation to GMOs [§ 56(1)].
Damage to the environment or biological diversity is 
explicitly included as a type of harm covered by this 
provision [§ 56(2)]. In these cases, compensation 
includes the cost of restoration and the cost of 
preventive measures, where applicable [§ 56(4); 58]. 
It also applies to harm or damage caused to “the 
economy, social or cultural principles, livelihoods, 
indigenous knowledge systems, or indigenous 
technologies” [§ 59]. The Regulations require operators 
to take out a policy of insurance against liability [§ 35(1)].
Harm caused by synthetic biology could lead to 
civil liability under common law principles of tort, or 
civil law delict. For example, intrusion of modified 
organisms onto private property could give rise to 
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claims of nuisance or trespass (Strauss, 2012). In the 
United States and Canada, farmers have brought 
lawsuits against biotechnology companies alleging 
contamination of their fields with genetically modified 
crops which rendered their yield less valuable or 
made it impossible for them to achieve organic 
accreditation (Rodgers, 2003). To bring a tort suit 
alleging environmental harm from synthetic biology, 
claimants would need to show standing, causation 
and damage, as well as fault or strict liability. Each of 
these elements could be challenging in the context of 
synthetic biology. Where damage is to an environmental 
interest rather than a private person, it may be difficult 
to prove standing. Some of the potential damage 
from synthetic biology is extremely attenuated; even 
where it is possible to show “but for” causation, there 
may not be a sufficiently close causal link between 
the activity and the damage to show liability. Fault-
based liability may be difficult to prove and ineffective; 
if significant harm occurs despite best safety practices, 
the cost may lie with the state. Strict liability is typically 
reserved for particularly hazardous activities or activities 
listed in statute, and may not be available for harm 
caused by synthetic biology in many jurisdictions.
2.2.3 Intellectual property
There are differences in how countries deal with 
inventions and discoveries linked to genetic 
resources. These can promote or limit development 
or use of synthetic biology in conservation. While 
intellectual property decisions are made mainly 
at national and regional levels, international law, 
including bilateral treaties on trade and intellectual 
property, has played a role, e.g. through the 
harmonisation of patent and plant variety rights.
In general, industrialised countries allow the patentability 
of genes and gene sequences (Kumar & Rai, 2007). 
For example, in 1998, the EU harmonised patent law 
relating to biotechnological inventions and – though 
excluding the discovery of a gene or gene sequence 
from patentability – allowed for an isolated gene or 
gene sequence to constitute a patentable invention, 
if it met other patentability criteria. In the US, a recent 
Supreme Court decision found isolated genomic 
DNA not to be patentable, based on the law of nature 
exception to patentability [Association for Molecular 
Pathology v Myriad Genetics, Inc]. However, the 
Supreme Court maintained non-naturally occurring 
molecules may be patented, which may limit the 
impact of the finding in fields such as synthetic biology 
(Holman, 2014). Developing countries, for example 
in Latin America, tend not to allow the possibility of 
patenting genes and gene sequences (Bergel, 2015). 
For example, in Brazil, biological material, including 
the genome or germplasm of living organisms, found 
in nature or isolated therefrom, is not considered 
an invention [Industrial Property Law, art. 10].
Intellectual property in organisms, including genetically 
modified ones, are also treated differently by different 
states. While the United States provides for patent rights 
in plants and animals under certain conditions (Rimmer, 
2008), the EU allows patenting of microorganisms but 
excludes patenting of plant and animal varieties [EU 
Directive 98/44/EC Art. 4; Regulation (EC) 2100/94 
Art. 1]. In the EU, intellectual property in plant varieties 
is only possible in the form of plant variety protection. 
Farmers are allowed to further propagate their plants 
and develop new breeds (farmers’ and breeders’ 
exemptions) [Regulation (EC) 2100/94 Arts. 13 and 
14]. The EU does not provide for intellectual property 
rights in animals, so that in practice trade secrecy 
protection is used as a substitute [EU Directive 
98/44/EC Art. 4 (1) (1); Winter, 2016]. This means 
for products of synthetic biology that, for example, 
the malaria vector mosquito that is engineered to be 
non-reproductive (Case study 6) would be patentable 
in the United States but not in the EU; the engineered 
blight resistant chestnut (Case study 4) would be 
suitable for patent as well as plant variety protection 
in the US, but only for plant variety protection in the 
EU. Modified microorganisms would be patentable in 
both systems. Methods of plant and animal production 
are also suitable for patenting. This is however 
excluded in the EU if the processes are “essentially 
biological” [EU Directive 98/44/EC Art. 4 (1) (2)].
Proponents of intellectual property protection view 
it as a tool indispensable to promote innovation in 
synthetic biology (Calvert, 2012). J. Craig Venter, 
co-founder of Synthetic Genomics, views intellectual 
property as fundamental for “a vital and robust science 
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and biotechnology industry”(Nelson, 2014). Others 
in the field of synthetic biology worry about negative 
impacts of intellectual property and advocate for 
more open innovation, in line with experiences in 
engineering and computer science. For proponents 
of open innovation, intellectual property in the 
context of synthetic biology may create a “perfect 
storm” (Rai & Boyle, 2007). As in other fields, 
patents may be both too broad (e.g. foundational 
patents) and too narrow (e.g. patent thickets) that 
stifle innovation (Martin, 2008; Winter, 2016b). 
Openness in synthetic biology is often adopted also 
as a fundamental principle – though such principle 
is not always interpreted in the same way (Calvert, 
2012). Several initiatives are promoting the synthetic 
biology commons. For example, the iGEM Registry 
of Standard Biological Parts is a growing collection of 
genetic parts that can be accessed to build synthetic 
biology devices and systems (Section 6.6). This 
Registry is an open community with a “Get & Give (& 
Share)” philosophy. Users get parts, samples, data and 
tools – and give back the new parts they have made. 
They also share experiences in the open community.
Commentators have compared these efforts to 
the open-source software model, as an alternative 
to proprietary rights (Kumar & Rai, 2006). Unlike 
software, though, copyright does not apply to 
synthetic biology products. Moreover, the modularity 
of synthetic biology makes it difficult to mediate how 
its parts are shared and re-shared (Pottage & Marris, 
2012). As a result, the BioBricks Foundation, created 
in 2006, has developed tools such as BioBricks 
Public Agreement and OpenMTA, which facilitate 
access to synthetic biology parts as a public access 
resource, but impose no obligation on users to 
‘return’ derivative products to the common pool. 
This is due, in part, to uncertainties as to the existing 
ownership status of parts, but also to a recognition 
that different forms of property may not only coexist 
in synthetic biology, but also contribute to mutual 
flourishing (Calvert, 2012; Pottage & Marris, 2012).
In terms of intellectual property rights, synthetic biology 
has been characterised as a tug-of-war between 
open and proprietary approaches. It may be that such 
dichotomy is not so clear, but rather that tools such 
as the BioBricks Public Agreement and OpenMTA 
are leading to a “diverse ecology” of both proprietary 
and open systems (Calvert, 2012; Grewal, 2017). 
Such a system may see a role for patents, particularly 
for more complex inventions. As explained in Nature 
through a Lego analogy, “the bricks would be free but 
a design for a complex rocket ship made of hundreds 
of Lego pieces would be patentable”(Nelson, 2014).
Intellectual property may also be one of the tools 
used to safeguard synthetic biology commons. As 
products of synthetic biology do not have copyright 
protection, it may be possible to create patent-
based commons such as the one established by 
the group Biological Innovation for Open Society 
(BIOS). Cost may be a hindering factor (Kumar and 
Rai, 2006). Sui generis intellectual property systems 
may be developed, such as has been done for 
plant varieties, databases and – in some countries – 
traditional knowledge. Contracts may also be used 
to guarantee access to synthetic biology parts and 
– possibly after some time – to resulting products.
2.2.4 Access and benefit sharing
The CBD recognises that the sovereign rights of 
countries over natural resources extend to genetic 
resources, and access to such resources is subject 
to national authority and regulation. The Nagoya 
Protocol to the Convention on Biological Diversity 
affirms that these sovereign rights entail the right to 
regulate access to genetic resources and negotiate 
terms for the fair and equitable sharing of benefits 
from their utilisation. Both instruments recognise 
rights of holders of traditional knowledge associated 
with genetic resources to provide approval for and be 
involved in utilisation of such knowledge and to share 
in resulting benefits. These provisions are relevant 
to synthetic biology insofar as it is based on genetic 
resources accessed for their utilisation (UN CBD, 2015). 
Under the Nagoya Protocol, access to genetic 
resources should be based on prior informed consent 
and mutually agreed terms, subject to legislative 
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and regulatory requirements established by the 
countries where these resources are accessed. 
Many countries, including, for instance, the UK and 
Germany have decided not to introduce restrictions 
on access to their own resources, though, as 
described below, these countries have requirements 
on compliance with access rules in other countries. 
An increasing number of countries, however, have 
established national frameworks to regulate access 
to genetic resources within their territories.
Ownership of genetic resources is defined through 
national laws and regulations. Most countries that have 
introduced national frameworks for access and benefit 
sharing distinguish between biological resources, 
generally owned by private or public persons, and 
genetic resources, generally owned by the state 
[absch.cbd.int]. In some countries, such as in South 
Africa, the state is a trustee of biodiversity, but it does 
not have ownership over genetic resources, unless 
these resources occur in public land [South African 
National Environmental Management Biodiversity Act, 
2004]. The landowner or local communities in South 
Africa own both the biological and genetic resources 
on their property. Nevertheless, bioprospecting in 
South Africa requires not only prior informed consent 
from the owner of the land where plant material is 
collected, but also the competent authorities, and 
benefits arising from utilisation of genetic resources are 
channelled through the state [South African National 
Environmental Management Biodiversity Act, 2004, 
art. 3, 81, 85]. In both cases, access to genetic 
resources is predicated on permits from competent 
authorities and agreements for sharing of benefits. 
These requirements would apply to genetic resources 
accessed for the purpose of synthetic biology.
The Nagoya Protocol aims at ensuring compliance with 
provider state requirements through corresponding 
user state obligations. User states are obligated 
to take “appropriate, effective and proportionate 
legislative, administrative or policy measures” to ensure 
that researchers utilising genetic resources within 
their jurisdiction have accessed them in accordance 
with the provider state requirements [art 15]. Such 
requirements also apply to synthetic biology involving 
genetic resources obtained from a provider state.
Disclosure requirements in patent law provide a 
mechanism for ensuring compliance with ABS 
regulations, by requiring patent applicants to disclose 
the origin of genetic resources on which the invention 
was based, facilitating confirmation that ABS 
procedures were followed. A 2017 study published 
by the World Intellectual Property Organization 
found that over 30 countries have established 
specific disclosure requirements related to genetic 
resources and/or traditional knowledge for patent 
applications (WIPO, 2017). For example, Article 26 of 
the Chinese Patent Law requires that the applicant 
for a patent on an invention-creation accomplished 
by relying on genetic resources indicate the direct 
and original source of the genetic resources. Under 
the Chinese Patent Law, patent rights may not be 
granted for inventions that are accomplished by relying 
on genetic resources that are obtained or used in 
violation of the provisions of laws and administrative 
regulations [Chinese Patent Law, art. 26].
There is an ongoing negotiation on a new international 
agreement on marine biodiversity in areas beyond 
national jurisdiction, including questions of sharing 
of benefits from genetic resources originating in 
the high seas or the deep seabed [UNGA Res. 
72/249, 2017]. The implications of synthetic 
biology and associated tools such as digital 
sequence information have become part of
the discussion. 
Synthetic biology tools such as digital sequence 
information challenge ABS frameworks by impeding 
traceability, as discussed in Section 2.3.4. There are 
also questions of how to address benefit-sharing 
questions where inventions involve genetic elements 
from multiple organisms including organisms both 
within and beyond national jurisdiction, elements which 
are functionally identical in different organisms, and 
elements which are used in the research process but 
not found in the resulting invention (Bagley & Rai, 2013; 
Bagley, 2016). The global ABS mechanism is based on 
the premise that benefit sharing is an important incentive 
and source of funding for conservation. The challenges 
raised by synthetic biology could impact this intended 
contribution to conservation and sustainable use.
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Figure 2.4 Overlaps in normative systems. Adapted from Meinzen Dick and Pradhan, 2002.
2.2.5 Indigenous, customary 
and religious frameworks
Statutory frameworks are not the only sources of 
law relevant for synthetic biology. Legally binding 
norms and authorities governing research and use of 
synthetic biology can derive from religious, indigenous 
or customary systems. Multiple legal and normative 
systems may overlap in the same geographical space, 
Many countries formally recognise indigenous, 
customary or religious law as well as civil and common 
law in national legal systems. An IUCN analysis in 2011 
found that 60 per cent of the world’s countries have 
constitutional provisions relevant to customary law, 
ranging from provisions that protect cultural practices to 
provisions that define customary law and its legal weight 
(Cuskelly, 2011). In other countries, legal principles or 
norms from customary or religious systems can be 
incorporated into legislation. Indigenous or religious 
authorities can be legally granted exclusive or shared 
jurisdiction over specific territory or subject matter, 
or granted the right to participate in national decision 
making (Cuskelly, 2011). Even where non-statutory law 
is not formally recognised, it has legal weight within 
the communities and territories where it is practiced.
The CBD AHTEG has noted that customary law of 
indigenous peoples and local communities should be 
taken into account in implementing risk management 
measures for synthetic biology [CBD/SBSTTA/22/4, 
community or subject field (Figure 2.4; Meinzen-Dick 
& Pradhan, 2002). This legal pluralism is important for 
synthetic biology, as researchers, regulators and users 
of synthetic biology may be faced with a maze of legal 
rules from different sources. Failure to navigate these 
rules can result in violations that lead to conflict. 
2018, para. 47]. However, there have been few analyses 
of application of indigenous or customary law to 
synthetic biology or genetic engineering more broadly. 
Some of the most advanced research addresses Maori 
perspectives of synthetic biology and its products and 
processes. A recent report explored how moving genes 
between species, introduction of genes from non-
native species, extraction of genetic material from an 
organism and other practices associated with synthetic 
biology would have direct implications for Maori values, 
concluding that there are differing positions and 
interpretations, and that the perceived potential benefits 
of the technology may vary according to the intended 
use of the techniques (Mead, Hudson & Chagne, 2017).
Several groups of indigenous peoples have developed 
formal statements and declarations on the topic of 
genetic technologies. Many of these assert the right to 
free, prior and informed consent for research relating 
to their biological resources, and restrict patenting of 
such resources (Mead & Ratuva, 2007). The Statement 
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There has been some examination of the interaction 
between customary law and intellectual property 
aspects of biotechnology. While traditional knowledge 
is legally protected under the Nagoya Protocol, in 
practice legal frameworks for ABS and patenting of 
genetic material focus on statutory law and may exclude 
customary legal systems relating to property rights and 
the status of genetic resources (Vermeylen, 2010).
Synthetic biology has spurred active discussion by 
religious legal experts, raising questions ranging from 
whether modern biotechnology amounts to “playing 
God” to whether laboratory meat can be considered 
kosher or halal (Dabrock, 2009; Gross, 2014). While 
these discussions influence ethical perspectives on 
synthetic biology, as discussed in Section 2.3.9, they 
also relate to applicability of religious law to synthetic 
biology and constitute a form of governance separate 
from the role they play in influencing governance under 
statutory structures. In his 2015 Encyclical, Laudato Si, 
Figure 2.5 World legal systems. Adapted from a map by the University of Ottawa. 
Pope Francis called for “a broad, responsible, scientific 
and social debate” regarding genetic modification, 
which he characterised as a “complex environmental 
issue,” recognising both the potential benefits and the 
ethical questions (Francis, 2015). In 2010, the Church 
of Scotland produced a report finding that “synthetic 
biology does not put humanity on a par with God,” 
as synthetic biology techniques do not amount to “ex 
nihilo creation,” but should be guided by humankind’s 
special responsibility for the rest of creation under the 
doctrine of “Imago Dei” (Church of Scotland, 2010). 
The Catholic Commission of the Bishops’ Conferences 
of the European Union (COMECE) issued an opinion 
on synthetic biology in 2016, also finding that synthetic 
biology techniques do not amount to “playing 
God” and recognising the potential benefits arising 
from synthetic biology while calling for appropriate 
governance measures and public participation 
(COMECE, 2016; Heavey, 2017). These documents 
do not constitute sources of binding canon law, but 
of Bioethics Consultation from the Tonga National 
Council of Churches establishes the principle that 
“scientific and commercial advances should not be 
allowed to proceed past the deliberations necessary 
to provide for their social, moral and ethical control” 
(Tonga National Council of Churches, 2001).
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they do provide a sense of how the Catholic system 
may view synthetic biology activities and products.
Use of synthetic biology implicates religious law 
particularly in the context of food. Synthetic meat 
production could reduce land and water use, 
with positive benefits for conservation, but there 
are questions as to how such meat would fit into 
religious dietary systems (Wolinsky & Husted, 2015). 
Rabbis at Yeshiva University in Israel have argued 
that, depending on the circumstances, even artificial 
pig could be kosher, and could be eaten with dairy 
([https://www.ynet.co.il/articles/0,7340,L-5185466,00.
html]). Cultured meat could potentially also be 
halal, depending on the origin of the source cells 
and the medium used (Hamdan et al., 2018).
2.2.6 Governance by industry 
and communities of practice
Non-state actors can play an important role in 
regulating new technologies where the technologies 
develop rapidly, risks and benefits are uncertain, and 
there is a need for specialised knowledge (Abbot, 
2012). In relation to synthetic biology, there is a 
growing body of standards created and imposed by 
industry, researchers and communities of practice. 
The emerging private sector of synthetic biology uses 
so-called ‘soft’ standards, which can facilitate norms 
and behaviour within the sector, and impact how 
synthetic biology is perceived by the society (Parks et 
al., 2017). The soft standards applied by the industry 
are not binding or legally enforced; instead they rely on 
personal values and are often ‘borrowed’ from other 
relevant standards and more established industries, 
such as biotechnology and genetic engineering.
Scientists working on engineered gene drive 
applications have had numerous conversations on 
self-governance and good practices for safe and 
responsible research. In 2015, prominent engineered 
gene drive researchers working on different projects 
published recommendations for safeguards to 
contained experiments of engineered gene drive (Akbari 
et al., 2015). There are ongoing attempts to organise 
a more formal coordination of researchers working 
on engineered gene drive technology. For example, 
the Foundation for the National Institutes of Health 
convenes the Gene Drive Research Consortium to 
discuss communication, safe testing and engagement 
in relation to gene drive technology (FINH, 2018a). 
The safety board of the International Genetically 
Engineered Machine (iGEM) international student 
competition has established a policy specifically 
discussing safety of their projects and developed a 
separate policy on work related to engineered gene 
drive systems and how to prevent accidental gene 
drive release. These guidelines were established after 
a team of students attempted to reproduce a scientific 
paper discussing engineered gene drive development, 
though discussion of an engineered gene drive policy 
preceded the incident (iGEM, 2017). The do-it-
yourself biology community has developed a code of 
conduct, which generally draws from good practices 
applied by the scientific community (DIYbio, 2011).
The role of funding organisations is also important 
for the governance of research. In its report on gene 
drive the American National Academies of Sciences, 
Engineering and Medicine recommended several 
actions to the funders of research, including the need 
to collaborate with scientists and regulators to “to 
develop oversight structures to regularly review the 
state of gene drive science and its potential for misuse” 
[recommendation 8.7] (NASEM, 2016a). In addition, 
the Presidential Commission for the Study of Bioethical 
Issues established the responsibility of funders to 
promote some key principles for a responsible research 
and use of synthetic biology (Weiss, Gutmann and 
Wagner, 2010). In response to these calls, a number 
of organisations sponsoring or supporting gene 
drive research have agreed to a set of principles for 
responsible research (Emerson et al., 2017). Beyond 
the key principles, this forum of supporters and 
sponsors holds regular meetings to discuss key issues 
around gene drive research, including topics like data 
sharing, regulatory capacity, etc. (FINH, 2018b). 
Several academies of sciences have been looking 
at synthetic biology or engineered gene drive, 
trying to establish some recommendations for 
researchers but also beyond this community 
proposing guidance for regulators, decision-making 
authorities and more generally the public (Table 1.1).
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2.3 Governance challenges 
raised by synthetic biology 
and conservation
Synthetic biology challenges existing governance 
systems in many respects, of which only a few will be 
addressed here. New techniques of genetic modification 
and characteristics of novel organisms create questions 
relating to the applicability of existing regulations and 
the methodology of risk/benefit assessment. The 
potential intended and unintended spread of synthetic 
biology products, including engineered gene drive, raise 
challenges for mitigation, liability and compensation 
systems relating to transboundary harm. Tools and 
practices associated with synthetic biology, such as 
use of digital sequence information and the growing 
“Do-it-yourself Biology” (DIYbio) community, potentially 
undermine enforcement approaches predicated on 
monitoring, regulating and tracking genetic material and 
researchers. Different countries may have different levels 
of capacity to engage in synthetic biology research 
and provide effective regulatory frameworks and 
oversight. A multitude of social, ethical and practical 
concerns also surround synthetic biology, including the 
question of moral hazard and concern about sources 
of funding for research. Engaging with these questions 
and perspectives creates challenges of its own. There 
may be particular challenges for developing countries 
related to research and governance capacity.
2.3.1 Applicability of existing 
regulations to new techniques
There is a debate over whether existing regulations 
developed to manage genetic engineering are also 
applicable to new techniques of synthetic biology. This 
question goes to the heart of concerns that existing 
legislation is not adequate to address changing genetic 
technology. Many regulatory systems were developed 
for the paradigm of transfer of genetic material (DNA, 
RNA, etc.) between species – transgenesis. Such 
systems may not apply to mutagenesis – techniques for 
modifying the genome without introducing foreign DNA 
(Duensing et al., 2018). Engineered gene drives may fall 
into an area of regulatory ambiguity, uncertainty or even 
overlap – it may not be clear how they fit into existing 
frameworks addressing pest control, animal drugs, 
toxins or environmental protection (Oye et al., 2014).
As outlined above (see Section 2.2.1), in the EU, the 
definition of GMOs and thus the scope of regulatory 
oversight is very broad, but certain techniques are 
excluded if they “have conventionally been used in a 
number of applications and have a long safety record” 
[2001/18/EC]. Mutagenesis was initially classified as 
one of those techniques [2001/18/EC Art. 3 with Annex 
I]. In July 2018, the EU Court of Justice decided that 
while physical and chemical mutagenesis qualifies as 
having a sufficient safety record this is not so for new 
genome editing techniques. They are therefore not 
covered by the mutagenesis exemption [ECJ Case 
528/16 paras 46–53]. This means that in the EU all new 
synthetic biology techniques involving transgenesis 
and non-physical and non-chemical mutagenesis 
are within the scope of the regulatory oversight. 
The EU legislator has the possibility to modify the 
exemptions and decide what applications of synthetic 
biology are safe enough to be listed as exempted 
techniques, or subject certain techniques to less 
stringent tools of oversight, such as prior notification 
or ex post monitoring and reporting instead of
prior authorisation.
In the United States, certain synthetic biology 
products may not be covered by existing product-
related legislation. The US Plant Protection Act, for 
instance, only covers plants if a plant pest, such 
as an agrobacterium, was used to introduce the 
genetic material. This would not cover new synthetic 
biology techniques which use CRISPR-Cas9 or 
other pathways to insert a gene or otherwise modify 
the organism (Bergeson et al., 2015, 45). The US 
Department of Agriculture issued a statement in March 
2018 that it would not regulate plants developed 
through genomic editing techniques which are 
indistinguishable from plants that could be developed 
through traditional breeding techniques ([https://
www.aphis.usda.gov/aphis/ourfocus/biotechnology/
brs-news-and-information/2018_brs_news/
pbi-details][https://www.usda.gov/media/press-
releases/2018/03/28/secretary-perdue-issues-
usda-statement-plant-breeding-innovation]). 
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Another example is the dengue transmitting mosquito 
Aedes aegypti into which a lethal gene was inserted 
that through reproduction could lead to a reduction 
in populations. The modified mosquito was initially 
determined to be covered by the US Federal Food, 
Drug and Cosmetic Act (FFDCA) as an animal drug, 
analogous to other drugs used for animal population 
control. However, unlike other such drugs, the 
mosquito was intended to be released in the wild and 
used for the purpose of addressing human disease, 
raising questions about the appropriateness of FDA 
jurisdiction (Bergeson et al., 2015, 20). In 2017, the 
FDA announced that products “intended to function 
as pesticides by preventing, destroying, repelling, or 
mitigating mosquitoes for population control purposes” 
would not be considered “drugs” under the FFDCA, 
but would instead be regulated as “pesticides” by 
the EPA (FDA, 2017a). In 2018, the EPA opened 
public comment on an application for an experimental 
use permit for genetically engineered Aedes aegypti 
mosquitos ([https://www.epa.gov/pesticides/
epa-reopens-public-comment-period-application-
experimental-use-permit-combat-mosquitoes]).
In Japan, the Advisory Panel of GMOs of the Minister 
for the Environment has proposed that any product 
not categorised as genetically engineered under 
the Cartagena Protocol shall be exempted from the 
existing regulation. The Panel suggested that this 
would include any product created through genome 
editing that does not involve introduction of foreign 
nucleotides, such as deletions, as well as any product 
developed through introduction of material from 
species which could naturally cross with the host 
organism. The proposal is open for public comment 
and has not been formally adopted (USDA, 2018a).
In New Zealand in 2014, the Environmental Protection 
Authority decided that plants produced via gene 
editing methods, where no foreign DNA remained 
in the edited plant, would not be covered by GMO 
legislation. However, this decision was successfully 
appealed to the High Court, which overturned the 
decision on the basis that creating exceptions to the 
GMO regulations was a political decision and not within 
the power of the Authority [Sustainability Council v EPA, 
2014, 69] (Kershen, 2015). In reaching its decision, the 
Court affirmed the applicability of the precautionary 
approach based on the scientific uncertainty related 
to environmental effects of rapid changes caused by 
the technology [Sustainability Council v EPA, 2014, 
68]. Following this decision, all products of gene 
editing are currently captured within the scope of 
legislation in New Zealand (Fritsche et al., 2018).
A number of additional countries are currently 
considering what applications of genetic modification 
fall within the scope of risk assessment frameworks 
for GMOs. Chile, Brazil, Israel, Argentina and 
Australia, among others, have adopted or introduced 
regulations clarifying whether products of genome 
editing can be considered GMOs for the purpose 
of risk assessment regulation (Duensing et al., 
2018). In general, the likelihood of biotechnology 
products falling within the scope of existing regulation 
relates to the use of recombinant DNA and the 
degree of change to the host DNA sequence.
2.3.2 Risk/benefit assessment 
of novel organisms
Synthetic biology applications challenge existing risk 
assessment paradigms due to their potential to express 
novel traits, persist in the environment, and cross 
geographic and political boundaries (NASEM, 2016a). 
Existing risk assessment paradigms for genetically 
engineered organisms have largely been developed 
and used to assess the risks from two novel traits 
in plants: insect resistance and herbicide tolerance. 
Novel synthetic biology and gene drive applications 
will have traits that differ quite drastically from these. 
While the overarching risk assessment process may 
not change, specific steps within risk assessment 
will need to be tailored to these new applications. 
Decisions will have to be made concerning how to 
change risk assessment approaches to adequately 
assess the potential harm caused by organisms that 
have not previously existed (NASEM, 2016a; Hayes 
et al., 2018). New concerns may arise, for example 
relating to the uncertainty and difficulty of conducting 
a complete environmental risk assessment without 
environmental release. Furthermore, the values-laden 
judgments inherent to the risk assessment process 
(Section 3.4.3) will receive extra scrutiny, given the 
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novel and controversial nature of synthetic biology 
(Stirling, Hayes & Delborne, 2018; Thompson, 2018). 
A major characteristic of risk assessment for traditional 
GMOs is the familiarity or comparison approach. 
This has been described as a “comparison of the 
characteristics of the GMO(s) with those of the non-
modified organism under corresponding conditions 
of the release or use” and is intended to help identify 
“the particular potential adverse effects arising from 
the genetic modification” [Directive 2001/18/EC 
Annex II sec. B. 1st indent and sec. C. 2.1]. There 
are suggestions that the comparison with parental 
and/or non-modified organisms loses validity where 
synthetic biology does not only marginally modify an 
organism but can create essentially new ones (Winter, 
2016b). A proposed alternative to the comparison 
approach is use of a set of tests following a step-
by-step and case-by-case approach to information 
generation before the release of the modified or new 
organism is approved (see above Section 2.2.1.3).
Applications of synthetic biology can create irreversible 
effects. In some cases, as in use of engineered gene 
drives to eradicate a species from a certain habitat, 
irreversibility could be seen as part of the intent. There 
have been calls for development of effective reversal 
drives as part of regulatory requirements for engineered 
gene drives (Oye et al., 2014). Such risk management 
measures could provide a means to address indirect or 
unintended environmental impacts, but even if effective, 
they would not address intended impacts. Moreover, 
permanent damage could be caused before the 
reversal drive reached all members of the 
population (Esvelt et al., 2014).
2.3.3 Transboundary movement
International and national law have established 
mechanisms for managing transboundary movement 
of genetically modified organisms and potentially 
hazardous substances as well as principles for 
addressing transboundary harm (see Section 2.1.2). 
To some extent these existing structures provide a 
framework applicable to transboundary impacts of 
synthetic biology. However, certain applications of 
synthetic biology, including engineered gene drive 
systems, create questions related to coverage 
and implementation of these frameworks.
Two types of transboundary movements can be 
envisaged when considering synthetic biology: 
unintended and intended. Some applications of 
synthetic biology focus on particular geographies, 
contained within country borders. This is the case for 
applications against invasive species that intend to 
suppress those species locally but are not intended to 
have such effect on a global scale. If those applications 
were to be moved across borders, it would be an 
unintended or illegal transboundary movement [for 
definitions of unintended or illegal transboundary 
movement, refer to Decision VIII/16 of the Cartagena 
Protocol on Biosafety and its annex Operational 
definitions of the terms “unintentional transboundary 
movement” and “illegal transboundary movement”]. 
This could happen through natural dispersal of modified 
individuals, or through human transport (intentional 
or unintentional). For unintended transboundary 
movement, there are existing governance frameworks. 
Under Article 17, the Cartagena Protocol requires 
countries to notify other countries that might 
be affected by an unintentional transboundary 
movement that may have an adverse effect
on biodiversity. 
Another set of the technologies, approaches and 
tools are intended to move across boundaries. For 
example, the vector control applications of engineered 
gene drive for malaria (see Chapter 6) are intended to 
address vector movement across different countries, 
as this would be an important factor for success. 
Several recent reports looking at engineered gene 
drive for malaria control have raised the importance 
of regional approaches (James et al., 2018), or 
coordination and communication between neighbouring 
countries (NASEM, 2016a). The Cartagena Protocol 
requires states from whose territory organisms are 
intentionally moved across borders to obtain advance 
informed agreement from the importing state. 
However, this provision was developed in the context 
of transboundary import and export, and it is not 
clear how it applies to intended or anticipated spread 
of modifications across borders (NASEM, 2016a).
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Transboundary damage can create particular problems 
for compensation or restitution. The Supplementary 
Protocol applies to damage resulting from both 
intentional and unintentional transboundary movement 
as well as illegal transboundary movement, and requires 
Parties to mandate response measures in the event 
of damage [Arts 3, 5]. However, the application of civil 
liability in the event of transboundary damage is largely 
left to be determined under domestic law. This can raise 
questions relating to proving causality and quantifying 
harm, particularly where the modified organism does 
not cause direct economic or environmental damage.
These issues are in some ways analogous to 
the governance of biological control agents. In 
that context, they have been addressed through 
discussion and harmonisation of measures at the 
regional level (Bateman, Sulaiman & Ginting, 2014). 
The African Union has started looking at regional 
harmonisation around the possible use of engineered 
gene drive for malaria control (NEPAD, 2018).
In addition to the regulatory question, the 
potential of intended or unintended transboundary 
movement raises challenges for stakeholder 
engagement, to ensure that public consultation 
can be carried out at the appropriate level.
2.3.4 Digital sequence information
The growing use of genetic information derived 
from digital sequencing in synthetic biology creates 
uncertainty for access and benefit-sharing regimes 
(see Section 6.6.1 for a description of technological 
advances in digital sequence information). There 
have been numerous studies examining the 
impact digital sequence information and synthetic 
biology may have on access and benefit-sharing 
agreements around genetic material (Bagley & 
Rai, 2014; Bagley, 2016; Welch et al., 2017; 
Wynberg & Laird, 2018b; see also Table 1.1). 
At the CBD, where “genetic resources” were primarily 
envisioned and defined as genetic material, a process is 
now underway to respond to the potential implications 
of the use of digital sequence information on CBD 
objectives [CBD COP13 Decision 16; COP14/L.36]. 
An ad hoc technical expert group on digital sequence 
information on genetic resources was established 
to consider the potential implications of the use of 
digital sequence information on genetic resources
for the CBD. 
Submissions from countries and other stakeholders to 
the CBD expert group show the range of perspectives 
on considering digital sequence information 
“genetic resources.” For certain non-governmental 
organisations, such as the Third World Network, not 
regulating such information under the CBD could 
“economically and culturally undermine indigenous 
peoples and local communities, thereby negatively 
impacting the conservation and sustainable use of 
biodiversity.” They point to the use of synthetic biology 
to produce vanilla and vetiver as examples of the 
potentially disruptive impact on farmers and other local 
actors (AHTEG, 2018b). For research organisations 
such as the UK Natural History Museum, Royal 
Botanic Gardens Kew, and Royal Botanic Gardens 
Edinburgh, there are potentially negative implications 
in regulating access to digital sequence information. 
They highlight the value of digital sequence data in 
the public domain for biodiversity conservation and 
sustainable management and the impracticability 
of asking open-access international databases to 
regulate the use of digital sequence data. It is also put 
forth that the current mechanism for sharing digital 
sequence information might already be considered 
the equivalent of a global multilateral benefit-sharing 
mechanism (AHTEG, 2018a). Some researchers have 
argued that including digital sequence information 
under the Nagoya Protocol would create a global 
damper on research(Kupferschmidt, 2018).
A scoping study commissioned by the CBD found that 
the use of information on genetic resources, including 
in synthetic biology, could create opportunities for 
new forms of non-monetary and monetary benefit-
sharing (Wynberg & Laird, 2018). At the same 
time, the study noted the risk that access to digital 
sequence information would allow researchers to 
look at the genetic or biochemical composition of 
genetic resources without having to physically access 
the resources themselves, which could undermine 
existing approaches to access and benefit sharing.
42
If the genetic information is deemed to fall within the 
scope of “genetic resources” in the CBD, the challenge 
will be defining whether and how the principle of 
sovereignty over genetic resources and the system 
of access and benefit-sharing based on this principle 
can address these vastly different dynamics. In his 
book on genetic resources as natural information, 
Ruiz (2015) notes that: “Inasmuch as information 
constituents can be stripped from their physical medium 
in biological samples, attempting to institutionalize 
controls over the flow of information, disembodied 
at different moments, by different actors, and in 
different places, is not only impossible but absurd.” 
Ruiz advocates a conceptual framework for ABS 
based on the economics of information, as well as 
an alternative mechanism for ABS that is multilateral, 
non-contractual and focused on fairness and equity in 
the sharing of monetary benefits. Such a multilateral 
benefit-sharing mechanism is possible under Article 
10 of the Nagoya Protocol. In discussions under 
this article, at least one country – Argentina – has 
noted that a global multilateral mechanism may be 
useful for the use of digital sequence information
(SBI, 2018).
The evolving technological, legal and institutional 
context surrounding the exchange and use of digital 
sequence information (DSI) for synthetic biology 
and genomic research may affect access to ABS 
frameworks under the ITPGRFA (Welch et al., 2017). 
The availability of sequence data through decentralised 
data libraries and organisations may challenge 
the multilateral system set up by the ITPGRFA 
(Welch et al., 2017). Other factors including partial 
sequence combinations, and the fact that the same 
sequence may occur in multiple organisms create 
further questions for ABS (Welch et al., 2017).
2.3.5 “Do-it-yourself” (DIY) biology
The tools associated with synthetic biology are 
becoming increasingly accessible to private actors, 
including actors who may not have the backing of 
an established institution. This raises governance 
questions as well as some public concern (Charo & 
Greely, 2015). Many of these concerns may be based 
on an inaccurate understanding of the activities and 
capabilities of community laboratories (Kuiken, 2016). 
However, as with any decentralised activity, the DIY 
aspects of synthetic biology research create certain 
challenges to traditional models of governance.
One concern centres on safety. DIY biologists may not 
be held to the same standards of safety as formally 
trained biologists (Garrett, 2013). In some jurisdictions, 
licensing requirements on laboratory biologists, 
including training in safety and ethics, may not apply 
to community laboratories (Kolodziejczyk, 2017). 
However, in Germany and other countries in Europe, 
community laboratories, like other laboratories, need 
licenses to undertake experiments involving genetic 
engineering (Seyfried, Pei & Schmidt, 2014). In all 
countries, biosafety regulations and risk assessment 
and management procedures covering synthetic 
biology activities – including requirements relating 
to notification, authorisation, containment, transfer 
and monitoring – would apply to DIY biologists as 
well as formal labs. The DIY biology community has 
also developed its own safety standards (Guan et 
al., 2013) as discussed above, and continues to 
evaluate their effectiveness and develop additional 
resources associated with biosafety and biosecurity
(Yassif, 2017).
Where they are held to the same or similar licensing 
standards as formal laboratories, community 
laboratories will also be required to obtain 
insurance. In some countries, such as Tanzania, all 
operators engaging in activities involving genetic 
modification are required to carry insurance 
[Tanzania Biosafety Regulations, 2009, § 35(1)]. In 
other countries, DIY biologists operating outside an 
institutional setting may not have explicit insurance 
requirements, though many of the labs may carry 
this type of insurance regardless. This creates a 
potential problem if something does go wrong, as 
community biologists may not have the resources 
to cover costs of compensation or remediation.
As DIY biology becomes more accessible to users 
not associated with a particular institution, this 
may raise challenges for enforcement of biosafety 
and environmental regulations against actors with 
bad intent. While the community’s own regulations 
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may support safe practices among well intentioned 
operators, informal or illegal operators with bad 
intent may be difficult to identify and hold liable 
(Garrett, 2013). However, there are still limits on 
the capability of community laboratories to create 
organisms that would cause significant environmental 
damage, and to date there has been no evidence 
of attempts or intent to do so (Lentzos, 2016).
Much of the concern around DIYbio centres relates 
to questions of biosecurity. These questions are 
outside the scope of this assessment, though there 
has been some thinking in the biosecurity context that 
could be relevant to governance of DIYbio to prevent 
environmental impacts. Kelle (2009) proposes a “5P” 
strategy that outlines five points of intervention for 
managing risks: principal investigator, project, premises, 
provider (of genetic material) and purchaser. At each 
of these points, measures ranging from awareness 
raising and education to industry codes of conduct 
to national and international laws and regulation 
could be used to prevent misuse (Kelle, 2009). 
An issue hardly discussed is the application of 
ABS regulations to DIY biology. Any rules user 
states may have established to ensure compliance 
with pertinent provider state regulation also apply 
to DIY synthetic biologists. But DIY biologists 
may not be aware of this, and it could be difficult 
for user state authorities to supervise their 
research and development in termsof ABS.
2.3.6 Research and 
governance capacity
Emerging economies represent significant potential 
markets and research centres for synthetic biology 
as well as providers of genetic material that may be 
used. However, capacity varies across jurisdictions, 
with implications for both research and governance.
In emerging economies, research capacities across 
disciplines and departments with regards to synthetic 
biology are underdeveloped. Developing and upgrading 
research and development facilities represents 
significant capital investment. There is consensus that 
emerging economies require support in this regard 
[Cartagena Protocol art. 22] but the form and nature of 
capacity needed is still unclear. Advanced applications 
require advanced skills and capital which can delay 
synthetic biology development and the deployment 
process. The African Union recognises the need for 
strengthening the capacity on the continent in order to 
harness the potential benefits of these developments 
while being able to ensure that those are co-developed 
with African scientists (African Union, 2018). Recent 
growth in digital innovation in Africa and Asia indicate 
potential for technological entrepreneurship. In 2018, 
teams from Uganda, Egypt, Singapore and Pakistan, 
among others, participated in the International 
Genetically Engineered Machine Championship
(iGEM.org).
Emerging economies also represent potential markets 
for synthetic biology applications and products. Certain 
types of technology may be nationally or regionally 
prioritised based on context and needs (African Union, 
2018). In Africa for instance, production of synthetic 
biofuels may have immediate environmental, social 
and economic benefits (Stafford et al., 2018). 
There is evidence of gaps in legal frameworks and 
capacity for regulatory oversight in many developing 
countries. Few countries have enacted biosafety 
laws that could act as reference points for synthetic 
biology development and diffusion (Figure 2.1). Of 
significance is the lack of or inadequate provisions 
for post-release phases. Governments also faced 
the challenge of balancing a precautionary approach 
with the potential economic benefits of synthetic 
biology applications (Kingiri & Hall, 2012).
Reduced technical and regulatory capacity made 
worse by porous national and regional borders 
raise questions of biosafety and potential misuse 
of synthetic biology. There have been calls for 
harmonisation of biosafety- and trade-related policies 
with clear guidelines for deployment of synthetic 
biology applications and products at respective 
national levels to enhance responsible and productive 
synthetic biology piloting, products release, 
monitoring and surveillance (Escaler et al., 2012).
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Figure 2.6 Biosafety Laws in Africa. Adapted from a graphic by the African Biosafety Network of Expertise.
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2.3.7 Funding and financial flows
The funding sources and financial flows associated 
with synthetic biology (Section 1.6) have influenced 
the discourse around governance. Availability and 
access to funding drives innovation. While some 
private organisations, such as the Gates Foundation-
funded Target Malaria project, fund work pursuing 
the safe and effective use of engineered gene drive 
systems, most funding comes from public sources. 
In Europe, funding for synthetic biology has primarily 
come from public funding organisations such as the 
Swiss National Science Foundation, UK Research 
Councils and the Netherlands Organisation for 
Scientific Research (Pei, Gaisser & Schmidt, 2012). 
In the United States, there are few publicly funded 
research programmes outside military programmes, 
such as the US DARPA Safe Genes Program (DARPA, 
2018d). Before 2008, the US federal government 
invested relatively small amounts in synthetic biology. 
By 2014, it had invested approximately US$ 819 
million in synthetic biology research (WWC, 2015). 
Since 2012, the majority of that funding came from 
Department of Defense initiatives (see Chapter 1). 
A recent exception is approximately US$ 2 million 
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from the US Department of Agriculture’s National 
Institute of Food and Agriculture (NIFA) for research 
on the implications of gene edited technologies, 
including one project explicitly focused on engineered 
gene drive systems in agriculture (USDA, 2018b).
There have been calls for increased funding for 
research into ethical, legal and social issues 
relating to synthetic biology. A 2012 review of 
European public funding organisations showed 
that where such funding is available, there can 
be problems in linking funding opportunities with 
the research community (Pei et al., 2012).
Concerns have been raised about synthetic biology 
funding patterns, partly regarding the agenda behind 
the funding, and the purpose, or alternate purposes, 
to which the technology and its applications might 
be used (Lentzos, 2015; Kuiken, 2017; Reeves et al., 
2018). Concerns range from the power funders have 
to determine the trajectory of research to problems 
of conflict of interest in scientific research, whereby 
the objectivity of researchers is compromised – or 
perceived to be compromised – by sources of funding 
or other institutional commitments (Krimsky, 2004, 
2013). In addition, synthetic biology’s technical and 
institutional connections to agricultural biotechnology 
create discursive links to critiques of the political 
economy of first-generation genetically-modified 
organisms (Charles, 2001; Schurman, Kelso and Kelso, 
2003; Worthy et al., 2005; Kleinman & Vallas, 2006; 
Delborne, 2008; Kinchy, 2012). As such, concerns 
have been raised that synthetic biology will benefit 
private over public interests, continue enclosures of 
genetic commons through aggressive intellectual 
property practices, concentrate power in the hands 
of elites, and undermine more holistic and traditional 
approaches to sustainability (e.g. ETC Group, 2018). 
More research is required to understand where and 
under what conditions these concerns may actualise, 
and how to prevent them from doing so (Pottage, 
2006; Calvert, 2008; Lawson & Adhikari, 2018). 
2.3.8 Moral hazard
Synthetic biology creates a fundamental challenge for 
risk assessment and conservation governance more 
broadly in the form of what is called moral hazard. 
“Moral hazard” means that new technologies may 
correct the symptoms of, and provide an excuse 
not to address, more fundamental socio-political 
failures which caused the symptoms in the first place. 
For example, climate change caused by increased 
emissions of greenhouse gases into the atmosphere is 
projected to cause changing weather patterns including 
increased droughts potentially affecting food production. 
Fundamental change would require that emissions 
are drastically reduced. Moral hazard occurs if new 
technologies, such as drought-resistant crops, create 
excuses for decision makers not to implement mitigation 
policies to prevent droughts. In this example, even 
if synthetic biology can lessen the severity of certain 
consequences from climate change-induced droughts, 
the vast number of consequences caused by such 
droughts simply cannot be addressed through synthetic 
biology alone – the fundamental problem needs to 
be addressed. The same applies to engineered gene 
drive technology. If applied as a means of nature 
conservation it may foster a vision that traditional 
habitat and species protection can be replaced by just 
making species and habitats resilient to new stresses.
2.3.9 Engaging with multiple 
perspectives and ethics
As has been highlighted in Chapter 1, there are a 
number of ethical questions raised by synthetic biology. 
Ethics are value systems that shape the perception, 
assessment and management of a technology. Ethics 
also shape governance systems in multiple ways. Many 
governance systems are based on norms and concepts 
deriving from ethics. Ethical considerations are behind 
calls for limits on certain applications of synthetic 
biology, such as use of gene editing on human beings, 
which can influence national and international law (e.g. 
Convention on Human Rights and Biomedicine of the 
Council of Europe; Grubb, 1994). Ethical considerations 
will influence the scrutiny of risk assessment, the 
determination of acceptable risk, and the weighing of 
benefits and risks in decision making related to synthetic 
biology research and introduction into the environment.
There is wide recognition that ethical arguments are 
important to take into consideration when considering 
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synthetic biology applications and they need to be 
clearly framed when responding to the concerns of 
different cultural traditions and political orientations 
within and between particular communities or regions 
(Winter, 2016a; Zetterberg & Edvardsson Björnberg, 
2017). The ethical debate about science and technology 
is often done in absolute terms at a given time, but 
increased experience and exposure can change 
perspectives, sometimes in favour of technology and 
sometimes against it (UNESCO, 2015). The diversity 
of moral perspectives and values inform decision 
making, but also creates a challenge for regulation. 
Scientists themselves have questioned their practice in 
response to ethics with normative instruments such as 
the UNESCO World Conference on Science Declaration 
on Science and the Use of Scientific Knowledge [1999] 
that calls for responsible science and its interaction 
with society’s values. Synthetic biology researchers 
are becoming increasingly cognisant of the ethics and 
value-based discussion about synthetic biology and 
how its potential application as well as the research 
itself can question values in society. This recognition 
has been translated to action with the integration 
of “ethical, legal and social implications” (ELSI) into 
research networks and programmes (Synbiosafe, 
2018) and a growing interaction between ELSI experts 
and synthetic biology researchers (DARPA, 2018d).
Even in the absence of guidelines or regulatory 
requirements, researchers and scientific associations 
drawing on field experience and literature argue that 
transparency and openness are the foundation for 
ethical engagement (Esvelt et al., 2014; NASEM, 2016a; 
Resnik, 2018). They agree that engagement should 
ensure that evidence and uncertainties about both 
potential risks and benefits are shared with the public. 
Engagement also needs to be responsive to input 
and information received from stakeholders. The 
Royal Society dialogue on gene editing (Van Mil, 
Hopkins & Kinsella, 2017) showed the importance 
for stakeholders of ensuring the engagement was 
not a box-ticking exercise and was going to be 
taken into consideration by policy makers (Van Mil, 
Hopkins & Kinsella, 2017). Organisations such as 
LEAP Synthetic Biology made calls to use deliberative 
dialogues to ensure that communities’ perspectives 
would be taken into consideration seriously during 
policy-making processes (Ritterson, 2012).
While the dialogue might enable discussion of 
different values, perspectives and understanding of 
evidences, researchers recognise that it is important 
to build mutual understanding in order to achieve a 
meaningful dialogue (UNESCO, 2015). Practitioners 
also recognise the need for a structured and 
continuous engagement and the establishment of 
clearer engagement pathways (NASEM, 2016a).
Although researchers’ commitment to engagement 
is critical, it is not sufficient. There is also a need 
for national governance mechanisms to provide 
guidelines about the remits and scope of the 
engagement and of stakeholders’ participation 
in decision making so that engagement can be 
aligned (NASEM, 2016a). While there are existing 
guidelines for public consultation (EFSA, 2018), 
there have been criticisms from concerned NGOs 
and scholars about bias in engagement, particularly 
where it is undertaken by the proponent of the 
technology, as well as limited identification of who is 
entitled to give consent and how consent is sought 
(Unknown, 2014; Bäckstrand et al., 2010). 
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3.1 What does it mean to 
be “evidence-based”?
This assessment is charged with the task of conducting 
an evidence-based examination of the potential benefits 
and risks of synthetic biology and engineered gene 
drive applications to biodiversity conservation. In the 
context of a contentious and emerging field such as 
synthetic biology, the idea of “evidence-based” requires 
examination. This chapter discusses evidence with 
the goal of fostering productive conversations on the 
science and governance of synthetic biology and 
sets the stage for this assessment. The chapter has 
three sections that follow this introductory discussion. 
Sections 3.2 and 3.3 introduce the topic of scientific 
evidence by discussing peer review, reproducibility, 
replicability and uncertainty. Section 3.4 explores the 
broader factors that influence the creation and synthesis 
of scientific evidence. As a whole, the chapter offers 
a nuanced view of the challenges and importance of 
integrating scientific knowledge into decision making.
 
What explicitly is meant by an evidence-based 
assessment? “Evidence-based” is an often-cited goal 
for assessments and decision processes surrounding 
technology and the environment, but what this exactly 
means can vary. On the one hand, it can be used to 
emphasise that decisions on the use of technologies 
need to be informed by empirical studies examining 
their efficacy, potential benefits and risks. On the other 
hand, the term evidence-based can be understood 
as an attempt to remove values and politics from 
assessments or decision-making processes. This latter 
interpretation, rarely feasible, fails to acknowledge 
the subjective judgements and values that inform 
assessments and decision making. This could in turn 
privilege the values of scientific experts, which may 
differ from those of other stakeholders and publics 
(Sarewitz, 2015). Scholars of science and technology 
policy have argued that it is far more responsible and 
productive to acknowledge the role of values within 
such processes and to use an appropriate form of 
deliberative engagement to sort through evidence, 
uncertainty and preferences (Jasanoff, 2003; Rowe & 
Frewer, 2005; Pielke Jr, 2007). This assessment thus 
adopts the first interpretation: decisions on the use of 
technologies need to be informed by empirical studies 
examining their efficacy, potential benefits and risks. 
The chapter therefore explores the factors that impact 
the production and synthesis of scientific evidence 
and how they were navigated within this assessment, 
including how deliberation was used throughout the 
process. While the focus of this chapter is on the factors 
impacting scientific evidence, other types of evidence 
and concerns – as discussed in the previous chapter on 
governance – also need to be incorporated into decision 
making surrounding synthetic biology and gene drive. 
To inform the discussion of how evidence, values and 
deliberation shape this assessment, the scholarly 
field of responsible research and innovation provides 
four principles: anticipation, inclusion, reflexivity and 
responsiveness (Stilgoe, Owen & Macnaghten, 2013). 
These principles were originally developed to inform 
the governance of emerging technologies, and their 
significance for an assessment like this is apparent. 
Anticipation refers to the need to predict the potential 
futures of synthetic biology, including engineered gene 
drive systems, so as to guide them towards desired 
ends and away from undesired ones – epitomised 
by the Resolution that mandated this assessment. 
Inclusion highlights the need to pay close attention 
to who is involved in decision-making processes, 
including, in this assessment, the process of deciding its 
scope and synthesising relevant evidence. The decision 
to conduct the assessment was an inclusive one, since 
it was IUCN’s diverse and representative membership 
of 1,303 government, civil society and indigenous 
peoples’ organisations that passed Resolution WCC-
2016-Res-086. For the assessment itself, as referenced 
in the accompanying statement of principles (Front 
Matter) and the process flow (Figure 1.10), inclusion 
has been achieved through: (i) disciplinary, gender and 
geographical diversity being considered in selecting the 
group to complete the assessment, which, unusually, 
falls under the mandate of all six IUCN Commissions 
as well as the Director General, and (ii) opening this 
assessment to external peer review from all IUCN 
Members and anyone else who wished to participate. 
Reflexivity denotes the need to be aware of the key 
assumptions and judgements being made within this 
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assessment. This includes, for example, reflecting 
upon the assumptions informing how evidence is 
selected and synthesised – a process that motivated 
the inclusion of this chapter. Deliberative processes 
were used during the creation of this assessment 
to foster this reflection, and peer review processes 
(Section 3.2.1) offered further opportunities for 
reflection inspired by external perspectives. 
Responsiveness embraces the need to be open 
to changing in response to insights garnered 
through inclusive deliberation – embodied in the 
assessment’s process for responding to peer 
review, including the transparent documentation of 
responses to all comments (see iucn.org/synbio). 
These pillars of responsible research and innovation 
serve as a reminder that seeking “evidenced-based” 
decision making is about more than the quality of the 
data and the identification of key experts; it requires 
careful attention to the processes through which 
evidence is generated, gathered and considered in 
decision processes that must reflect the complexity 
of society itself. Indeed, as Ascher, Steelman and 
Healy (2010) argue, knowledge for environmental 
decision making extends beyond formal scientific 
knowledge to local and indigenous knowledge, as 
well as knowledge about public preferences.
3.2 What is scientific 
evidence?
Scientific evidence derives from a rigorous process 
that serves to either support or counter a theory 
or hypothesis (Popper, 2005). The significance of 
scientific evidence often relies on collection and analysis 
protocols (Bilotta, Milner & Boyd, 2014) and is based on 
the results of quantitative (e.g. statistical) and qualitative 
(e.g. textual) analysis. Scientific evidence is generally 
expected to be empirical; however, standards may 
vary depending on the field of inquiry (Becker, Bryman 
& Ferguson, 2012). Because of this variation, some 
scholarship has shown how standards of scientific 
evidence are defined and negotiated among the 
participants in different disciplines (Knorr-Cetina, 1999), 
suggesting that there is no absolute or incontestable 
standard for evidence in any field (Collins, 1983), 
especially an emerging field such as synthetic biology. 
Nevertheless, the existence of scholarly traditions in 
ecology, molecular biology, science and technology 
studies, and ethics provide guidance in evaluating 
the power and importance of scientific evidence in 
emerging fields (Knorr-Cetina, 1999; Sismondo, 2010).
Scientific evidence drawn from a single study will rarely 
provide a meaningful answer to a given question. As 
such, it is important to examine and weigh the pieces 
of scientific evidence from a broader body of research 
to make an informed conclusion (EFSA Scientific 
Committee, 2017). To be considered established, 
scientific evidence must be consistent and generally 
accepted by the broader scientific community, though 
traditions of scepticism and dissent are also important 
in visions of advancing scientific understandings 
(Kuhn, 1970; Merton, 1973; Delborne, 2008). 
Scientific communities often distinguish between 
a hypothesis and a theory. Generally, a hypothesis 
is a proposed explanation, often based on prior 
knowledge or basic experiments, that can be tested 
through further experiments and observations. 
Further data are required in order to confirm or reject 
a hypothesis, whereas a theory is a widely accepted 
concept supported by a substantial body of evidence 
(Sutton & Staw, 1995). While some synthetic biology 
theories are already supported by significant bodies 
of evidence, many hypotheses are yet to be proven 
due to the relative immaturity of the field. The scientific 
community has mechanisms for overturning accepted 
theories based on new evidence. This is often a 
complex process – not solely determined by the 
quality of evidence – that is influenced by disciplinary 
norms, challenges launched from related disciplines, 
changes in cultural understandings, and other social 
factors (Kuhn, 1970; Longino, 1990; Gieryn, 1999).
In certain cases, it might not be possible to draw 
conclusions based on observations because the 
work in question has not been done; in such cases, 
mathematical models may be used to support informed 
decisions (Knight et al., 2016). Using mathematical 
models and simulations is of specific relevance to 
synthetic biology and biodiversity conservation, 
where experimental evidence is limited. For instance, 
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computational models have recently been used 
to model the potential spread and persistence of 
engineered gene drive organisms without actually 
releasing them into the environment (Unckless, Clark 
& Messer, 2016; Eckhoff et al., 2017; Noble et al., 
2018). Such efforts further scientific understanding 
without producing any direct environmental 
impact. Of course, models never perfectly capture 
ecological, biological and social contexts, meaning 
that experimental evidence will be required to 
challenge model predictions and solidify scientific 
understanding. Negotiating such experiments is 
complex and may be contested in the field of synthetic 
biology, where the testing of new technologies such 
as gene drive organisms creates the potential for 
environmental impact beyond the boundaries of a 
field trial (NASEM, 2016a). Making decisions about 
such field trials thus triggers governance processes 
that weigh the needs for empirical data against the 
potential for unintended ecological adverse effects.
3.2.1 Peer review
Peer review is a process meant to ensure research 
quality, validity and appropriate presentation of scientific 
evidence (Gannon, 2001). Peer review serves as a 
key gatekeeping mechanism to expose proposed 
scientific evidence to critique by experts (Merton, 
1973). The peer review process is carried out by 
employing experts with relevant expertise (Voight and 
Hoogenboom, 2012) and is designed to ensure the 
appropriateness of data collection and analysis and to 
prevent scientific fraud (Kelly, Sadeghieh & Adeli, 2014).
 
The peer review process is not perfect (Mulligan, 
Hall & Raphael, 2013). Most importantly, the process 
relies on existing knowledge and tends to assess the 
validity of work based on previous studies or what 
is generally accepted by the scientific community 
(Gannon, 2001). Findings that challenge existing 
understanding thus might be criticised and rejected as 
poor or incorrect (Kuhn, 1970). Peer review can also 
be challenging when credible studies offer conflicting 
interpretations or conclusions or when multidisciplinary 
work makes it challenging to find reviewers with an 
adequate range of expertise (Langfeldt, 2006).
This assessment included a peer review process for 
solicited independent experts, IUCN stakeholders and 
interested members of the public to provide feedback 
– including comments, critiques and suggestions for 
consideration of additional evidence. In this review 
process neither authors’ nor reviewers’ identities were 
hidden, making this a so-called “open” peer review. 
The application of open review was guided mainly 
by the technical group’s principles of transparency, 
inclusivity and consultation, as well as IUCN’s generally 
accepted practices. The potential disadvantage of 
open review is that some reviewers may limit the 
feedback provided due to concerns of being identified 
personally with their comments. The wide range of 
supportive and critical comments received on the draft 
of this assessment, however, offers some reassurance 
that this disadvantage of open review was minimal. 
This final draft of the assessment thus represents 
the technical group’s best effort to incorporate 
and respond to the comments received (to view all 
comments and responses, see iucn.org/synbio).
3.2.2 Norms of reproducibility 
and replicability
Reproducibility and replicability are two concepts 
that play significant roles in evaluating the quality and 
reliability of scientific work (Stodden, 2009; Jasny et 
al., 2011). Scientific evidence is valued more if the 
same observations and conclusions can be drawn from 
multiple independent studies. In emerging disciplines, 
such as synthetic biology, the lack of a sufficient 
number of independent studies can be challenging.
In the biological sciences, independently reproducing 
a set of observations can be costly and time 
consuming. For instance, reproducing gene drive 
observations in wild populations would take 
generations. It might be feasible for species with 
short lifespans, but becomes more challenging (given 
the pressure for rapid scientific results) for longer-
lived species. Reproducibility, while highly valued, 
has generated significant recent controversy in a 
number of fields where researchers have found it 
difficult or impossible to reproduce accepted findings 
(Arrowsmith, 2011; Begley & Ellis, 2012; Baker, 2016).
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of a gene drive modified organism). The Governance 
chapter of this assessment addresses the decision 
uncertainty surrounding the application of synthetic 
biology and gene drive to biodiversity and conservation. 
This assessment engages an explicit framework 
to describe the certainty of key messages. A four-
quadrant diagram qualitatively describes the degree 
of certainty associated with a finding or idea (see 
Figure 3.1), drawing upon the Intergovernmental Panel 
on Climate Change (IPCC) uncertainty classification 
(Moss & Schneider, 2000) and the Intergovernmental 
Science-Policy Platform on Biodiversity and Ecosystem 
Services (IPBES) classification (IPBES, 2016b). In 
this framework the degree of certainty is dependent 
upon the quantity and quality of evidence, in addition 
to the level of agreement on that evidence. Well 
established refers to a finding that is supported by 
a meta-analysis or multiple independent lines of 
evidence. Established but incomplete refers to a 
finding that is generally agreed upon but supported by 
a limited number of studies. Competing explanations 
denotes a situation where many independent studies 
exist but different conclusions are drawn from them. 
Speculative findings are where there is low consensus 
on the limited evidence that exists – this quadrant 
represents areas with major knowledge gaps. 
3.3 Engaging with uncertainty
As with most emerging technologies, uncertainty 
complicates efforts to assess the impacts of synthetic 
biology. Uncertainty concerning the impacts – intended 
and unintended – of synthetic biology applications may 
be caused by a variety of factors, such as the limitations 
of modelling or low levels of empirical evidence. In 
considering the release of gene drive altered organisms 
into the environment and their impact on wild 
populations, for example, uncertainties are relevant to 
questions involving the effectiveness of the engineered 
gene drive, its stability over time, the fitness costs 
of the genetic constructs, and effects on non-target 
organisms (NASEM, 2016a). Scholars have developed 
many different methodologies to evaluate and classify 
uncertainty (Milliken, 1987; Warmink et al., 2010; 
Hayes, 2011). Here we provide a typology of sources 
of uncertainty and provide a four-quadrant model to 
help classify the degree of confidence in evidence. 
Hayes (2011) identifies four sources of uncertainty: 
epistemic uncertainty, variability, linguistic uncertainty 
and decision uncertainty. Epistemic uncertainty, likely 
the most common in discussions about emerging 
technologies, is the uncertainty associated with the 
production of knowledge. It is the result of imperfect 
knowledge regarding something that is in principle 
knowable, and, therefore, additional research can 
reduce this type of uncertainty. Variability refers to the 
unavoidable uncertainty caused by natural variation 
or inherent randomness. Unlike epistemic uncertainty 
that can be decreased with further study, this type of 
uncertainty cannot be reduced. Variability is relevant 
for this assessment because biodiversity conservation 
never happens in a perfectly uniform environment. 
Linguistic uncertainty results from the imprecision 
of language and has five causes: vagueness, 
context dependence, ambiguity, indeterminacy and 
underspecificity. This assessment seeks to reduce 
linguistic uncertainty by defining key terms in the 
Glossary and presenting a conceptual framework 
for evidence-based decision making in this chapter. 
Decision uncertainty occurs when there is ambiguity 
concerning how to quantify or compare social objectives 
to inform a decision (e.g. how to weigh relative risks and 
potential benefits in the decision to permit a field trial 
Figure 3.1 Qualitative uncertainty terms. Synthesis of Moss and 
Schneider (2000) and IPBES (2016). 
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In contrast to the epistemic uncertainty suggested by 
Figure 3.1, so-called “unknown unknowns” are the 
most challenging type of uncertainties due to their 
unknowable nature, which makes them difficult to 
address in a risk assessment or even a precautionary 
approach (see Section 2.1.1). This uncertainty 
can result from inherent randomness and a lack 
of evidence to even conceive of and characterise 
what is known and not known. As such, effective 
strategies to anticipate unknown unknowns do not 
exist. This type of uncertainty has to be dealt with 
as evidence emerges. While specific cause and 
effect relationships are generally not established 
with unknown unknowns, it may still be possible 
to explore whether certain effects are occurring — 
even without knowing causes — by conducting 
field studies or monitoring small-scale releases. 
Paradoxically, seeking to reduce epistemic uncertainty 
by performing a risk assessment on emerging 
technologies may require research activities that 
themselves pose some risk. For example, in the 
context of synthetic biology, while modelling and 
assessing risk in closed laboratory situations will 
lead to answering some safety-related questions, full 
knowledge of environmental impacts would require 
some degree of release into the environment. As such, 
there may be trade-offs between reducing uncertainty 
and avoiding risk. Decision makers will need to weigh 
such trade-offs, for example, in permitting field trials or 
confined field trials of gene drive altered organisms.
3.4 Factors influencing the 
production of evidence
There are a variety of factors that influence the 
production of evidence. This discussion is organised 
around two topics: (i) factors that influence what 
evidence-related questions are asked (research and 
development; the economic, political and regulatory 
contexts; and risk assessment) and (ii) factors that 
influence how such questions are answered (risk 
assessment guidelines; who conducts scientific 
studies). These factors influence what questions are 
researched, what evidence is produced, and ultimately 
what evidence is available to inform assessments such 
as this one and decision making more broadly. Essential 
to these concerns is the question of who is involved 
in asking and answering these questions. This section 
has three objectives: (a) to review the factors that 
impact what evidence this assessment considers; (b) to 
describe how the assessment navigated these factors; 
and (c) to discuss key evidence-related issues that will 
need to be navigated in future assessments concerning 
conservation applications of synthetic biology.
3.4.1 Research and development
In research and development, one of the first factors 
influencing the creation and use of evidence is how 
a synthetic biology product is designed in terms 
of desired attributes. For example, in the context 
of applying synthetic biology to an endangered 
organism for conservation purposes, this may entail a 
combination of assessing what traits should change 
to achieve a conservation goal, what traits should not 
change, and what ecological outcomes should be 
achieved. These design goals will impact the creation 
of evidence because they specify the focus of the 
studies conducted within the research and development 
process. This often includes examining potential risks 
caused by a product and how the design could be 
changed to minimise them. Due to the significant 
sway the research and development process has on 
the final forms technology takes, there have been 
repeated calls for inclusive engagement to inform this 
process (Jasanoff, 2003; Macnaghten et al., 2014).
3.4.2 Economic, political and 
regulatory contexts
Another arena that impacts what questions are asked 
is the economic, political and regulatory context. First, 
given the importance of economic profit and societal 
need in determining technological priorities, political and 
economic contexts are vital factors influencing what 
products make it to the research and development 
stage (see Chapter 6.3). Actors with economic and 
political power can exert influence over how problems 
are framed, which influences whether and how synthetic 
biology applications emerge as potential solutions. 
The political contestation over framing is thus a key 
factor influencing the generation of evidence (Bardwell, 
1991; Nelson, Andow & Banker, 2009). Second, the 
regulatory context can also influence how evidence 
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is created and used, as it often specifies the kinds of 
studies that need to be completed as part of human 
health and environmental safety review processes. 
If there are low levels of trust among communities, 
stakeholders and regulators, however, product 
developers may need to conduct a broader set of 
studies than those required by regulators to create 
the necessary trust in a product for a successful and 
supported deployment (Delborne et al., 2018).
3.4.3 Risk assessment
While the process of undertaking this assessment 
is not a risk assessment in itself, risk assessment is 
fundamental to the interaction of synthetic biology and 
biodiversity conservation. As such, this assessment 
necessarily draws upon the ideas within risk 
assessment (Chapters 4–6); the formal risk assessment 
process is also a governance tool for synthetic 
biology (Section 2.2.1). Ecological risk assessment, or 
environmental risk assessment, will be an important part 
of considering the environmental impacts of synthetic 
biology and gene drive. Ecological risk assessments 
can take many forms and vary based on the specific 
regulatory contexts, so the discussion here considers 
how the basic structure of ecological risk assessment 
influences the production and use of evidence. Risk 
assessment, along with risk communication and risk 
management, are classically defined as the three parts 
of risk analysis. The ecological risk assessment process 
embodies a mixture of explicit and implicit decisions 
impacting the production of evidence concerning the 
environmental risks of a particular application. Ecological 
risk assessment contains three major steps: problem 
formulation, exposure and effects analyses, and risk 
characterisation (Figure 3.2) (US EPA, 1998). While the 
specific form that ecological risk assessment takes 
depends upon the context and stressor in question, the 
overall steps generally stay the same. There are a host 
of decisions made across the risk assessment process 
that influence what questions are asked and determine 
what studies are called for to adequately assess the 
potential for harm (Hartley & Kokotovich, 2017).
Problem formulation is where the scope of the 
assessment and many other foundational decisions 
are determined, including identifying the stressors, 
ecological entities and risk hypotheses. Exposure 
analysis is used to assess with what likelihood, 
under what conditions, and to what extent the 
stressor will come into contact with the identified 
ecological entities. Effects analysis is used to 
assess the ecological effects that will result from 
potential levels of exposure. Risk characterisation 
synthesises the previous stages to assess the risk 
and address the initial goals of the assessment. 
Figure 3.2 Overview of the ecological risk assessment process. Adapted from US EPA, 1998.  
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Problem formulation is the step in the risk assessment 
process that most explicitly engages with the factors 
influencing what questions get asked. The influence 
of values-based decisions within problem formulation 
has been recognised and studied (Jensen et al., 2003; 
Thompson, 2003; Myhr, 2010), and participation from 
stakeholders and affected parties proposed as a way 
to transparently and productively incorporate diverse 
perspectives (Nelson, Andow & Banker, 2009). For 
example, determining whether changes to ecological 
entities represent harm, inconsequential change or 
beneficial change is fundamentally a question of values 
that may be answered differently based on worldview, 
perspective or lived experience. To ensure evidence 
is produced that is decision-relevant and trusted, it is 
thus important for engagement processes to integrate 
these value judgements within risk assessment in 
a deliberative, inclusive and context-appropriate 
way (NASEM, 2016a; Hartley & Kokotovich, 2017; 
Thompson, 2018). Engagement around potential 
applications of synthetic biology or gene drive, 
therefore, often needs to include local communities 
and indigenous peoples, who frequently hold different 
values and perspectives than scientific experts. 
It should also be acknowledged that this discussion 
of risk assessment is relevant for benefits assessment 
conducted for specific applications. Although the 
methods for benefits assessment are less developed 
and agreed upon than for risk assessment, 
adequately assessing potential benefits will be just 
as important for informing decision making about 
whether and how to use applications of synthetic 
biology and gene drive (NASEM, 2016a). Essential 
benefits-related questions include, for example, what 
beneficial impacts are likely to be realised and how 
will they be distributed? Who gets to define what 
counts as beneficial? What, if any, non-synthetic 
biology applications could achieve similar benefits?
3.4.4 Risk assessment 
guidelines and standards
Similar to the ways that risk assessment can influence 
what questions get asked, it can also influence how 
questions get answered; this is also true with regards to 
formal and informal standards for research processes 
(Knorr-Cetina, 1999). One part of risk assessment 
that influences how questions are answered is risk 
assessment guidelines, the cookbook-like instructions 
that guide how risk assessments for particular topics 
are completed (NRC, 1983; Suter II, 2016). While 
risk assessment guidelines differ based on topic (e.g. 
for human health, invasive species and genetically 
engineered plants), different guidelines can also exist 
for a particular topic. This is significant because 
these guidelines can call for different processes to 
be used when conducting studies. For example, 
differences between two risk assessment guidelines 
for assessing the non-target impacts of insect-
resistant, genetically engineered plants led to a variety 
of significant differences in how studies are to be 
completed, including: (1) whether surrogate species or 
local species are used in tests, (2) whether and when 
semi-field and field studies are completed, and (3) 
whether certain indirect effects need to be assessed 
(Hilbeck et al., 2011; Meyer, 2011; Kokotovich, 2014). 
These differences can be seen as contributing to 
different types of “selective ignorance” which result 
from “the wide range of often subtle research choices 
or ‘value judgments’ that lead to the collection 
of some forms of knowledge rather than others” 
(Elliott, 2013). As this example illustrates, different 
guidelines directly impact the form of the resulting 
evidence and therefore require careful attention.
3.4.5 Who conducts studies
Similar impacts on knowledge production can emerge 
as a result of who conducts studies that feed into 
risk assessment processes. First, the subtle research 
choices that are part of conducting scientific studies 
may be influenced by recognised or unrecognised 
assumptions and biases about a product’s safety 
(Krimsky, 2013). Therefore, it is vital to be aware 
of this potential and to remove potential conflicts 
of interest from the conduct of research. Second, 
differences across disciplines can alter how questions 
are answered – an ecologist will likely design and 
conduct studies differently than a toxicologist. Thus, 
disciplinary, institutional and personal affiliations all 
combine to influence the production of knowledge in the 
context of risk assessments. This phenomenon can be 
managed to some degree with explicit risk assessment 
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guidelines, commitments to transparency and the 
avoidance of perceived or real conflicts of interest.
3.4.6 Situating this assessment
This assessment relates to evidence in two ways: it 
is at once informed by evidence and also will serve 
as evidence. Throughout, the chapters draw upon 
and synthesise existing scientific studies, and are 
therefore based upon existing evidence. At the same 
time, this assessment will serve as an input into the 
IUCN policy process, and in that way it is evidence. 
One might ask, then, what this chapter on evidence is 
evidence for. First, while it falls outside of the scope of 
this assessment to conduct full-scale risk and benefit 
assessments on specific applications, this chapter 
affirms that risk and benefit assessments will provide 
a vital set of evidence to inform decision making on 
specific products and applications on a case-by-
case basis. What form risk and benefit assessment 
guidelines take and who is involved in conducting these 
assessments will be of consequence to the production 
and synthesis of evidence for decision making. The 
case-by-case nature of this decision making is key. 
The concern has been raised that conservation uses 
of synthetic biology will serve as a smokescreen for 
detrimental uses. That is, applications of synthetic 
biology that seem beneficial for the environment will lead 
societal actors, government regulators and the public 
more broadly to turn an uncritical eye towards future, 
more questionable synthetic biology applications such 
as those involving military-related ends or the corporate 
control over agriculture. However, the fact that one 
application may be beneficial in a certain social, political, 
economic and ecological context does not imply that 
the same technology would be beneficial in another 
context, and does not imply that other applications 
are more likely to be beneficial. Furthermore, different 
applications require different assessments, even if 
some knowledge is transferable. Polarised thinking 
that bundles all synthetic biology applications together 
for summary judgement, for or against, masks this 
complexity in favour of highly charged politics that fails 
to notice when different applications of synthetic biology 
could be beneficial, detrimental or a mix of both. Thus, 
this assessment should not be read as a judgement – 
positive or negative – on all synthetic biology or even all 
conservation applications of synthetic biology. Rather, 
it serves as an initial discussion of factors that will need 
to be considered in case-by-case decision making by 
the full range of appropriate stakeholders, operating 
with free access to all information, and informed 
by the framework of the precautionary principle.
Second, while it also falls outside of the scope of this 
assessment to suggest whether and how research and 
development on synthetic biology and gene drive should 
advance, this chapter emphasises how the evidence 
that will often take centre stage in such debates will 
depend not just on a narrow definition of scientific 
rigour, but rather on the way that multiple perspectives 
and values create the context for knowledge 
production. Important questions include how successful 
products are defined, what values determine the 
formulation of problems, how engagement integrates 
multiple perspectives in risk assessment processes, 
and who is trusted to produce credible knowledge. 
In the spirit of reflexivity, this chapter concludes with 
a reflection on such questions with regards to the 
assessment as a whole. First, in terms of context 
and scope, the priorities of the IUCN membership 
helped focus this assessment uniquely on the 
conservation implications of potential synthetic biology 
applications, including engineered gene drive systems. 
These priorities also helped determine the analytical 
framework used in this assessment to analyse potential 
applications of synthetic biology (see Chapter 4). 
Second, the selection of authors for this assessment is 
clearly consequential. Authors have primary expertise 
in a diversity of areas including synthetic biology, 
engineered gene drive systems, natural science, social 
science, conservation management, governance and 
law. A key aspect of this assessment’s scope involved 
an examination of the potential synthetic biology and 
engineered gene drive applications relevant to the 
conservation and sustainable use of biodiversity. To 
do this rigorously required engaging with those who 
are knowledgeable about the applications, such as 
those who have been involved in its development. 
Readers will notice that the authors of the case 
studies used in Chapters 5 and 6 are developers or 
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researchers closely tied to these applications. Many 
of these case study authors, due to their involvement 
in research and innovation processes, demonstrate 
enthusiasm for the potential of these applications 
to impact the world in beneficial ways. To provide 
balance, the assessment lead authors ensured that the 
discussion explored potential detrimental impacts on 
the conservation and sustainable use of biodiversity, 
as well as broader social, economic, cultural and 
ethical considerations, as mandated by WCC-2016-
Res-086. Thus, Chapter 2 explores issues surrounding 
governance, broadly defined; this Chapter 3 offers a 
critical and reflexive view of the production and use of 
evidence; and the case studies in Chapters 5 and 6 
specifically address each of the following questions:
• What is the conservation issue to be addressed?
• What are the existing interventions 
and their limitations?
• What is the synthetic biology 
intervention under consideration?
• What are the potential conservation benefits 
of the synthetic biology approach?
• What are the potential adverse effects 
and limitations of the approach?
• What are the relevant social, economic 
and cultural considerations?
Yet, even with attention to this balance of questions 
and the disciplinary diversity of the assessment 
authors, not all potential perspectives were captured 
in the assessment. This shortcoming was at least 
partially rectified through the process of open 
peer review, which generated 742 comments and 
critiques from persons across the globe that informed 
revisions to this final version of the assessment. 
This chapter thus concludes with the observation 
that this assessment is not – and cannot be – 
perfectly objective, unbiased and comprehensive. 
Instead, this report as a whole offers evidence and 
frameworks for analysis with the aim of informing 
future deliberations, within IUCN and more broadly, 
about the responsible innovation and governance of 
synthetic biology and engineered gene drive systems. 
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This assessment analyses synthetic biology and 
engineered gene drive and their potential impacts 
on biodiversity conservation in two ways: in general 
terms, summarising across the available evidence 
for the different potential types of application, and 
through case studies. This chapter focuses on 
the second of these types of evidence, the
case studies.
4.1 Role of the case studies
The case studies in the chapters that follow provide 
examples of potential applications of synthetic biology 
and engineered gene drive to conservation. The 
goal of the examples is to supplement the broader 
analysis of the evidence regarding such applications 
withmore focused discussions of potential benefits
and harms. 
The primary technical section of this assessment 
(Chapters 4–6) follows the two main categories 
of synthetic biology applications that can 
potentially impact biodiversity conservation:
• synthetic biology applications intended to have 
a conservation benefit (Chapter 5); and
• synthetic biology applications that have a 
different primary aim but could also have 
impacts on conservation goals (Chapter 6).
4.2 Selection process 
for case studies
The potential synthetic biology applications 
in conservation and across sectors of society 
are too broad, and the speed at which they 
are currently being developed too rapid, to 
describe all of them in this document. 
The Technical Subgroup is committed to the principle 
of inclusivity. Accordingly, the Technical Subgroup 
selected case studies in a way designed to present 
the breadth of issues that synthetic biology and 
engineered gene drive applications are trying to 
address — with respect to both conservation 
objectives and to diverse threats.Therefore, 
Chapter 5 is structured using two key conservation 
objectives: reducing threats to species; and improving 
species, community and ecosystem resilience
to threats.
When selecting the case studies, the Technical 
Subgroup carried out a horizon scanning of proposed 
applications to identify those that were already in 
development, as well as those frequently mentioned, 
either through publication, personal familiarity, or 
because they raise particular concerns by civil society 
or within parts of the conservation community. Only 
case studies for which there was adequate evidence 
of potential impacts were included. There is one 
additional box on chytridiomycosis in amphibians, 
for which there is no synthetic biology solution 
under development, but it is included because of its 
significant potential impact on biological diversity. 
There were initially 14 case studies considered 
for Chapters 5 and 6, but some of them were 
subsequently dropped because of lack of sufficient
published evidence. 
Case studies in Chapter 6 draw on applications 
from the broad categories of product replacement 
and pest management. The chapter also briefly 
discusses potential agricultural applications. There 
are clearly other categories in which synthetic biology 
interventions might indirectly affect conservation 
(e.g. in human health) but at this stage discussion 
of most of these would be speculative rather than 
evidence-based. The level of available knowledge 
differs amongst applications: for some, research 
is quite advanced and scientists participating in 
these developments were involved in drafting the 
case studies. For others, the Technical Subgroup 
members had to rely on publiclyavailable evidence. 
The case studies represent a diversity of applications 
and the level of data and evidence available for 
them varies (Table 4.1). This is one of the primary 
challenges for Chapters 5 and 6, and the authors 
have highlighted the related uncertainties pointing 
to areas where additional data are needed.
Case studies also vary in their scale and specificity. 
Some consider application to particular regions 
(e.g. preventing avian malaria impacts to Hawaiian 
birds), while others, frequently only speculative or 
at earlier stages of development, are more broadly 
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looking at the opportunity of using synthetic biology 
and engineered gene drive to address particular 
conservation goals (e.g. potential approaches to control 
or eradicate rodentsimpacting island biodiversity). 
Table 4.1 Characteristics of the case studies presented in Chapters 5 and 6.
Case study
1. Eradicating invasive 
rodents from islands
2. Controlling invasive 
mosquitoes to prevent bird 
extinctions in Hawaii
3. Synthetic biology to address 
conservation threats to 
black-footed ferrets
4. Transgenic American 
chestnut for potential 
forest restoration
5. Corals and adaptation to 
climate change/acidification
6. Horseshoe crab 
replacement for Limulus 
Amebocyte Lysate test
7. Gene drive approach 
for malaria vector 
suppression in Africa
8. Addressing honeybee 
colony collapse
5
5
5
5
5
6
6
6
Stage of development
Technical development underway, but 
laboratory proof of concept still to be achieved;
Social and policy engagement underway.
Technical development underway, but 
laboratory proof of concept still to be achieved;
Analysis of socio-economic and cultural 
considerations hasn’t yet been carried out.
Technical approach speculative;
could have a significant economic impact 
because of the indirect impact on grassland/
prairie ecosystem recovery.
Trees potentially ready for field trials;
Specific research on socio-economic and 
cultural considerations should be carried out 
to identify specifically what the benefits or 
adverse effects could be.
Technology development in early stages;
Specific socio-economic and cultural 
consideration assessment would need to 
consider a particular intervention in a given 
ecosystem and context.
Recombinant assay available since 2003; 
factors such as uncertainty over efficacy, 
regulation, availability and industry inertia have 
limited its adoption.
Technical development underway, but 
laboratory proof of concept still to be achieved;
Analysis of socio-economic and cultural 
considerations hasn’t yet been carried out. 
Technical approach speculative;
significant loss of pollinators can have a large 
impact on biodiversity and ecosystem services 
in natural landscapes.
Chapter Context and scale
Rodents impact island 
biodiversity globally
Vectors of disease 
impacting birds in Hawaii
Disease impacting black-
footed ferrets in North America
Disease impacting American 
chestnut in North America
Ocean warming impacting 
coral globally
Four Asian and North 
American species 
threatened by overuse 
in biomedical industry
Target transmission of malaria 
parasite by suppressing 
population of Anopheles 
mosquitoes in Africa
Colony Collapse Disorder 
associated with widespread 
loss of managed 
honeybee colonies
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4.3 Analytical framework 
for the case studies 
IUCN Resolution WCC-2016-Res-086 calls for 
an examination of “the organisms, components 
and products resulting from synthetic biology 
techniques and the impacts of their production 
and use, which may be beneficial or detrimental to 
the conservation and sustainable use of biological 
diversity and associated social, economic, cultural 
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and ethical consideration,” and “the implications 
of engineered gene drives and related techniques 
and their potential impacts on the conservation and 
sustainable use of biological diversity as well as 
equitable sharing of benefits arising from genetic 
resources.” The case studies presented in Chapters 
5 and 6, commissioned for this assessment, are 
centred around six questions, to provide the necessary 
context and provide examples of potential impacts: 
• What is the conservation issue to be addressed? 
• What are the existing interventions 
and their limitations? 
• What is the synthetic biology 
intervention under consideration? 
• What are the potential conservation benefits 
of the synthetic biology approach? 
• What are the potential adverse effects 
and limitations of the approach? 
• What are the relevant social, economic 
and cultural considerations?
4.3.1 Conservation issue
The case studies present a range of conservation 
issues that might be addressed through synthetic 
biology tools and techniques. For Chapter 5, these 
issues are directly related to conservation goals, while 
for Chapter 6 the issues are not directed at achieving 
conservation goals but are designed for other objectives 
(e.g. agriculture, human health, product replacement) 
but might have secondary impacts on conservation.
The authors of these case studies were selected on the 
basis of their expertise and familiarity with conservation 
issues and the potential synthetic biology applications. 
They are uniquely suited to describe the situation in 
a way that will foster deeper understanding of how 
synthetic biology and conservation may intersect. In 
most cases, the authors also have a strong interest in 
investigating the feasibility of the application, so they 
are not entirely neutral observers. The overall chapter 
authors reviewed the case studies (see Principle-
based assessment section below) and provide the 
necessary context for the case studies in the
accompanying text. 
4.3.2 Existing interventions and limits
While current conservation actions are yielding 
substantial positive impacts on biodiversity 
(Hoffmann et al., 2010), overall they are still falling 
well short of delivering on societal expectations and 
intergovernmental commitments to halt extinctions, 
prevent conversion of natural ecosystems, and maintain 
genetic diversity (Tittensor et al., 2014). In some 
cases, appropriate conservation tools exist, but the 
extent of their deployment is insufficient to mitigate the 
threat. For example, protected areas can be effective 
in safeguarding key biodiversity areas (Butchart et 
al., 2012) , even though many protected areas are 
not located in the most important places (Venter et 
al., 2018) and are insufficient to mitigate external 
threats like climate change (Bruno et al., 2018). 
The insufficient deployment of conservation tools 
is often due to a lack of resources, vested interests 
that oppose conservation, and other limitations 
that constrain taking successful conservation 
actions to the necessary scale. In addition, there 
are some gaps between actions and impacts 
because conservation tools simply do not exist 
to mitigate certain threats, for example, chytrid 
fungal disease in amphibians (Section 5.3.1). 
The case studies attempt to frame the potential 
benefits of proposed synthetic biology and engineered 
gene drive approaches in light of current, more 
conventional conservation interventions (in other 
words, the “counterfactual” (Ferraro & Pattanayak, 
2006)). As such the current interventions and 
their potential limits are briefly analysed. 
4.3.3 Synthetic biology description
Each case study describes how synthetic biology 
may be used to address the identified challenge. 
As not all approaches are equally advanced, the 
descriptions range from theoretical ideas that still 
need to be demonstrated, to applications that 
have already been extensively researched and 
have yielded proof of principle (showing evidence 
that the concept can work as anticipated in the 
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laboratory) to a few cases where researchers have 
evidence that their technology is ready to make 
regulatory applications for small-scale field testing.
The case studies briefly describe the proposed synthetic 
biology approach, and what the application intends to 
achieve. In most cases, the case studies do not provide 
the technical details of these applications; references 
are provided to scientific papers, and Appendix 3
(www.iucn.org/synbio) presents the technical details. 
The scale or specificity of the approach is also included 
in the technology description. To the fullest extent 
possible, the case studies describe the feasibility of the 
proposed approach and its current level of progress.
4.3.4 Potential conservation benefits
This assessment is not a benefit assessment, but rather 
provides initial indications of potential conservation 
benefits that might warrant further considerations 
in future case-by-case benefit assessments. This 
section looks at the extent to which synthetic biology 
applications could potentially complement or even 
replace existing interventions or address some of 
the limits of those interventions. This section also 
points to knowledge gaps that are common for 
technologies in early stages of development.
4.3.5 Potential adverse 
effects and limitations
This assessment is not a risk assessment, but rather 
provides initial indications of potential adverse effects 
that might warrant further considerations in future 
risk assessments. Concerns raised by stakeholders 
are also presented when known from literature or 
other published information. Risk assessment is a 
complex and thorough process for any technology 
(Section 3.4.3). Existing risk assessment frameworks, 
some of which are embedded in regulation, and 
information on past exercises (for instance from 
the Living Modified Organism experience) are also 
available (Section 2.2.1). A full-fledged risk assessment 
requires, among other things, consideration of the 
specific characteristics of the organisms, as well as 
of the receiving environment (UN CBD, 2000).
4.3.6 Social, economic and 
cultural considerations
All significant conservation actions have consequences 
for human economy and cultures, some positive 
and some negative. Conservation has often 
had particularly significant impacts, positive and 
negative, on indigenous, and other peoples due to 
their greater reliance on goods and services from 
the natural environment (Garnett et al., 2018).
Socio-economic and cultural considerations are 
important in assessments by IUCN and other 
institutions, as well as decision-making frameworks 
for technologies (UN CBD, 2000). Conner (2016) 
proposes a rigorous approach for full evaluation of 
socio-economic dimensions that can analyse both 
the potential opportunities and adverse impacts. 
However, similar to a risk assessment, the assessment 
of socio-economic and cultural considerations 
requires specific information about the technology 
proposed and the receiving society, economy and 
culture. Therefore Chapters 4 and 5 identify areas 
where socio-economic and cultural considerations 
would need to be taken into consideration according 
to existing evidence — when available — and will 
warrant further studies and/or consultation, usually on 
a case-by-case basis. Whenever possible, the socio-
economic and cultural considerations for the proposed 
synthetic biology approach should be weighed 
against those of more conventional interventions. 
4.3.7 Principle-based assessment 
Scholars studying responsible research and innovation 
emphasise the importance of key principles to inform 
the governance of emerging technologies (Chapter 2.1). 
Recognising the need for a broad and inclusive process, 
the Technical Subgroup charged with completing this 
assessment developed a set of principles that have 
guided its work (see Front Matter). The underlying 
principles of objectivity and robustness adopted for 
this process have been rigorously applied to each 
case study. The process of writing these case studies 
has been iterative. Case study authors were asked 
to present their text based on the framework and the 
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Technical Subgroup members reviewed the objectivity 
and robustness of content. Drawing from the principle 
of objectivity, the Technical Subgroup then ensured 
that the case studies were objective; this is, they were 
not written from an advocacy perspective but that 
statements were based on available evidence. The 
reviewers also ensured that the cases were robust; that 
is to ensure that the strength of statements made was 
justifiable. Case studies are presented in boxes, with 
context provided in the accompanying text of Chapters 
5 and 6 to fulfil the mandate outlined in the Resolution.
Many case studies present applications that are still in 
the early days of development and testing, so a high 
degree of uncertainty remains about what the final 
technology could be, as well as the exact potential 
benefits, adverse impacts, and social, economic and 
cultural considerations. It is essential to recognise 
uncertainty when presenting these case studies 
(Section 3.3), and when possible to identify some of 
the knowledge gaps that might need to be further 
evaluated for decision making on potential technology 
application. Although not within the scope of this 
assessment, rigorous, context specific, case-by-
case risk assessments need to be completed for any 
future proposed synthetic biology and engineered 
gene drive applications. The discussion of potential 
adverse effects included within these case studies 
may help inform these formal risk assessments, but 
they are in no way substitutes for them. Oliver (2018) 
demonstrates how uncertainties — often confused 
with risks — can shape public acceptance and 
decision making. It is thus important to recognise 
the level of uncertainty in the case studies. 
5 .
Synthetic biology 
applications intended for 
conservation benefit 
Daniel M. Tompkins, Elizabeth L. Bennett, Hilde Eggermont
Image by: Free styler / Shutterstock.com
5.1 Overview  
Biodiversity decline has dramatic ecosystem-
wide consequences for how species interact, 
how communities are organised, and the ability of 
ecosystems to provide services such as nutrient 
cycling and carbon sequestration. The loss of 
biodiversity is at least equal to climate change as a 
driver of ecosystem change (Hooper et al., 2012). 
About 50 per cent of the Earth’s land has been 
converted to cropland, rangeland and urban areas, 
with net natural forest area declining annually by 
65,000 km2 between 2010 and 2015 (FAO, 2017).
In the past two decades, many global, regional and 
national policies and legislations promoting biodiversity 
conservation have been adopted or expanded (Section 
1.8). Some successes have been achieved (Sodhi 
et al., 2011); examples include the recovery of great 
whale populations globally (Gales, 2011), and the more 
local improving conservation status of the giant panda 
(Swaisgood, Wang & Weif, 2016; Xu et al., 2017) and 
Arabian oryx (IUCN SSC Antelope Specialist Group, 
2013; Barichievy et al., 2018). However, biodiversity 
continues to decline globally, with an estimated 25 
per cent, 13 per cent and 41 per cent of all mammals, 
birds and amphibians respectively threatened with 
extinction in 2017, up from 19 per cent, 10 per cent 
and 2 per cent respectively in 1996/98 (IUCN, 2017).
The conservation of biodiversity requires the continued 
application of proven approaches; e.g. a greater 
proportion of the planet being designated as protected 
areas and managed effectively (Jones et al., 2018), and 
a step-up in the management of invasive alien species 
(IUCN, 2016). However, past experience has shown 
that scaling these efforts up to the level necessary 
to reverse the declines in biodiversity and allow for 
Figure 5.1 The proportion of extant (ie., excluding extinct) species in The IUCN Red List of Threatened Species. Version 2019-1 assessed 
in each category for the more comprehensively assessed groups. The numbers to the right of each bar represent the total number of 
extant species assessed for each group. EW - Extinct in the Wild, CR - Critically Endangered, EN - Endangered, VU - Vulnerable, NT 
- Near Threatened, DD - Data Deficient, LC - Least Concern. Adapted from IUCN Red List of Threatened Species Summary Statistics. 
http://www.iucnredlist.org
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recovery will continue to be a major challenge using 
current approaches, given the costs and the seemingly 
intractable nature of some of the threats (Veitch & 
Clout, 2002; Glen et al., 2013). Certain synthetic 
biology applications, if appropriately designed and 
targeted, may have potential for enhancing biodiversity 
conservation, while others could potentially damage 
it (Redford et al., 2014; Piaggio et al., 2017).
This chapter explores how engineered gene drives 
and synthetic biology organisms, applications and 
products might directly benefit or impact conservation 
through their use for the purpose of conservation 
management. It thus focuses specifically on situations 
where the intended use of synthetic biology is to 
achieve conservation goals or protect conservation 
values. It explores the potential positive conservation 
outcomes from such applications and details 
important considerations, while also recognising 
that many situations, if not managed appropriately, 
could potentially also have negative impacts on 
conservation. The chapter will review potential 
applications of synthetic biology and engineered 
gene drives that could reduce threats to species, 
and improve species, community and ecosystem 
resilience to threats. It will introduce and draw upon 
specific case studies that use the framework outlined 
in Chapter 4 to illustrate the direct conservation 
impacts, both positive and negative, and the potential 
benefits and adverse effects associated with some 
of the potential applications of synthetic biology.
5.2 Mitigation of threats
5.2.1 Tackling invasive alien species
The increasing global complexity of transportation 
systems on land, air and sea has broken down 
the natural barriers to species movements formed 
by rivers, oceans and mountains, the barriers that 
isolated populations and allowed species diversity to 
evolve and be maintained (DiCastri, 1989; Meyerson 
& Mooney, 2007). As a result, invasive alien species 
effects on native wildlife and ecosystems are immense 
(IUCN, 2000) being the second biggest driver of 
species extinction (Clavero & García-Berthou, 2005; 
Bellard, Cassey & Blackburn, 2016) and having large 
negative impacts on ecosystem function (Pejchar 
& Mooney, 2009; Ehrenfeld, 2010). Invasive alien 
species also cause multiple other costs globally; for 
example, they cause huge infrastructure damage 
(Scalera et al., 2012; IASC, 2016), and agricultural 
losses in Australia due to invasive alien species were 
estimated to be worth an average of A$ 620 million 
per annum over five years (Gong et al., 2009). 
Invasive alien species are found in all taxonomic 
groups, from fungi and bacteria to mosses, higher 
plants, invertebrates and vertebrates (Lowe et al., 
2000), and their impacts can be exacerbated by 
habitat disturbance and climate change (Early et al., 
2016). Of 170 animal extinctions for which the causes 
of extinction are known, 20 per cent and 54 per cent 
are solely and partly due to invasive alien species 
respectively (Clavero and García-Berthou, 2005). A 
total of 1352 mammal, bird, reptile and amphibian 
species worldwide classified as threatened (i.e. in the 
IUCN Red List, Vulnerable, Endangered or Critical 
categories) are primarily imperilled by invasive alien 
species impacts (Bellard, Genovesi and Jeschke, 2016). 
The number is particularly high for amphibians (N = 
565; ~8 per cent of amphibian species) and birds (N 
= 443; ~5 per cent), compared with mammals (N = 
183; ~3 per cent) and reptiles (N = 161; ~2 per cent).
Invasive alien species are the primary driver of species 
extinctions on islands (Doherty et al., 2016; Spatz 
et al., 2017). Islands make up 5.3 per cent of the 
Earth’s land area, yet maintain an estimated 19 per 
cent of bird species, 17 per cent of rodents and 17 
per cent of flowering plants (Tershy et al., 2015). 
They are also home to invertebrate assemblages 
with frequently high levels of endemicity and often 
performing key ecosystem functions (St Clair, 2011). 
Species diversity is disproportionately threatened on 
islands in relation to the islands’ proportion of both 
global land area and species, with 37 per cent of 
all critically endangered species being confined to 
islands. Sixty-one per cent of all extinctions within the 
last 500 years have been island species, and invasive 
alien species are one of the most important threats to 
remaining insular diversity. For vertebrates, seabirds 
are especially vulnerable since most species are 
obligate island breeders where their colonial ground-
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breeding behaviour has evolved in isolation from 
terrestrial predators (Schreiber & Burger, 2001). For 
invertebrates, large-bodied species are particularly 
threatened by invasive rodents (St Clair, 2011).
Non-native diseases, frequently vectored by non-native 
animals, also have had and continue to have large 
impacts on animal, plant and human health, impacting 
biodiversity and other values (Crowl et al., 2008; 
Hulme, 2014; Tompkins et al., 2015). For example, 
avian malaria, vectored by non-native mosquitoes, is 
the primary cause of endangerment and extinction of 
endemic Hawaiian honeycreepers, among the most 
critically endangered birds globally (Liao et al., 2017), 
with impacts also in regions such as the Galapagos 
Islands (Wikelski et al., 2004). Similarly, the spread of 
chytrid fungus threatening amphibians globally (Fisher, 
Garner & Walker, 2009) is considered to have been 
facilitated by the introduction of non-native species 
(Fisher & Garner, 2007). Such issues can potentially 
be addressed by managing either threatened hosts 
(e.g. management to increase their resilience to 
disease) or any vectors of disease (e.g. by reducing 
their populations or their vector competence).
Synthetic biology offers potential novel approaches 
to managing invasive alien species, but as with any 
management approach there are also potential 
adverse effects (Harvey-Samuel, Ant & Alphey, 2017; 
Ricciardi et al., 2017). The applicability of different 
actions for invasive alien species management tends 
to vary across scale, with the success of actions 
frequently being limited as spatial scale increases 
(Veitch & Clout, 2002; Glen et al., 2013). In addition 
to the management of established ‘legacy’ invasive 
alien species that are currently impacting biodiversity, 
synthetic biology and engineered gene drive also offer 
novel potential approaches for rapid response and 
eradication of new invasive alien species incursions. 
In such contexts, synthetic biology application may 
be more feasible and have less potential adverse 
effects due to management efforts being more tactical, 
targeted and at a smaller scale. The benefit and 
adverse effect profiles of applying potential synthetic 
biology approaches to the management of invasive 
alien species will thus likely vary with both application 
scale, context and targeted species or population.
5.2.1.1 Potential synthetic biology 
applications: Management of 
invasive vertebrates
Especially damaging invasive alien species include 
cane toads, rodents, pigs, goats, carp and crayfish, 
and mammalian predators such as feral cats, foxes, 
raccoons, stoats and mongooses (Moro et al., 2018). 
Invasive mammals are the main cause of animal 
extinctions on islands, both by direct predation – 
especially of birds and their eggs – and also destruction 
of native habitat (Doherty et al., 2016; Spatz et al., 
2017). Feral cats on islands are responsible for at 
least 14 per cent of global bird, mammal and reptile 
extinctions, and are the principal threat to almost 8 per 
cent of critically endangered birds (mainly seabirds), 
mammals and reptiles (Medina et al., 2011).
Eradicating invasive mammals has been attempted 
on more than 700 islands globally; at least 107 highly 
threatened birds, mammals and reptiles on the IUCN 
Red List of Threatened Species (6 per cent of highly 
threatened species) have probably benefited from 
invasive mammal eradication on islands (Jones et al., 
2016). Some species are seemingly easier to eradicate 
than others; goats have been successfully eradicated 
from 120 islands worldwide using a combination of 
approaches (Campbell & Donlan, 2005). Rodents 
have been eradicated successfully on 73 per cent of 
the 387 islands where rodenticide programmes have 
been deployed; however, for many other islands where 
invasive rodent eradication would benefit threatened 
species it is not possible to use rodenticides at this 
time due to social and biological barriers (Howald et 
al., 2007; Campbell et al., 2015). Feral cat eradication 
had been achieved on at least 83 islands worldwide, 
including 11 large islands over 2000 hectares (Parkes et 
al., 2014), but remains challenging particularly on islands 
with significant human presence (Nogales et al., 2004).
Current control techniques for invasive alien mammal 
species typically consist of integrated chemical 
and physical management practices (e.g. poison 
baiting combined with fencing), direct intervention 
(e.g. shooting, trapping) and biological control with 
natural enemies (Eason et al., 2017). Eradication 
programmes can be costly, particularly over larger 
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areas, and have varying levels of efficacy (Bomford & 
O’Brien, 1995; Courchamp et al., 2003); eradicating 
invasive alien species entirely is challenging, and 
the results of local eradication are often short-term 
if sources for reinvasion persist (Myers et al., 2000). 
Impacts on non-target species are also a concern; 
for example, poison deployment requires extensive 
planning and caution to minimise mortalities of non-
target species (Pitt et al., 2015; Novak, Maloney & 
Phelan, 2018). Poison baits aimed at invasive alien 
species have caused declines of non-target species 
that eat them, although populations in most cases 
then recover once the invasive alien species have been 
eradicated (Jones et al., 2016). Biological control of 
invasive alien mammal species offers target species-
specificity and landscape scale applicability (due to 
its self-disseminating nature), for which there have 
been some population suppression successes (e.g. 
biological control of rabbits in Australia; Cooke et al., 
2013); but evolution of resistance generally necessitates 
periodic release of novel control agent strains or 
species (Cox et al., 2013) and there are societal 
concerns over non-target population impacts (e.g. to 
domestic rabbits). There is also increasing concern 
with regards to animal welfare about the impacts of 
current control techniques for invasive alien species 
management, particularly when applied to invasive 
mammals (Littin et al., 2004; Warburton et al., 2012). 
These constraints are causing scientists and managers 
to seek additional tools that are more species-specific, 
economical, self-sustaining, and with lower animal 
welfare impacts; however, there are currently no widely-
applicable alternative solutions (Campbell et al., 2015).
For potential synthetic biology application to vertebrate 
invasive alien species, attention is currently focusing on 
engineered gene drive systems (Chapter 1.4) with the 
potential for self-dissemination through populations over 
generations (Campbell et al., 2015; Piaggio et al., 2017). 
This is because, with the exception of approaches 
based on traditional biocontrol, non-gene-drive control 
is generally not self-disseminating and thus logistically 
more challenging to employ at a landscape scale 
(Moro et al., 2018). While researchers can envisage 
non-gene-drive solutions for some vertebrate pests, 
such as cane toad, bighead carp and sea lampreys 
(Harvey-Samuel, Ant & Alphey, 2017), such approaches 
have more potential hurdles to overcome (linked to 
the large numbers of organisms needing to be reared 
and released) than approaches with more potential 
for self-dissemination such as engineered gene drive 
systems (Appendix 3 (www.iucn.org/synbio)).
All engineered gene drive systems are currently only 
theoretical for application to vertebrates (Appendix 3 
(www.iucn.org/synbio)). Functional engineered gene 
drive mechanisms are not yet developed in such 
species (Grunwald et al., 2018). There is also the 
challenge of identifying genetic manipulations that 
cause the desired population-scale effects when 
spread by drive mechanisms (Gemmell & Tompkins, 
2017). These could potentially be of multiple forms, 
such as gene cargos (genes that drive mechanisms 
are used to increase the frequency of) or endogenous 
gene knock-outs (i.e. drive mechanisms spreading 
loss of function) that cause population decline 
when spread (Burt, 2003). With the relative ease of 
applying the CRISPR-Cas9 toolkit for gene editing, 
the identification of suitable genetic manipulations to 
spread with engineered drive mechanisms is likely 
the bigger hurdle, and there is no evidence yet that 
it can be overcome for vertebrate pest targets.
Engineered gene drive approaches to invasive alien 
species management will also be generally less 
applicable to invasive vertebrates than other invasive 
alien species taxa, due to gene spread through 
populations taking longer to occur in species with longer 
generation times. There are also practical issues that 
may limit gene drive efficacy when applied in the field, 
such as reproductive behaviour (Gemmell & Tompkins, 
2017), spatial and temporal heterogeneity in populations 
and landscapes (Deredec, Burt & Godfray, 2008) and 
evolution of resistance (Unckless, Clark & Messer, 2016; 
Champer et al., 2018). Thus, such approaches, while 
offering potential for application to vertebrate pests, 
have several developmental hurdles to overcome. 
Given the relationship to generation time noted 
above, and the role of the mouse as a model species 
for genetic studies, should engineered gene drive 
population suppression or eradication for vertebrate 
invasive alien species management be achievable 
it will most likely be first developed for rodents.
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Case study 1:
Eradicating invasive rodents
from islands   
Nick Holmes, Karl Campbell
Issue
Rodents remain one of the most widespread 
invasive species, estimated to occur on 80 per 
cent of the world’s island groups (Atkinson, 
1985), where they contribute to species decline 
and extinction via mechanisms including 
predation and disruptive habitat modification. 
The eradication of invasive rodents has been 
applied on more than 500 islands globally 
(Russell & Holmes, 2015), with demonstrable 
conservation benefit (Jones et al., 2016).
Existing interventions and limitations
The current toolbox for insular rodent eradications 
relies on the sufficient application of anticoagulant 
rodenticides into every potential rodent territory on 
an island (Broome et al., 2014). Despite significant 
advances in the use of these toxicants over recent 
decades, in many situations these eradication 
methods are extremely challenging or unfeasible. 
These include islands with significant human 
populations, stakeholder communities adverse 
to the method, co-occurrence of livestock and 
domestic animals, or potential negative impacts 
to native species (Campbell et al., 2015).
Synthetic biology and engineered 
gene drive description
Synthetic biology presents potential solutions to 
overcome these challenges by using, among other 
approaches, engineered gene drive systems to 
bias gene inheritance throughout a population to 
drive it to local extinction, for example by distorting 
the sex ratio (Webber, Raghu & Edwards, 2015). 
In such cases, the drive mechanism employed 
would need to be strong enough to overcome 
any selective disadvantage incurred by the 
individuals carrying the genetic manipulation for it 
to spread. The potential benefits include species 
specificity, reduced toxicant use, more humane 
(non-lethal) approaches and expanded application 
on human inhabited islands (Campbell et al., 
2015). This represents a potentially transformative 
advance for the island restoration field not 
readily achievable with current technology.
Potential adverse effects and limitations
Three general potential adverse effects are evident 
in considering synthetic biology for invasive 
rodents. First is the concern of direct effects on 
the biology and ecology of non-target species, and 
associated community and ecosystem knock-
on effects, due to genetic changes spreading to 
them from targeted species. Since animals are 
largely unaffected by horizontal gene transfer 
and thus gene transfer generally only occurs 
through sexual reproduction (Andersson, 2005), 
this is a minimal concern for islands where no 
related species occur (Campbell et al., 2015). 
In addition, multiple genes are generally needed 
for phenotypic change, and these vary from 
species to species (Johnson et al., 2016).
Second is the concern of effects on non-target 
populations of the same species, and associated 
community and ecosystem knock-on effects, due 
to gene modified organisms moving beyond the 
target population; i.e. they swim or are transported 
beyond the target site by human activity. The 
likelihood of such occurring is logically reduced 
if the target population is restricted to one or 
more isolated islands rather than being closer to 
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other land-masses. Notably, rodent incursions 
to islands have been effectively managed using 
biosecurity policy and protocols (Russel et 
al., 2008), offering confidence in the ability to 
prevent rodent movement away from islands. 
Third is the concern that rodent elimination could 
have adverse effects on food webs or impact 
ecosystem processes; however, this could occur 
for eradications using either traditional toxicant 
or synthetic biology methods, and consideration 
of such effects is an existing recommendation 
for management (Zavaleta et al., 2001).
Social and regulatory acceptability are as 
significant as technical factors, and these three 
components are prerequisites for any potential 
field trial or future release. Social acceptability will 
be strongly influenced by the public’s perceptions 
of the need for action, potential efficacy of the 
technology, potential benefits and adverse effects, 
and how these inter-relate with socio-economic 
and cultural factors. Regulatory acceptability will 
depend upon the specific country, state, local 
regulations and case-by-case assessments.
Technical uncertainties in deploying genetic 
biocontrol to eradicate invasive rodents from 
islands include the engineering of modified 
rodents, competitiveness of modified rodents 
in wild populations, and potential resistance to 
engineered gene drive systems over multiple 
generations (and hence the ability to achieve 100 
per cent gene transfer throughout the population to 
achieve eradication). Research needed to reduce 
these technical uncertainties, allowing adverse 
effects to be minimised and potential gains to 
be maximised, includes advancing knowledge 
of genome engineering, mating success of 
engineered and wild rodents, mechanisms to 
contain engineered gene drive systems locally 
or temporally (Dhole et al., 2018) and delivery 
strategies. Such knowledge will be necessary for 
any field trial proposal to be effectively evaluated.
There is yet no consensus on what type of field 
sites may be best for trialling genetic biocontrol. 
At this stage, potential trial sites need to be 
considered on a case-by-case basis. Key technical 
factors on which such consideration should 
House mouse (Mus musculus) (Rudmer Zwerver / Shutterstock.com)
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be based, for potential application to invasive 
rodents on islands, would include characteristics 
of the target population, the local ecosystem, the 
characteristics of the modification introduced, 
the potential for off-island dispersal, the ability to 
conduct comprehensive monitoring and the ability 
to shut down trials (e.g. with traditional rodenticide 
methods) should such a step be required.
Technologies to engineer mice, and more recently 
rats, are well established and have been used for 
several decades for biomedical applications. The 
genetic approaches for eradicating or reducing 
the impact of invasive rodents are still in their 
infancy; the timeline to develop a comprehensive 
field trial proposal is estimated to be a decade 
(http://www.geneticbiocontrol.org/). Urgency 
exists because the motivation for developing 
new tools – extinctions and endangerment on 
islands – continues (Doherty et al., 2016).
Socio-economic and cultural considerations
Although the situation will differ depending on 
the island considered, some potential areas for 
impacts of rodent eradication using synthetic 
biology approaches on socio-economic and 
cultural considerations can be identified: (i) 
perception of likely effectiveness of the method; 
(ii) acceptability of genetic modification as 
interpreted by cultures and belief systems at a 
particular site; (iii) perceptions of, and likely positive 
and negative impacts to natural resources and 
culturally significant species; (iv) perceptions of, and 
potential positive and negative impacts to income 
generating activities such as tourism, farming, 
agriculture and exports; (v) potential human health 
benefits due to the reduction of rodents that 
could vector diseases (Morand, Jittapalapong 
& Kosoy, 2015); and (vi) the socio-economic 
and cultural effects of accidental transfer to
non-target populations.
5.2.1.2 Potential synthetic biology 
applications: Management of 
invasive invertebrates and plants
Priority invasive alien species threats to native 
species cover the full range of biological taxa (Lowe 
et al., 2000). Thus, while invasive vertebrates 
are a large issue, especially on islands, mainland 
conservation and biodiversity impacts are also 
frequently incurred from invasive invertebrates and 
plants, and also introduced disease (Section 5.3.1).
For the management of invasive invertebrates impacting 
biodiversity, engineered gene drive is arguably closer 
to realisation than for vertebrates, and likely more 
applicable due to generally shorter generation times 
leading to faster spread through populations. Indeed, 
it has been argued that engineered gene drive for the 
management of conservation pests should logically 
be developed first for invasive invertebrates such as 
common and German wasps (Dearden et al., 2017). 
Technology development for application to invertebrates 
is further developed than for vertebrates, both in-silico 
(mathematical modelling on computers) and in the 
laboratory. In general, a variety of self-disseminating 
engineered gene drive systems have been proposed, 
with many now functional at the proof-of-principle 
stage in several targeted insect species, predominantly 
mosquitoes (Sinkins & Gould, 2006; Harvey-Samuel, 
Ant & Alphey, 2017). It is also generally accepted that 
there are fewer technological hurdles to overcome (i.e. 
simpler genetic control of breeding than in vertebrates, 
making it easier to identify target genes for desired pest 
control effects), and potentially fewer ethical, social and 
cultural issues surrounding application for invertebrate 
as opposed to vertebrate invasive alien species control.
For the management of invasive invertebrates impacting 
biodiversity, many non-gene-drive synthetic biology 
control approaches may also be applicable. This is 
because it is more feasible to breed large numbers 
of target invertebrates over extended periods of time 
than target vertebrates. So, approaches such as 
Release of Insects carrying Dominant Lethals (RIDL) 
and Wolbachia reproductive sex-bias (Appendix 4 
(www.iucn.org/synbio)) may have greater potential 
in this context than for the management of
invasive vertebrates.
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For the management of invasive plants impacting 
biodiversity, the synthetic biology approaches currently 
under consideration for application to vertebrates and 
invertebrates are less relevant; they only potentially 
apply to strictly sexually reproducing species, with 
highest efficiency predicted for short-lived taxa, while 
many plants are capable of breeding asexually and 
can be long-lived (e.g. trees). However, researchers 
are exploring genetic methods for controlling sexually 
reproducing short-lived weed species such as 
waterhemp (Amaranthus rudis and A. tuberculatus) 
and Palmer amaranth (A. palmeri) (Appendix 3 (www.
iucn.org/synbio); https://www.eurekalert.org/pub_
releases/2018-03/uoic-uii032818.php). Researchers 
claim that synthetic biology could eradicate invasive 
plants where conventional approaches cannot, while 
avoiding non-target impacts of herbicide application. 
Mechanisms currently being explored are male-
biased reproductive sex ratio engineered gene drive 
approaches similar to those being investigated for 
invasive animals. For other invasive plants, genetic 
alterations are being considered to improve the 
efficacy of traditional biocontrol approaches (Gressel, 
2002; Duke, 2003; Tranel & Horvath, 2009).
Case study 2:
Controlling invasive mosquitoes to 
prevent bird extinctions in Hawaiʻi   
Chris Farmer, Brad Keitt
Issue
Native Hawaiian forest birds are among the most 
threatened in the world. It is widely accepted 
that introduced mosquito-vectored avian 
malaria and pox virus are responsible for past 
extinctions, and ongoing range contractions 
and declining populations (Atkinson & LaPointe, 
2009a; Atkinson & LaPointe, 2009b). No native 
mosquitoes are present in Hawaiʻi. The southern 
house mosquito (Culex quinquefasciatus) was 
introduced to Hawaiʻi in the early 1800s, avian 
pox arrived in the late 1800s, and avian malaria 
in the early 1900s. With no prior exposure or 
natural immunity, the native songbirds were, and 
remain, highly susceptible to these non-native 
pathogens transmitted by C. quinquefasciatus. 
These factors contributed to the extinction of 
more than 24 species of Hawaiʻi’s honeycreepers, 
plus another seven species from other taxa 
(Pyle & Pyle, 2017) including the extinction of 
the entire Mohoidae family (Fleischer, James &
Olson, 2008).
Presently, almost no native songbirds exist in 
Hawaiʻi at elevations below 1,370 metres, where 
mosquitoes are abundant. With global warming, 
mosquitoes are expanding into higher elevation 
forests and causing rapid declines in many native 
bird populations (Atkinson et al., 2014; Fortini et 
al., 2015; Paxton et al., 2016). Mosquitoes are 
expected to spread to all remaining disease-free 
forest habitats and cause the extinction of up to 
12 species of Hawaiʻi’s remaining honeycreepers 
(Atkinson & LaPointe, 2009a; Atkinson & 
LaPointe, 2009b; Fortini et al., 2015; Paxton et 
al., 2016) and have a strong negative effect on 
the remaining native thrushes, flycatchers and 
corvid (Atkinson & LaPointe, 2009b; Vanderwerf 
et al., 2006; Atkinson et al., 2014; Fortini et al., 
2015). However, populations of three honeycreeper 
species are showing signs of resistance or 
tolerance in lowland populations, and might be 
able to survive an increase in disease prevalence 
(Woodworth et al., 2005; Krend, 2011; Atkinson
et al., 2013).
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Existing interventions and limitations
Significant effort is dedicated to the conservation of 
Hawaiʻi’s forest birds, including localised predator 
control, habitat restoration and management, and 
captive propagation. However, most populations 
Southern house mosquito (Culex quinquefasciatus) (Gado Images / Alamy.com)
‘I’iwi (Drepanis coccinea) (Thomas Chlebecek / Shutterstock.com)
continue to decline (Gorresen et al., 2009; 
Paxton, Gorresen & Camp, 2013; Paxton et al., 
2016; Genz et al., 2018; Judge et al., 2018). For 
example, two honeycreeper species on Kauaʻi, 
the ‘Akeke’e (Loxops caeruleirostris) and the 
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‘Akikiki (Oreomystis bairdi), both listed by IUCN 
as Critically Endangered, have shown recent 
population declines of 89–98 per cent and are 
projected to become extinct in the near future 
(Paxton et al., 2016). Maui parrotbill (Pseudonestor 
xanthophrys), or Kiwikiu, is also listed by IUCN 
as Critically Endangered, with only a few hundred 
individuals left and is projected to lose 90 per cent 
of its habitat due to climate change, mosquitoes 
and avian disease (Fortini et al., 2015; Judge et 
al., 2018). The ‘I’iwi (Drepanis coccinea), likely 
Hawaiʻi’s most iconic bird, is declining and was 
declared as threatened by the US Fish and Wildlife 
Service in 2017 and Vulnerable by IUCN (Paxton, 
Gorresen & Camp, 2013; US FWS, 2017). The 
species is highly susceptible to avian malaria 
(Atkinson et al., 1995; Atkinson & LaPointe, 2009a).
Efforts to address the issue of mosquito-vectored 
avian diseases to protect Hawaiian forest birds 
are limited, primarily because few tools have been 
available (LaPointe, Atkinson & Samuel, 2012; 
Reed et al., 2012). Spray insecticides would 
cause significant damage to native arthropod 
populations, and likely have direct negative impacts 
on forest birds (LaPointe et al., 2009; Reed et al., 
2012). Reducing mosquito breeding sites is being 
attempted, but in what are some of the wettest 
and most rugged habitats on earth, this is only 
practical at small scales and is impossible at a 
landscape scale (LaPointe et al., 2009; LaPointe, 
Atkinson & Samuel, 2012). It is clear that these 
conventional mosquito control methods are unlikely 
to safely and permanently suppress or eradicate 
mosquitoes and mosquito-borne avian disease in 
Hawaiian forests (LaPointe et al., 2009; LaPointe, 
Atkinson & Samuel, 2012; Reed et al., 2012).
Synthetic biology description
The US Fish and Wildlife Service, Hawaiʻi 
Department of Land and Natural Resources, and 
the American Bird Conservancy are exploring the 
Wolbachia Incompatible Insect Technique (IIT). 
Wolbachia is a naturally occurring genus of bacteria 
found in 50 per cent of arthropods (Weinert et al., 
2015). This technique involves injecting mosquitoes 
with a novel strain of Wolbachia in a lab and rearing 
large numbers of infected mosquitoes. While 
Wolbachia-infected males can reproduce with 
females infected with the same strain of Wolbachia, 
and their offspring will also harbour Wolbachia, 
Wolbachia males cannot produce viable offspring 
with non-Wolbachia females or females with a 
different strain of Wolbachia (Atyame et al., 2016). 
Thus, releasing Wolbachia males to mate with wild 
(non-Wolbachia) females can lead to population 
suppression and even eradication (Zabalou et al., 
2004; Atyame et al., 2016; Mains et al., 2016).
Potential adverse effects and limitations
There are two general potential adverse effects 
to consider. The first is the concern of foreign 
Wolbachia effects on non-target species. 
However, the IIT has a calculated probability of 
success and a growing body of evidence that 
it is safe, based upon extensive trials in other 
locations with C. quinquefasciatus and various 
Aedes spp. (Hoffmann et al., 2011; O’Connor 
et al., 2012; Atyame et al., 2015, 2016; Mains 
et al., 2016). Because Wolbachia is a naturally 
occurring endoparasite that is only passed on 
through sexual reproduction (Atyame et al., 
2015, 2016), and only the non-biting males are 
released, the likelihood of the foreign bacterium 
being passed to other species is low (Vietnam 
Eliminate Dengue Project, 2011; US EPA, 2017). 
The second is the concern that eradication or 
significant population suppression of native 
mosquito populations that play important 
ecological roles could have adverse community 
and ecosystem effects. This is not a concern in 
Hawaiʻi where all mosquitoes are introduced.
Even though Wolbachia-infected males are 
only fertile with Wolbachia-infected females, 
Wolbachia-infected females are fertile with both 
infected and uninfected males (Atyame et al., 
2015; Mains et al., 2016). Release of a small 
number of infected females could thus lead to 
the unintended spread of the Wolbachia infection 
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into the wild population, thereby weakening or 
preventing the desired population suppression. 
Therefore, rigorous sex-separation is required 
before any and all releases (Atyame et al., 2016).
There are significant, substantial and widespread 
concerns by local stakeholders about the use of 
synthetic biology to control mosquitoes in Hawaiʻi. 
Ultimately, the decision to proceed with field trials 
will be up to the residents and regulatory agencies 
of Hawaiʻi. A key step is a community engagement 
process that provides opportunities for robust 
discussion and sharing of information to facilitate 
informed decisions on the part of the stakeholders.
Socio-economic and cultural considerations
Some potential areas that warrant further study 
and engagement are: (i) the socio- economic 
and cultural impact of an increase of tourism 
from the potential protection of native birds 
(Department of Business Economic Development 
and Tourism, 2004); (ii) whether the increased 
abundance of culturally important birds used 
for traditional practices would have unintended 
effects on the islands’ social dynamics (Amante-
Helweg & Conant, 2009) and (iii) concerns 
about how synthetic biology approaches 
could create stress and conflict within local 
communities and impact their social fabric.
5.2.1.3 Potential adverse 
effects and limitations
A key influence on the field applicability of synthetic 
biology approaches for invasive alien species 
management will be the potential adverse effects 
of such approaches (Harvey-Samuel, Ant & Alphey, 
2017). The critical concern for engineered gene drive 
application is adverse effects on non-target populations 
of the same species due to their spread beyond the 
target population (Marshall & Hay, 2012). In such 
circumstances, conservation gains achieved through 
impacts on the targeted invasive population could 
be offset or even outweighed by conservation losses 
elsewhere, if populations are impacted where the 
species targeted is native or performs essential roles in 
community structure and ecosystem dynamics. Several 
lines of technical development have been proposed 
to make engineered gene drive systems self-limiting, 
such that they can be applied more tactically with 
reduced potential for spread to non-target populations. 
Such development is currently only theoretical or at 
early stages (Appendix 3 (www.iucn.org/synbio)).
There are also concerns for most synthetic biology 
approaches of adverse effects on non-target species 
(direct effects on their biology and ecology, and 
associated community and ecosystem knock-on 
effects), should there be viable mechanisms for 
horizontal gene transfer through which new or modified 
genes could find their way into other species. The 
reliance on sexual reproduction for such gene transfer 
(Andersson, 2005) reduces this risk for application 
to invasive vertebrates, although they need to be 
front-of-mind for cases where interbreeding between 
species can occur. When one is considering application 
to invertebrate and plant invasive alien species, the 
likelihood of such transfer is higher due to the greater 
propensity for interbreeding in some species groups 
and contexts (Moro et al., 2018). However, the 
potential for gene transfer via interbreeding is generally 
relatively low, since instances where interbreeding 
may occur can in most cases be identified from 
existing knowledge (e.g. Hopper, Britch & Wajnberg, 
2006). In addition, multiple genetic changes are 
generally needed for phenotypic change, and these 
vary from species to species (Johnson et al., 2016).
Irrespective of the technology employed, should 
synthetic biology field trials occur, concerns over 
spread make sites from which organism dispersal 
is naturally limited, and/or can be effectively limited 
through management, potentially more appropriate 
places for testing and initial deployment. Similarly, pest 
populations with identifiable “private alleles” (alleles 
found only in the target population) or unique fixed 
alleles may be more appropriate targets, since drive 
mechanisms can potentially be self-limited to such 
population genetic characteristics (Esvelt et al., 2014). 
Initial trials may also be better conducted in limited 
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spatial areas (where potential drive mechanisms are 
less likely to be confronted with scaling-up issues 
that could lead to the interruption of dissemination 
through the targeted pest population (Unckless, Clark 
& Messer, 2016; Champer et al., 2018)) and over 
limited timescales (to further safeguard both against 
organism spread away from the target population and 
the interruption of dissemination). Finally, there should 
be due consideration of societal and cultural concerns, 
including impacts on people, their pets, domestic 
stock, water catchments, animals for hunting and 
edible plants (Wright, 2011), for any potential trial site.
Since there is as yet no consensus on what type of 
field sites may be best for trialling genetic biocontrol 
(James et al., 2018), trial sites need to be considered 
on a case-by-case basis. Should field trials progress, 
a lot can be learned from other fields for their design, 
in particular in health for vaccines and medicines, or 
for the development of biological control agents. Key 
technical factors on which such consideration should 
be based may include characteristics of the target 
population, the local ecosystem, the characteristics of 
the modification introduced, the potential for spread, 
the ability to conduct comprehensive monitoring, and 
the ability to shut down trials should such a step be 
required. In addition, conducting formal risk assessment 
processes prior to any use of synthetic biology for 
invasive alien species management, be it as a trial or 
an operational application, would ensure compliance 
with all relevant laws and regulations, and further 
ensure that the values of decision makers are explicit 
in the specific risk assessment. Such risk assessments 
should include experts from a variety of fields, including 
conservation scientists and practitioners. Additionally, 
given the novelty of technologies and approaches 
being considered, community engagement at all stages 
of any proposal or project would greatly increase the 
capacity of all stakeholders, including the general 
public, to robustly consider the approaches proposed 
in an informed and open manner. For engineered drive 
mechanisms, key factors that need to be taken into 
consideration when assessing their potential viability 
include the life history, fecundity and generation time 
of the target invasive alien species and the dispersal 
and survival ability of introduced animals into extant 
populations of the target species (Moro et al., 2018).
5.2.2 Reducing pressures 
from wildlife trade 
Unsustainable international commercial trade in 
wildlife, whether legal or illegal, is one of the greatest 
threats to wildlife today (Butchart et al., 2010; Nijman, 
2010; Duckworth et al., 2012; Challender, Harrop & 
MacMillan, 2015; Eaton et al., 2015). Wildlife trade 
affects multiple species, from timber and ornamental 
plants, to corals, to marine and terrestrial vertebrates. 
Unsustainable trade, by definition, threatens the 
survival of the target species, and also the biodiversity 
of their habitats, since the animals hunted for trade 
are often keystone species that act as predators, 
pollinators, dispersers, browsers and ecosystem 
engineers (Waldram, Bond & Stock, 2008; Blake et 
al., 2009; Estes et al., 2011; Ripple et al., 2016). Many 
unsustainably traded terrestrial and marine species 
are key to local communities, and their loss often 
threatens the livelihoods of some of the world’s poorest 
and most marginalised people (Cooney et al., 2015). 
For high value species, international trade is linked 
to organised crime, and presents security threats to 
local communities and regions (Wyler & Sheikh, 2013). 
Illegal trade of such species is facilitated by corruption 
at all points in the trade chain (Bennett, 2015).
Conventional approaches to addressing unsustainable 
trade have been numerous. If trade is unsustainable 
but legal, options are (i) to continue to operate it but 
put measures into effect to increase sustainability 
(e.g. quotas, seasonal closures, zoning); (ii) enact 
legislative change to render the trade illegal and 
implement programmes of enforcement at all points 
along the trade chain, from source to market; (iii) 
reduce demand; and (iv) community engagement 
and provision of alternative livelihoods. All have had 
considerable success; however, illegal trade in species 
with low productivity and high levels of demand, 
and hence high value, is extremely challenging 
for management, given the levels of corruption 
and involvement of organised crime networks.
Increasingly sophisticated, technology-supported 
systems are being deployed to protect animals 
at their source (e.g. the enforcement programme 
SMART; http://smartconservationtools.org/), and to 
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support intelligence networks around sites and key 
transportation routes. Where well-resourced, these 
can be successful at individual sites (WCS, 2018). 
Demand reduction programmes in key consumer 
countries are also being undertaken. However, as long 
as demand for particular wildlife species and products 
remains high, conserving the target species remains 
one of the greatest challenges in conservation today. 
One approach to supply markets while taking pressure 
off wild populations is to provide substitutes for wild-
caught species. Traditionally, these have come from 
cultivated (e.g. ornamental plants) or captive bred 
sources (e.g. tortoises and turtles for the food and 
pet trades; skins and furs). Under the Convention on 
International Trade in Endangered Species of Wild 
Flora and Fauna (CITES), captive-bred specimens 
from registered facilities can be sold legally, even if 
wild-caught specimens of the same species cannot 
be. This can be successful when a verifiable chain 
of custody prevents laundering of illegally-obtained 
wild-caught products into legal markets (e.g. peccary 
skins) (Bodmer, Pezo Lozano & Fang, 2004) or, more 
commonly, that the cultivated or captive-bred product 
is preferred over the wild one due to higher quality 
or lower price (e.g. many ornamental plants, certain 
reptile skins). This approach is challenging for high 
value species, especially if their biological productivity 
is low, given the ease in a corrupt system with which 
wild-sourced products can be laundered into legal 
markets (Gratwicke et al., 2008; Bennett, 2015).
5.2.2.1 Potential synthetic 
biology applications
Synthetic biology has been proposed as another way 
of producing items demanded in trade while taking 
pressure off the wild species (Appendix 3 (www.
iucn.org/synbio)). If the synthesised item is a perfect 
substitute for the wild product, this could indeed 
potentially be highly positive for conservation, taking 
pressure off the wild species while supplying market 
demand. A good example is the recombinant Factor 
C (rFC), a synthetic horseshoe crab blood used by 
the pharmaceutical industry which replaces the need 
for the wild product (Case study 8). Squalene is 
another example; since the oil is used in cosmetics, 
it is the property of the oil that is important, not its 
origin. Hence, synthetic substitutes could indeed 
reduce or remove the need to exploit wild species 
(Chapter 6.6). In general, the technology for other 
proposed synthetic biology applications for reducing 
wildlife trade pressures is still to be developed.
5.2.2.2 Potential adverse 
effects and limitations
Potential adverse effects of applying such technologies 
in the context of traded wildlife species arise if the 
synthesised item is not, in the eyes of consumers, a 
perfect substitute for the wild-sourced product. For 
example, for many species in demand for traditional 
Asian medicines, users frequently believe that wild-
sourced products are more efficacious (Gratwicke et al., 
2008) and, in the case of bear bile, are willing to pay a 
premium for a wild-sourced rather than farmed product 
(Crudge, Nguyen & Cao, 2018). There have been 
suggestions to manufacture rhino horn using synthetic 
biology (Africa Geographic, 2015). All trade in rhino 
horn globally is currently illegal (except for domestic 
trade within South Africa), with three of the five species 
of rhino being Critically Endangered and among the 
most imperilled species on the planet. Opening a legal 
market for the synthetically manufactured product 
could prove more harmful than beneficial, because 
it would render enforcement of illegal trade in wild-
sourced horns difficult or impossible, especially when 
the illegal trade is currently run by corrupt syndicates 
(Rademeyer, 2012), and when demand is almost 
inevitably likely to be greater for the wild-sourced 
product. For further information on potential CITES 
concerns see the legal analysis by Lyman & Wold 
(2013), with additional insights into the complexities of 
wildlife products made by advanced technologies.
5.3 Adaptation 
5.3.1 Improving species 
resilience to threats
Climate change and disease are exacerbating persistent 
challenges to biodiversity such as habitat destruction, 
invasive species and overharvesting (Sala et al., 2000). 
Together these processes can lead to the extensive 
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fragmentation and isolation of natural populations, 
with effective population sizes often much smaller than 
those under historical conditions (Stowell, Pinzone & 
Martin, 2017). When populations fall to low numbers, 
they can experience inbreeding depression, whereby 
the expression of deleterious recessive traits is more 
likely due to lower gene pool diversity, resulting in 
reduced fecundity and/or survival. They may also lack 
the adaptive variation necessary to overcome novel 
environmental challenges; bottleneck events may even 
increase the frequency of deleterious genetic variants 
in the remaining population (Marsden et al., 2016).
Bottleneck populations may experience an increase 
in susceptibility to disease (Hale & Briskie, 2007; 
Tompkins, 2007) or an increased frequency of genetic 
disorders that negatively impact survival (Räikkönen et 
al., 2009). Moreover, because many small populations 
are isolated by physical, environmental and ecological 
barriers, they may have few or no opportunities for 
infusions of novel genetic variation via gene flow. 
Habitat protection could help to increase population 
size, but for populations trapped in an extinction vortex 
(Gilpin & Soulé, 1986), habitat protection alone may 
be inadequate for successful conservation (Stowell, 
Pinzone & Martin, 2017). Where the proximate threat to 
inbred populations is disease, conventional vaccination/
treatment approaches can protect small numbers, but 
are increasingly unrealistic as the spatial scale over 
which populations occur increases (Cross, Buddle 
& Aldwell, 2007). In this context, fungal pathogens 
such as chytrid fungus threatening amphibians 
globally (Fisher, Garner & Walker, 2009; see Box 5.1) 
and white-nose syndrome in North American bat 
species (Blehert et al., 2009) are proving particularly 
intractable to conventional management approaches
(Fisher et al., 2012).
Box 5.1
Future challenge: The potential use of synthetic 
biology to control lethal fungal pathogens
of amphibians
Reid Harris & Louise Rollins-Smith
Note that this is a Future Challenge and not a Case study, as there is no current synthetic biology 
solution under development for this application.
Issue
Increasingly, there are major challenges to biodiversity 
conservation with no obvious solutions realisable in the 
time-scale necessary to make the difference needed. 
Examples include emerging infectious diseases and 
the impacts of climate change and ocean acidification. 
Researchers are searching for new technologies that might 
overcome these challenges; synthetic biology approaches 
have promise, but for most proposed applications we 
currently lack clear evidence for their usefulness and safety. 
We present some of the considerations for the design of 
a research agenda to explore the potential of synthetic 
biology approaches as solutions to one such challenge.
Chytridiomycosis is a fungal disease of amphibian skin that 
evolved in eastern Asia and emerged elsewhere in the early 
20th century, which coincided with the global expansion of 
commercial trade in amphibians (O’Hanlon et al., 2018). This 
disease has led to widespread mortality and extinction; for 
example, approximately 41 per cent of amphibian species 
in a montane region of Panama declined or went extinct 
once the causative agent, Batrachochytrium dendrobatidis 
(Bd), arrived (Crawford, Lips & Bermingham, 2010). It is 
thus considered the greatest disease threat to biodiversity 
(Wake & Vredenburg, 2008). A second chytrid fungus, B. 
salamandrivorans (Bsal), has caused population extinctions 
of the fire salamander Salamandra salamandra in Europe 
(Martel et al., 2013; Stegen et al., 2017). While currently not 
found in North America, susceptibility trials of native North 
American salamanders reveal that some species are lethally 
affected, including all tested species in the newt family (Martel 
et al., 2014). Given this, with North America being home to 
the largest number of salamander species globally, accidental 
introduction of Bsal could drastically reduce amphibian 
biodiversity and result in concomitant ecosystem effects.
Amphibians are major parts of ecological communities 
worldwide (Hairston & Hairston, 1987); for example, the 
biomass of salamanders in one North American forest 
was estimated to be 2.5 times that of all breeding birds 
and equal to that of small mammals (Burton & Likens, 
1975). This estimate was based on surface counts and 
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as such is an underestimate of the salamander biomass 
relative to birds and mammals. Removal experiments have 
shown that decimation of terrestrial salamanders would 
lead to CO2 release due to accelerated leaf decomposition 
caused by the release of leaf-shredding invertebrates from 
predation (Best & Hartwell, 2014; Hickerson, Anthony & 
Walton, 2017), potentially contributing to global warming 
(Wyman, 1998). Salamanders are also keystone species in 
temporary ponds; some frog species are greatly reduced 
in abundance if salamanders are removed (Morin, 1983). 
Fire salamander (Salamandra salamandra) (Beatrice Prezzemoli / Shutterstock.com)
Barking tree frog (Hyla gratiosa) (Jay Ondreicka / Shutterstock.com)
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Existing interventions and limitations
Two proposed non-synthetic-biology strategies to protect 
amphibians from chytridiomycosis are ‘vaccination’ 
with Bd or Bsal antigens (or attenuated strains), and the 
augmentation of naturally-occurring anti-chytrid skin 
bacteria (Bletz et al., 2013; McKenzie et al., 2018). A 
vaccination strategy could involve infection and ‘cure’ 
with heat or antifungal treatment (McMahon et al., 2014). 
Bioaugmentation has had success in laboratory trials and 
in one field trial, and new ‘omics’ analysis technologies 
(i.e. metagenomics, transcriptomics and metabolomics) 
might lead to better selection of probiotic strains for clinical 
trials (Rebollar et al., 2016). Both strategies may require 
considerable resources to bring to large-scale efficacy.
 
Potential synthetic biology solutions
Several synthetic biology approaches to counteract Bd 
and Bsal are being considered. First, can the pathogens 
be genetically modified to become avirulent? This might 
be possible using CRISPR-Cas9 gene editing, but it is not 
yet known what critical virulence factors are responsible 
for amphibian deaths, or whether avirulent strains of Bd 
or Bsal could displace or protect against virulent strains. 
Virulence appears to derive from growth rate (Mitchell et 
al., 2008; Fisher, Garner & Walker, 2009), so it is likely that 
virulent strains would be more competitive. Also, Bd and 
Bsal are asexual; thus, a gene drive mechanism would 
not be successful in spreading modified genes beyond 
one clonal line. Hybridisation has been inferred by genetic 
analyses of Bd strains; hence sexual reproduction must 
have occurred in the past but it has never been observed 
(Schloegel et al., 2012; Greenspan et al., 2018). 
Second, might gene editing techniques be used to modify 
the host species? Three components of amphibian defences 
can be considered: innate immunity, acquired immunity 
and the microbiome. There is evidence in some species 
that antimicrobial peptides (AMPs) of the innate immune 
system that are protective against Bd are secreted into 
the epidermal mucus (Woodhams et al., 2007). It might 
thus be possible to edit AMP genes into the genomes 
of species that lack them. For example, many ranid frog 
species have well-developed AMP genes, but bufonids 
(toads) appear to lack them (Conlon, 2011); if they 
were to be introduced into bufonid species, promoters 
would be needed that assure their expression in skin 
glands. CRISPR-Cas9 methods for deletion of genes 
and “knock in” of genes have been developed for the 
frog species Xenopus laevis, and could theoretically be 
developed for other amphibians (Banach et al., 2017). 
The amphibian acquired immune system is as complex 
as in all other higher vertebrates, and thus it would 
be difficult to identify a limited set of components to 
modify by gene-editing to provide protection against 
chytridiomycosis (Flajnik, 2018). There are also significant 
problems with the inducement of breeding in non-
model species, to supply eggs and sperm for genome 
manipulation (Trudeau et al., 2013; Clulow et al., 2014).
With regards to the microbiome, there is strong evidence 
in some species that skin bacteria secrete metabolites 
that can protect against Bd (Harris et al., 2009). However, 
probiotic addition experiments have had mixed success 
largely because the probiotic species do not persist 
(Becker et al., 2011). The genetic basis for production of 
some of these protective metabolites is known (August et 
al., 2000). Thus, the persistence issue could potentially 
be addressed by inserting such genes into skin bacteria 
that naturally occur at high abundance. For this approach 
to be successful the genetically modified bacteria 
would have to displace the unmodified members of the 
same species, the likelihood of which is unknown.
Synthetic biology approaches may thus help prevent 
continued losses of amphibian species due to 
chytridiomycosis. A next step would be to evaluate and 
compare approaches that do and do not involve synthetic 
biology, incorporating many of the considerations
outlined above.
Another strategy that aids the conservation of 
populations facing extinction is the deliberate 
introduction of individuals as vehicles for the infusion 
of novel alleles. This strategy has been variously 
termed genetic rescue, facilitated migration, intentional 
hybridisation or introgression, and admixture rescue, 
and is the topic of much discussion (Tallmon, Luikart 
& Waples, 2004; Whiteley et al., 2015). For simplicity, 
this chapter refers to actions taken by conservationists 
to increase gene flow, genetic diversity and fitness 
as “genetic rescue.” A suite of studies highlight the 
value of genetic rescue in increasing population 
fitness (Frankham, 2015), demonstrating the power of 
innovative methods for saving struggling populations. 
However, such approaches are limited to using the 
genetic variation remaining in extant populations; for 
many severely bottlenecked species this will likely be 
insufficient to prevent ongoing population decline.
In recent years it has been proposed that genome 
editing, most recently using the CRISPR-Cas9 
toolkit, might be applied to address this issue, for 
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example by attempting to alter or introduce genes 
with the goal of enhancing species survival against 
specific threats, including disease and climate 
change (Appendix 3 (www.iucn.org/synbio)). Several 
such applications have been proposed, as detailed 
below. Other synthetic biology approaches are 
also being pursued, such as improving general 
species viability through reintroducing extinct genetic 
variation stored in ‘frozen arks’ (and potentially also 
museum specimens) back into extant populations 
(cloning; Appendix 4 (www.iucn.org/synbio)). Note 
that it is conceivable that synthetic biology could 
also contribute to the restoration of ecosystem 
resilience and function, e.g. through the resilience 
or restoration of keystone species, and thus the 
prevention of ecosystem collapse (Bland et al., 2015).
5.3.1.1 Potential synthetic 
biology applications: Improving 
general species viability
Cloning approaches are being attempted, for example, 
to increase white rhino genetic diversity (Hildebrandt 
et al., 2018). The northern white rhino (Ceratotherium 
simum cottoni) population is down to just two 
infertile females; the last male died in March 2018. 
The southern subspecies is some 21,000 animals 
strong. Yet the genomes of northern animals, albeit 
based on a handful of samples, are more diverse. 
Researchers are attempting to create embryos by 
injecting northern white rhino sperm nuclei from 
frozen material into southern white rhino unfertilised 
eggs; to date they have survived to only an early 
embryonic developmental stage (Hildebrandt et al., 
2018). Similar approaches are being considered 
for other endangered species including the black 
footed ferret (Case study 3), yet in most cases 
such approaches are currently only speculative.
5.3.1.2 Potential synthetic biology 
applications: Improving species 
resilience against disease
Using synthetic biology approaches to improve 
species resilience against disease has been proposed 
for several species such as the black-footed ferret 
threatened by sylvatic plague (Case study 3), both 
Asian and African elephants threatened by elephant 
endotheliotropic herpes virus, amphibians and 
salamanders globally threatened by chytrid fungus, 
Northern white rhinoceros (Ceratotherium simum cottoni) (EcoPrint / Shutterstock.com)
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and bats in North America threatened by white-
nose syndrome (Redford, Adams & Mace, 2013).
Most proposed applications are currently speculative 
(Appendix 3 (www.iucn.org/synbio)), but a clear 
demonstration of potential has been made for resilience 
against a tree pathogen (Case study 4). The American 
chestnut was nearly wiped out by chestnut blight; 
research indicates that a synthetic biology solution 
is technically ready for field testing (Steiner et al., 
2017). Because the chestnut is fast-growing, long-
lived and resistant to decay, restoration of American 
chestnut using blight resistant stock could potentially 
increase carbon sequestration or storage in forested 
landscapes (Gustafson et al., 2017). However, 
carbon dynamics are also affected by interspecific 
competition, succession, natural disturbance and 
forest management activities, and it is unknown how 
chestnut restoration might interact with these processes
(Schmidt et al., 2011).
Case study 3:
Synthetic biology to
address conservation threats to 
black-footed ferrets   
Tom Maloney, Ben Novak
Issue
The black-footed ferret (Mustela nigripes) was 
once an ecologically important and widespread 
small carnivore in the Great Plains of North 
America. Efforts throughout the 20th century 
to eradicate the ferret’s chief food source, the 
prairie dog (Cynomys spp.), resulted in dramatic 
declines to near extinction by the late 1970s 
(Biggins and Schroeder, 1988). Twice presumed 
extinct, a population of ferrets in Wyoming was 
re-discovered in the early 1980s. The US Fish and 
Wildlife Service (US FWS) began a recovery effort 
in 1985. Traditional conservation approaches, 
including habitat protection and careful pedigree 
management in captive breeding including 
artificial insemination (Howard et al., 2016), have 
helped the recovery of the species. However, 
the species remains threatened by extinction.
Existing interventions and limitations
Recovery efforts have enabled the reintroduction 
of hundreds of ferrets within the former range, but 
all are descended from a founding population of 
just seven individuals. Two principal threats are 
seen as critical to address in order to achieve 
the sustained recovery of the species: genetic 
drift/inbreeding depression and susceptibility 
to sylvatic plague, a widespread non-native 
disease (Antolin et al., 2002; Abbott et al., 2012). 
Genetic drift has resulted in a loss of 15 per 
cent of original founding genetic diversity in the 
current ferret generation (Wisely et al., 2015).
Black-footed ferrets have no innate immunity to 
sylvatic plague, which causes high mortalities in 
wild populations (Roelle, 2006; Matchett et al., 
2010). The US Geological Survey developed a 
vaccine for sylvatic plague, which US FWS applies 
in a labour-intensive programme to vaccinate 
released ferrets (Abbott et al., 2012). However, it 
is difficult to deliver this vaccine (which requires a 
booster) to wild-born ferrets. Hence, at least at this 
stage, continued vaccination of both captive and 
wild-born ferrets is not a path to sustained recovery.
 
Synthetic biology description
Scientists at the San Diego Frozen Zoo had 
cryopreserved two cell lines from the last wild 
ferrets in Wyoming. Whole genome sequencing 
conducted in 2016 revealed that those cell 
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lines have significant genetic variation that 
could be used to restore lost genetic diversity 
(Revive & Restore, San Diego Zoo Global and 
Intrexon, 2016). Incorporating this variation 
would effectively introduce two new founders 
to the extant population (Wisely et al., 2002). 
In July 2018, the US Fish & Wildlife Service 
issued an endangered species recovery permit 
to authorise the development of laboratory 
methods to clone the frozen cell lines. 
There is also now the potential to use precise 
genome editing techniques to create inheritable 
immunity to plague (Novak, Maloney & Phelan, 
2018). Research has shown that plague immunity 
is antibody mediated (Hill et al., 2003; Liu et al., 
2017) and that black-footed ferrets have plague 
antibodies. The data from all plague challenges 
and exposures of non-vaccinated ferrets show 
that the antibodies respond slowly during an 
infection; only exposure to the vaccine brings 
about antibody expression at the early stage of 
infection (for subsequent exposure). It may now be 
possible to duplicate the plague-specific antibody 
genes that are triggered by vaccination in a 
manner that would produce lifelong expression of 
plague-antibodies, a process known as vectored 
immunoprophylaxis (Sanders & Ponzio, 2017). 
The above referenced permit also authorised 
efforts to test the viability and efficacy of genome 
editing to activate innate alleles to upregulate 
the antibody response and convey inheritable 
resistance to sylvatic plague in black-footed ferrets. 
A second, transgenic approach might be to edit 
plague-resistant alleles from the domestic ferret 
(for which plague is not fatal) into the genome 
of the black-footed ferret (Novak, Maloney &
Phelan, 2018).
Testing of these approaches is planned to be 
conducted first in laboratory mice for efficiency, 
since they have short generation times. If 
successful, methods and fitness testing could 
then be expanded to testing in black-footed 
ferrets. An experimental population of genome-
edited, disease-resistant black-footed ferrets 
could then be established to assess responses 
to plague and verify immunity. The fitness of this 
experimental group of ferrets would need to 
be carefully analysed over several generations, 
specifically replicating environmental conditions 
that black-footed ferrets face in the wild, to 
Black-footed ferret (Mustela nigripes) (Kerry Hargrove / Shutterstock.com)
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confirm the safety of integrating plague-immunity 
throughout the entireferret population.
Potential adverse effects and limitations
While these novel tools hold great promise, there 
are still many uncertainties. The use of the very-
closely-related domestic ferret as a surrogate 
parent for the cloned cell lines is untested. There 
may be incompatibility issues between the 
species (Wisely et al., 2015). The development 
and field-testing of vectored immunity techniques 
in ferrets is also uncharted territory and will take 
years to implement because long-term fitness 
testing is required to rule out any unexpected 
effects. However, these considerations are 
required steps to realise the potential of recent 
developments in synthetic biology to address 
widespread challenges that make the black-
footed ferret conservation dependent.
Socio-economic and cultural considerations
This species was one of the first endangered 
mammals to be listed in the US, and the public 
has a strong interest in its successful recovery. 
Regulators are embracing a deliberate and 
purposeful public engagement process to provide 
every opportunity for concerned stakeholders 
to participate in proposed recovery efforts. The 
potential recovery of the black-footed ferret could 
have a significant economic impact through 
recovery of the grassland/prairie ecosystem. 
Further investigations are required to analyse other 
indirect socio-economic impacts of this synthetic 
biology application, including the potential socio-
economic impact of replacing existing conservation 
approaches. There may also be ethical objections 
to modifying populations of endangered species, 
although the proposed effort has prioritised the 
enhancement of innate alleles over a transgenic 
approach, since these are already part of the 
black-footed ferret genome. Ranchers in the US 
have expressed their interest in the recovery of 
this species because of the land-use restrictions 
related to the protected status of the ferret 
(https://www.denverpost.com/2013/02/17/
ranchers-sought-to-help-black-footed-ferret/).
Issue
American chestnuts (Castanea dentata) once 
provided sustenance and shelter for wildlife and 
a healthy and profitable nut crop for humans 
in the US (Jacobs, Dalgleish & Nelson, 2013). 
These trees were large and long-lived compared 
to other species in America’s eastern forests 
(Woods & Shanks, 1959), but were almost entirely 
wiped out when an invasive blight fungus was 
accidentally introduced to the United States 
in the late 1800s (Anagnostakis, 1987). 
American chestnuts are not extinct; however, 
they are categorised as Critically Endangered on 
the IUCN Red List (http://oldredlist.iucnredlist.
org/details/62004455/0) and are generally 
limited to surviving as small seedlings or stump 
sprouts, rarely reaching maturity before blight 
Case study 4:
Transgenic American chestnut for 
potential forest restoration   
Andrew E. Newhouse, William A. Powell
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reinfection occurs (Paillet, 2002). The American 
chestnut will not survive indefinitely: without 
human intervention, wild populations of pure 
American chestnut will likely continue to decline 
until they are all but gone (Paillet, 1993). Relatives 
of the American chestnut in Asia that evolved 
with the blight fungus are usually able to tolerate 
blight infections without much damage
(Jaynes, 1964).
 
American chestnut tree (Castanea dentata) (William Ragosta / Alamy.com)
Existing interventions and limitations
Multiple efforts have been made to breed American with 
Chinese chestnuts to obtain desirable characteristics 
from both species, but traditional breeding is a slow 
and unpredictable process, limited by undesirable traits 
from the non-native Chinese chestnut (Woodcock et al., 
2017). The American Chestnut Foundation backcross 
breeding program (www.acf.org) shows promise in 
producing trees with American chestnut growth traits, 
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but since blight resistance in Chinese chestnuts 
is controlled by several genes, inheritance by 
future generations of chestnuts is inconsistent 
(Steiner et al., 2017). Recent technological 
advances in genomic screening are improving 
this process, but it will likely require multiple 
generations of breeding (Steiner et al., 2017), 
and blight resistance in backcrossed offspring 
will logically never surpass that of the Chinese 
chestnut ancestor (Woodcock et al., 2017).
Synthetic biology description
Researchers at the College of Environmental 
Science and Forestry in Syracuse, New York, have 
produced American chestnut trees that show 
promise to tolerate blight infections (Zhang et al., 
2013). This was achieved by inserting a single gene 
from wheat into a new line of American chestnut 
trees (Zhang et al., 2013). The same gene, which 
is found in many other wild and domestic plants, 
produces an enzyme — oxalate oxidase —that 
does not kill the fungus but rather breaks down the 
toxin oxalic acid, which is produced by the fungus 
and kills American chestnut tissues (Chen et al., 
2010). Since this enzyme has no direct fungicidal 
properties, selective pressure is reduced or 
eliminated. This effectively means that all potential 
plantings of transgenic chestnut trees would act 
as refugia, so the blight fungus is much less likely 
to evolve resistance over time (NRC, 1986).
Potential adverse effects and limitations
Frequent concerns regarding introducing a 
transgenic tree into the environment include the 
genetic diversity of the restored population of 
American chestnuts and environmental safety 
to surrounding organisms. Outcrossing lab-
produced transgenic trees with surviving wild 
American chestnuts has the potential to incorporate 
the necessary genetic diversity and regional 
adaptations in future generations of American 
chestnuts, while also protecting them from chestnut 
blight (Steiner et al., 2017; Westbrook, 2018). 
Transgenic chestnuts have been tested for safety 
to many other organisms, including ectomycorrhizal 
fungi (symbiotic fungi associated with roots that 
aid in water and nutrient uptake), tadpoles which 
consume leaf litter, and native seeds, and tests to 
date have shown no adverse effects compared to 
traditional breeding (D’Amico et al., 2015; Goldspiel 
Chestnusts in hand (nocostock / Shutterstock.com)
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et al., 2018; Newhouse et al., 2018). Nutrition 
testing on the nuts that people and animals would 
consume has confirmed that nutrition is equivalent 
to non-transgenic chestnuts. This testing has 
been completed but is awaiting publication.
Before any restoration with transgenic trees 
could take place in the US, regulatory approval 
must be received from at least three different 
federal agencies: Department of Agriculture, 
Environmental Protection Agency, and Food Drug 
and Administration. Specific mandates vary by 
agency, but the overarching goal is to ensure the 
transgenic product is not significantly riskier than 
similar products produced with traditional breeding. 
In addition to the comparatively well-defined 
regulatory requirements, there are also unique 
considerations regarding the public’s acceptance 
of a genetically engineered product intended 
for release in the wild. Compared to concerns 
surrounding genetically engineered food crops 
in commercial agriculture, the non-profit, non-
agricultural goals of restoration suggest reduced 
public concerns about corporate motives. But the 
long-term reality of introducing to the wild a forest-
type tree might warrant different risk analyses than 
those required by an annually-harvested food crop.
There is widespread potential for related synthetic 
biology tools to rescue other threatened wild 
species, including forest trees such as ash 
(Palla & Pijut, 2015; Lee & Pijut, 2017) and 
elm (Newhouse et al., 2007). Biotechnology 
certainly is not the only tool available to protect 
trees from environmental threats, but the case 
of the American chestnut indicates that it 
can potentially be a means to restore healthy 
and resilient trees to native ecosystems.
Socio-economic and cultural considerations
Research on socio-economic and cultural 
considerations should be carried out to identify the 
specific benefits or adverse effects of the restoration of 
the American chestnut. Some economic considerations 
around the potential revitalisation of the chestnut value 
chain could warrant further research, considering the 
potential adverse effect on this value chain if consumers 
reject what would be considered as a genetically 
modified product. The social and cultural impacts of 
this new approach on existing grassroots movements 
such as the American Chestnut Foundation for the 
restoration of this tree would require further assessment 
and engagement. However, the foundation’s leadership 
and membership are increasingly considering 
synthetic biology to be a valid and promising means 
of potential restoration (Steiner et al., 2017).
A small number of large-scale empirical surveys have 
been conducted on public opinion regarding the use 
of biotechnology for tree restoration or forest health 
(Hajjar & Kozak, 2015; Kazana et al., 2015; Needham, 
Howe & Petit, 2015; Fuller et al., 2016; Jepson & 
Arakelyan, 2017). These surveys took place in the US, 
UK and Canada, and a general consensus emerges: 
in the face of a concrete, human-caused threat, like 
chestnut blight, public acceptance of biotechnology 
solutions is generally similar to acceptance of 
traditional breeding or planting of non-native species, 
and often more acceptable than taking no action. 
This reinforces general responses frequently received 
by College of Environmental Science and Forestry 
chestnut team members: a small minority of people 
are sceptical about breeding with Asian chestnuts, 
another minority is sceptical about genetic engineering, 
but most people support the idea of restoring 
American chestnuts by whatever means are safe
and effective.
5.3.1.3 Potential synthetic 
biology applications: Increased 
resilience to climate change
It has been proposed that synthetic biology solutions 
could help enable species survival in the face of 
otherwise intractable threats such as climate change. 
In cases where species are unable to naturally adapt 
in a sufficient time-frame for survival, or disperse 
in either natural or assisted fashion (Ewen, 2012) 
into areas suitable for survival as native ranges 
become unsuitable through climate (or indeed other 
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environmental) change, synthetic biology approaches 
may be able to confer sufficient resilience to allow 
ongoing viability within the native range. Such 
adaptation has been the subject of much research 
for agricultural plants (Hunter, 2016), for example the 
creation of drought-tolerant maize (Marshall, 2014).
For conservation application, an example is seen in 
the fight against mass bleaching of coral reefs as a 
result of ocean warming (Case study 5). With synthetic 
biology, the alleles that provide resilience to ocean 
warming in certain species of coral could potentially be 
assimilated into the genomes of non-resilient species, 
reversing the loss of coral reefs around the world on a 
larger scale (van Oppen et al., 2015; Levin et al., 2017; 
Cleves et al., 2018). While considerable technological 
development is still required before synthetic biology 
can be applied to corals and their microbial symbionts, 
early achievements suggest such manipulations
are possible.
Issue
Coral reefs around the globe are being lost at an 
alarming rate due to a number of factors including 
climate change, declining water quality, crown-of-
thorns starfish outbreaks, coastal development and 
overharvesting. Climate change is believed to be 
the biggest threat to the persistence of coral reefs, 
particularly since the heat waves of 2014–2017 
assaulted coral reefs worldwide, resulting in the 
third global mass bleaching event and extensive 
coral mortality. For instance, approximately 50 per 
cent of the coral was lost from Australia’s Great 
Barrier Reef in just two years (2016 and 2017) 
when the reef experienced extreme summer 
temperatures (Hughes et al., 2018). Further 
warming will almost certainly occur within this 
century, with models showing only a 5 per cent 
chance that the global temperature increase since 
pre-industrial times will be less than 2°C by 2050 
(Raftery et al., 2017). Thus, ensuring coral reef 
persistence into the future until global warming is 
curbed might require alternative interventions that 
either reduce bleaching stress (such as cooling 
reef water or shading the reef) or increase coral 
bleaching tolerance (i.e. bio-engineering solutions).1
Existing interventions and limits
Elevated temperatures are known to cause 
oxidative stress in the coral host animal and its 
associated microalgal symbionts, triggering a 
cellular cascade and culminating in the loss of 
the algae (Symbiodiniaceae spp.) from the coral 
tissues (i.e. coral bleaching) (Weis, 2008). A number 
of traditional manipulations are being explored 
to increase coral climate resilience, including 
selective breeding, interspecific hybridisation, 
assisted gene flow and probiotics (van Oppen et 
al., 2015, 2017). Preliminary results are promising 
(Dixon et al., 2015; Chakravarti, Beltran & van 
Oppen, 2017; Damjanovic et al., 2017; Chan et 
al., 2018), but it is not yet clear whether these 
interventions can achieve the required results 
in time and at an appropriate scale. Therefore, 
researchers are assessing and developing 
Case study 5:
Corals and adaptation to climate 
change/acidification   
Madeleine van Oppen
3 The following paper was published too late to be included in this assessment but should be consulted: National Academies of Sciences, Engineering, and 
Medicine. 2018. A Research Review of Interventions to Increase the Persistence and Resilience of Coral Reefs. Washington, DC: The National Academies 
Press. doi: https://doi.org/10.17226/25279 
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genetic engineering and synthetic biology 
options in parallel with traditional approaches.
Synthetic biology considerations
Genetic engineering and gene editing tools 
may be used to insert coral or microbial genes 
encoding antioxidant enzymes (Levin et al., 
2017) or to introduce gene pathways or synthetic 
microbes able to produce non-enzymatic 
antioxidants (see Appendix 3 (www.iucn.org/
synbio)). Other genes involved in the thermal 
stress response may also prove to be useful 
genetic engineering targets to enhance thermal 
tolerance (van Oppen et al., 2017). Alternative 
synthetic biology approaches may be developed 
to prevent algal symbionts from becoming 
parasitic during heat stress (Baker et al., 2018).
 
Crown-of-thorns starfish (Acanthaster spp.) are 
among the largest predators of scleractinian (stony) 
corals in the Indo-Pacific and adult animals can kill 
whole coral colonies (Pratchett et al., 2014). High 
densities of the starfish cause rapid loss of corals 
and decline of coral reefs (Kayal et al., 2012); for 
instance, they were responsible for the loss of 
about 21 per cent of the approximately 51 per cent 
of coral lost from the Great Barrier Reef between 
1985 and 2012 (De’ath et al., 2012). The starfish 
are highly fecund and can therefore spread rapidly 
among reefs, sometimes leading to devastating 
population outbreaks (Babcock & Mundy, 1992). 
Current biocontrol methods for the starfish involving 
lethal injection of adults, hand-picking and barriers 
are only effective over small spatial scales (Hall 
et al., 2017). The recent identification of crown-
of-thorns-specific peptides used in intra-specific 
communication may lead to the development of 
starfish traps with a larger-scale impact (Hall et al., 
2017). CRISPR-Cas9 mediated engineered gene 
drive systems with the aim to reduce population 
growth through, for instance, reduced reproductive 
rates may also be developed as a biocontrol 
mechanism effective over large spatial scale.
Potential adverse effects and limitations
Genetic engineering methods are poorly developed 
for corals and their microbial symbionts. The 
recent development of genomic resources for 
Symbiodinium and the CRISPR-Cas9 gene 
editing technology, however, provide promising 
new avenues for genetic engineering of these 
dinoflagellates (Levin et al., 2017). For bacteria, 
well-established systems exist for knocking out, 
altering and introducing genes in taxa closely 
Coral reef bleaching (Sabangvideo / Shutterstock.com)
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related to those known to associate with corals 
(Blackall, Wilson & van Oppen, 2015), including 
Vibrio (Dalia et al., 2017), Serratia (Ito et al., 2017) 
and Rhodobacter (Swainsbury et al., 2017). A 
huge step forward was recently achieved in gene 
editing by the successful introduction of mutations 
targeted to three genes of the coral Acropora 
millepora by injecting zygotes with CRISPR-Cas9 
ribonucleoprotein complexes (Cleves et al., 2018). 
While considerable technological development is 
still required before genetic engineering methods 
can be applied to corals and their microbial 
symbionts, these early achievements suggest such 
manipulations are within the realm of possibility.
As with many proposed synthetic biology 
applications, there are potential non-target 
population and species concerns (effects on 
their biology and ecology, and associated 
community and ecosystem knock-on effects). 
Non-target population effects could arise should 
genetically modified stages disperse from the 
populations targeted for management to other 
populations of the same coral host or symbiont 
species. Non-target species effects could 
arise, should there be viable mechanisms for 
horizontal gene transfer, through which new or 
modified genes (and potentially their effects) 
could find their way into other species.
For any application of gene drive systems to 
suppress crown-of-thorns starfish population 
growth, additional potential concerns that need 
to be addressed include non-target population 
effects should modified individuals or their 
offspring spread from target populations, 
inadvertent population extinction rather than 
any desired suppression effect, and any wider 
ecological implications of both eventualities.
Socio-economic and cultural considerations
A specific socio-economic and cultural 
considerations assessment would be required 
for considering a particular intervention in a 
given ecosystem and context. Some of the 
socio-economic considerations around the 
impact of reducing coral bleaching could be 
particularly relevant to local fisheries (Kittinger 
Crown-of-thorns starfish (Acanthaster spp.) (Richard Whitcombe / Shutterstock.com)
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et al., 2015) as well as tourism activities 
(Spalding et al., 2017). The potential impacts 
on coastal protection – economic as well as 
cultural and social for communities traditionally 
living in these areas – should be further evaluated
(Creel, 2003).
5.3.1.4 Potential adverse 
effects and limitations
Any approach to enhancing genetic variability in a 
species (“genetic rescue”) can be controversial because 
it is hard to predict how a population will be affected by 
a migration event (Stowell, Pinzone & Martin, 2017). In 
some cases, genetic rescue has lowered the fitness of 
a population by swamping the population or increasing 
rare deleterious alleles (Hedrick & Garcia-Dorado, 2016); 
in others, rescue may only be a short-term solution. 
Some reviews clearly show that genetic rescue has 
worked (Frankham, 2015); others argue that genetic 
rescue could create unforeseen problems for the target 
species and that it overlooks the underlying problems 
that push species to the brink of extinction (Poppick, 
2018). There are also perceived moral barriers to genetic 
rescue, with some members of the public expressing 
concern for the taxonomic integrity or “naturalness” 
of species (Stowell, Pinzone & Martin, 2017), and 
concern that such interventions are a “slippery 
slope”. For example, if scientists insert one gene, 
why not more? When does it stop? This is especially 
problematic when considering endangered species.
There are no immediately identifiable potential 
adverse effects associated with utilising cloning to 
improve species resilience, although there are three 
key limitations (IUCN SSC, 2016): (i) it is currently 
a relatively inefficient process for many species; (ii) 
clones in some species have had a tendency towards 
developmental abnormalities and premature aging, 
leading to suffering and to short lives, which has led to 
significant ethical concerns that would offset potential 
benefits; and (iii) cloning is fully dependent on the 
availability of intact somatic cells that have been stored 
appropriately or used directly from living individuals.
CRISPR-Cas9 genome editing has accelerated 
and facilitated synthetic biology. Yet, it should be 
acknowledged that targeting just a few genes or 
genomic regions for editing may not always be sufficient 
for a phenotypic change, or at least in the way intended 
for conservation (Johnson et al., 2016). An increasing 
number of studies have shown that the genetic 
architecture of many fitness-related traits is largely under 
the control of many genes of small effect, or polygenic, 
including the influence of genetic epistatic interactions 
and functional intergenic regions (Taylor & Ehrenreich, 
2015). Therefore, although significant changes in 
phenotype have been produced with genome editing 
and transgenesis, including complex phenotypes such 
as behaviour, there are still significant challenges. Yet, 
new genomic technologies including CRISPR-Cas9 
have great promise for also making it much easier to 
link genotypes with phenotypes and fitness in non-
model species (Bono, Olesnicky & Matzkin, 2015). A 
clear demonstration of increasing resilience to plant 
disease has been made, but all animal work is currently 
speculative or at the early stages of progress.
Existing research identifies a variety of potential 
adverse effects that should be examined, including 
for example adverse effects involving non-target 
impacts and gene flow (Vettori et al., 2016). Where 
synthetic biology is used to alter the fundamental 
niche of a species (the entire set of conditions under 
which it can survive and reproduce itself), that it 
could potentially alter the ecological and evolutionary 
trajectories for that species (with potentially deleterious 
long-term consequences; e.g. a climate change 
adaptation is engineered, and climate change is 
eventually reversed) should also be considered.
5.3.2 Creating proxies of extinct species
There have been five mass extinction events in the past 
600 million years. In the worst, 250 million years ago, 96 
per cent of the marine species and 70 per cent of the 
land species died off. It took millions of years to recover 
(Benton, 2015). Many scientists are now predicting we 
are placed for a sixth mass extinction (e.g. Ceballos, 
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Ehrlich & Dirzo, 2017; Ceballos & Ehrlich, 2018). It 
has been estimated that currently three species on 
the planet go extinct every hour, and that this rate is 
orders of magnitude higher than the planet has seen in 
previous catastrophic extinction events (Kolbert, 2014). 
In this light, solutions are being explored to prevent 
extinction of endangered species, or even resurrect 
extinct species, especially keystone species that play a 
unique and crucial role in the way ecosystems function. 
De-extinction, or species revival, is the development 
of functional proxies for species which previously 
went extinct (IUCN SSC, 2016). Traditional methods 
to restore species involve: (i) selective or back 
breeding: this is essentially a version of existing 
domestic animal breeding. It is slow, and while it 
can result in an organism that looks like the extinct 
species, its genetic code, hence also the ecological 
functions it performs in the ecosystem, may be quite 
distinct; (ii) animal cloning: this requires the transfer 
of the nucleus of the adult cell of an extinct species 
(e.g. frozen tissue) into the unfertilised egg of a 
host animal cell from which the nucleus has been 
removed, creating a true clone (identical to the parent). 
However, the rate at which DNA degrades makes 
cloning possible only for relatively recently extinct 
animals, for which a suitable closely-related host is 
available. IUCN has developed guidelines for these 
more conventional techniques (IUCN SSC, 2016).
 
It has been proposed that species’ functional proxies 
might support ecosystem recovery by restoring 
ecological function, restarting latent ecological 
processes and restoring lost ecosystems or ecosystem 
states (Estes, Burdin & Doak, 2016). In turn, this 
might increase ecosystem stability in the face of 
environmental change, promoting network diversity 
and reducing loss of other species (IUCN SSC, 2016).
5.3.2.1 Potential synthetic 
biology applications
The technological approaches for the creation of 
proxy species are currently speculative or at the early 
stages of development (Appendix 3 (www.iucn.org/
synbio)). However, de-extinction has caught the public 
imagination through high-profile publications and events 
(TEDxDeExtinction, 2013), high profile projects such 
as the passenger pigeon project (Revive & Restore, 
2018) and media fascination with bringing back woolly 
mammoths, the ground sloth and other extinct species. 
Applying synthetic biology techniques for de-extinction 
is also hugely complex, and the technical challenges 
of fully and accurately sequencing the genomes 
of extinct species are immense (Shapiro, 2015). 
Although whole-genome sequencing technologies 
have become more accessible, allowing for the 
generation of genomic datasets for multiple individuals 
in species of conservation concern, additional 
advancements are needed in order to decipher the 
genomic architecture of complex traits important 
for species persistence (Johnson et al., 2016).
5.3.2.2 Potential adverse 
effects and limitations 
Creating proxies of extinct species could possibly 
distract attention and funding from more pressing issues 
and cost-effective conservation actions to conserve 
extant but threatened species and ecosystems (IUCN 
SSC, 2016). The financial and human resource costs of 
creating a proxy species, introducing it to the wild, and 
monitoring its progress, would likely be considerable, 
and could divert resources from the conservation of 
extant species. It pits an optimistic world of high-tech 
‘precision’ conservation against a more conventional 
vision of biodiversity conservation achieved primarily 
through protected areas (Adams, 2017), and broader 
species and landscape management and planning.
Another proposed adverse effect of resurrecting an 
extinct species is that it might diminish extinction 
itself, posing a moral hazard by changing public 
perceptions in a way that could undermine current 
and future conservation efforts (IUCN SSC, 2016). 
The creation of an apparent techno-fix to the crisis of 
species extinctions and biodiversity loss could have the 
perverse effect of making society feel better about its 
throwaway attitude towards nature (DeSalle & Amato, 
2017). The social and health welfare of individual 
animals during the process is a further concern. The 
severe welfare concerns in relation to processes 
around the production of animal clones are well 
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documented. Concerns include the potential suffering 
of new individuals and of gestational surrogates, the 
provision of appropriate animal husbandry, social and 
psychological environments for the species, and the 
post-release survival of animals following translocation 
into a novel ecosystem (IUCN SSC, 2016). 
A proxy species might potentially become invasive, 
due to genetic factors associated with the proxy 
species creation process, or factors arising from 
the rearing environment, or because of ecological 
and environmental changes since extinction that 
mean any release might be into an ecosystem 
where individuals of resident species have never 
encountered the original form of the proxy. There 
are also potential adverse disease effects, including 
the transfer of diseases from captivity (from multiple 
potential origins) into the wild (always a concern to 
be addressed in any reintroductions), and impacts on 
introduced animals of diseases for which they have 
no prior history of exposure. There is also a small but 
non-negligible likelihood of endogenous retroviruses 
being revived along with the proxy species, and 
thereafter becoming exogenous (IUCN SSC, 2016).
Finally, the status of de-extinct species is complex, 
and no existing legal framework is entirely suited 
to such species, and their status under different 
frameworks is unclear (e.g. Is it still an endangered 
species? Is it an invasive? Wagner et al., 2017). 
For this reason, CITES currently has a working 
group to examine the legal status of “de-extinct” 
species, and make recommendations for any 
changes in the Convention or national legislations 
to ensure that they are both legally protected 
where appropriate, and also do not undermine 
legal protections for extant threatened species. 
Given the multiple major implications of this concept 
for biodiversity conservation, IUCN has produced a 
document of Guiding Principles on the topic (IUCN SSC, 
2016). A key, and often overlooked, fact is that species 
cannot be brought back from extinction; none of the 
current pathways will result in a faithful replica of any 
extinct species, due to genetic, epigenetic, behavioural, 
physiological and other differences. However, synthetic 
biology, combined with traditional genetic, breeding 
and husbandry techniques, can theoretically produce 
proxies of extinct species. The IUCN Guidelines posit 
that the legitimate objective for the creation of a proxy 
of an extinct species is the production of a functional 
equivalent able to restore ecological functions or 
processes that might have been lost as a result of the 
extinction of the original species (IUCN SSC, 2016).
5.4 Summary
Certain synthetic biology applications, if appropriately 
designed and targeted, have potential for enhancing 
biodiversity conservation. Technological development 
of such approaches to date has occurred mainly 
for potential application to the suppression or 
eradication of invasive alien species. However, no 
technology developed for conservation purposes is 
yet ready to be tested in the field, let alone applied for 
management, with the possible exception of disease 
resistant American chestnut trees. Application and 
efficacy of proposed synthetic biology approaches 
(including gene drive) in the field are likely to 
encounter multiple hurdles which will require further 
development to overcome, or may even prove to 
be intractable barriers to useful application.
Significant concerns exist that genome-editing may 
cause harm to the individual or population and 
communities due to uncertainties with altering genome 
processes and potential subsequent knock-on effects 
(Lander, 2015). Such concerns arise from the fact that 
much remains to be learned about how the information 
that is encoded in the genome is transcribed into 
function. A further concern is that transgenes or genetic 
manipulations may horizontally transfer among species, 
particularly relevant when target species can breed 
with non-targets. Of greater concern is the potential 
for synthetic biology approaches intended to be self-
disseminating, such as engineered gene drives, to affect 
non-target populations. Multiple strands of development 
are thus exploring self-disseminating approaches that 
are self-limiting or tactically controllable in other ways.
There are also social and regulatory uncertainties 
surrounding affected communities’ interests in 
having synthetic biology tools deployed. Social 
science research and stakeholder engagement 
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will play a critical role in understanding stakeholder 
values around any potential application of synthetic 
biology for conservation, and whether the proposed 
tools are acceptable for use. Should communities 
and stakeholders support the progression of any 
synthetic biology approach to field trial stage, it must 
be borne in mind that consensus on the suitability 
of field sites for such trials is yet to be achieved. 
Case-by-case assessments are thus needed of 
any proposed field sites and trial designs. Such 
assessments should recognise all potential adverse 
effects; with the broad uncertainties surrounding 
impacts to individuals, populations and communities, 
comprehensive assessments (including ecological) 
that include contributions from conservation and 
social scientists and policy experts are critical to 
any potential deployments of such technology.
Final considerations relate to the ‘moral hazard’ of 
resources being removed from more conventional 
conservation actions and developments to fund 
investigation into synthetic biology solutions. However, 
these concerns, and the need to understand the 
potential adverse effects of the technology, need to be 
considered alongside the ‘moral hazard’ of potential 
species decline and extinction should potential solutions 
to their loss not be researched and implemented if 
successfully developed, or their development delayed 
by an over-emphasis on caution. Thus, such reasons 
both for and against a role of synthetic biology in 
biodiversity conservation (including the consideration 
of the counter factual of what alternative tools and 
approaches can and could achieve) should always be 
considered in tandem for robust decision making.
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6 .
Biodiversity conservation 
implications of synthetic 
biology applications not 
directly intended for 
conservation benefit  
Todd Kuiken, Edward Perello, Hilde Eggermont
Image by: Ye Maltsev / Shutterstock.com
6.1 Overview  
This chapter examines technology trends and specific 
examples of synthetic biology tools, applications and 
products that may indirectly impact conservation 
goals and threats. While the impacts themselves may 
be significant, they are indirect because the intended 
purpose of the technology or application itself is not 
for conservation. This means that the developers of 
the product or application have not stated specifically, 
or it cannot be inferred, that they were developed 
with the purpose of impacting conservation issues. 
This assessment does not explicitly address the many 
concerns and hopes surrounding genetically modified 
organisms, which has generated a large formal 
and informal body of literature (NASEM, 2016a).
The chapter begins with a discussion and case 
studies related to synthetic biology and genome 
editing techniques for agricultural applications, product 
replacement, pest management and improving 
habitat quality. The final section discusses new 
and emerging issues as well as communities that 
have access to a suite of technologies related to 
synthetic biology. These new communities themselves 
could have an indirect impact on conservation 
by expanding the community of conservation 
practitioners, expanding the potential toolbox of 
options for conservation solutions, and/or expanding 
the source of adverse effects on conservation.
6.2 Synthetic biology 
applications for agriculture
Agriculture in the form of croplands and pastures 
occupy approximately 40 per cent of the Earth’s land 
surface (Foley et al., 2005), making it the planet’s 
single most extensive form of land use (Campbell et 
al., 2017). Agriculture is also a major factor accounting 
for biodiversity loss (Chaudhary, Pfister & Hellweg, 
2016), ranked second in a global analysis of threats 
to threatened or near-threatened species (Maxwell 
et al., 2016). Land devoted to agriculture is also 
expected to expand in coming decades (FAO, 2016).
Agriculture is one of the major sectors for investment, 
research and development in synthetic biology. 
For example, in 2017 Ginkgo Bioworks and Bayer 
announced an investment of US$ 100 million in a 
new agricultural biotechnology company (ginkgo-
bioworks-bayer-invest-100m-new-agbio-company). 
Agricultural challenges that are being addressed with 
synthetic biology and genome editing include climate 
change (Abberton et al., 2016), soil fertility (Bender, 
Wagg & van der Heijden, 2016), plant microbiomes 
(Borel, 2017), photosynthesis (Bourzac, 2017) 
and crop nutrient content (De Steur et al., 2017). 
Applications are directed at a wide range of animals 
and plants (Table 6.1), and are expanding rapidly. To 
understand the impact of these synthetic biology and/
or gene drive approaches a risk assessment would 
Table 6.1 Examples of genome editing techniques of relevance to agriculture
Crop/Animal
Cacao
Cassava
Cotton
Maize
Rice
Rice
Gene disruption
Gene disruption
Viral gene disruption
Promoter disruption
Gene mutation
Gene disruption
Reference
(Fister et al., 2018)
(Gomez et al., 2018)
(Iqbal, Sattar & Shafiq, 2016)
(Shi et al., 2017)
(Miao et al., 2018)
(Wang et al., 2016)
Type of edit Results
Increased resistance to the cacao 
pathogen Phytophthora tropicalis
Increased resistance to cassava 
brown streak disease
Elevated resistance to cotton leaf curl disease
Improved maize grain yield under 
field drought stress conditions
Promoted rice growth and productivity
Enhanced resistance to M. oryzae
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need to be conducted and compared to alternative 
approaches (i.e. push-pull agriculture (International 
Centre of Insect Physiology and Ecology, 2018)).
Intervening in agricultural production systems can have 
positive or negative consequences for biodiversity 
(UN CBD, 2015). As with other synthetic biology 
applications discussed in this assessment, many of 
these with agricultural relevance are in the early stages 
of development and clear evidence is not available 
to properly evaluate their impacts on biodiversity. 
The potential negative impacts of synthetic biology 
applied for agricultural purposes on biodiversity and 
conservation have been discussed by a number of 
reviews (e.g. Science for Environment Policy, 2016). 
They include potential impacts such as: transferring 
genetic material to wild populations through horizontal 
or vertical gene transfer; having toxic effects on other 
organisms such as soil microbes, insects, plants and 
animals; creating new invasive species that may have 
an adverse effect on native species by destroying 
habitat or disrupting the food web; facilitating greater 
application of agrochemicals with biodiversity impacts; 
reducing soil fertility and structure by allowing for 
more intensive agriculture; and creating crops that 
can better utilise marginal land, or even use previously 
unusable land (Science for Environment Policy, 2016).
Potential benefits to biodiversity include: enhancement 
of decomposition rates and nutrient fixation (Good, 
Crop/Animal
Rice
Tomato
Wheat
Japanese black cattle
Pigs
Poplar trees
Promoter disruption
Gene disruption
Gene disruption
Gene/cell mutation
Gene disruption
Transgenes
Reference
(Jiang et al., 2009)
(Rodríguez-Leal et al., 2017)
(Wang et al., 2014)
(Ikeda et al., 2017)
(Burkard et al., 2017)
(Klocko et al., 2018)
Type of edit Results
Increased resistance to bacterial blight
Increased crop yields
Increased resistance to powdery 
mildew microcolonies
Correction of a disease mutation 
(Isoleucyl-tRNA synthetase syndrome) 
in Japanese black cattle
Increased resistance to Porcine Reproductive 
and Respiratory Syndrome in pigs
Tree sterility
2018); reduction in the application of fertiliser 
(Good, 2018); more efficient production of farm 
animals with concomitant reductions in feed and 
land use (Van Eenennaam, 2017); forest restoration 
(Dumroese et al., 2015); and production of livestock 
feed based on more efficient industrial production 
of microbial proteins (Pikaar et al., 2018).
6.3 Synthetic biology 
applications for pest control
Various applications have been proposed using 
synthetic biology to combat different types of pests, 
responsible for damage to both agricultural and human 
health. The case studies below examine two such 
applications in detail. The first explores the impact of 
an engineered gene drive approach for malaria vector 
suppression in Africa, while the second examines a 
synthetic biology application addressing honeybee 
colony collapse. While neither of these applications have 
been released into the environment, other applications, 
such as a genetically modified diamondback moth, 
are in the field trial stage (Shelton Lab, 2018). The 
development of engineered gene drive strategies for 
malaria vector control and other synthetic biology pest 
control applications is an emerging field based on 
modelled population level effects, derived from several 
different molecular strategies. Many of the plausible 
pathways to benefit or harm remain hypothetical in 
the absence of product-specific data to inform case-
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by-case risk assessment and manage uncertainty. 
Those studies largely depend on the final technology 
developed, its mode of action and unique molecular 
and phenotypic characteristics. Any application for 
pest control using synthetic biology or engineered 
gene drive systems would therefore need to be 
evaluated against a risk assessment framework
(Section 3.4).
Existing alternatives/baseline situation
Malaria is a leading cause of death in Africa 
amongst children under five. An estimated 427,000 
people died of malaria in 2016 (WHO, 2017). Every 
year 216 million cases of malaria are reported, 90 
per cent of which are in Africa, with an estimated 
cost of US$ 12 billion for Africa alone (Gallup 
and Sachs, 2001). Worldwide, human malaria 
is caused by any of five Plasmodium species; in 
Africa overwhelmingly by one of these, Plasmodium 
falciparum (Snow et al., 2017). The World Health 
Organisation (WHO) estimates that US$ 9 billion 
per year would be needed to cover 90 per cent of 
the population at risk in 2030 with existing malaria 
prevention and treatment tools; only US$ 2.4 
billion is currently available. This investment would 
significantly reduce but not eradicate malaria. 
There are two main types of malaria control 
interventions in Africa: interventions targeting 
the disease in humans; and vector control 
interventions targeting the transmission of the 
malaria parasite from an infected person to 
another person through the bite of a female 
mosquito from the genus Anopheles.
Considerable progress has been made 
towards targeting the disease in humans, 
however vector-based interventions 
remain crucial for malaria control.
Available vector control tools are diverse, but 
two have been primarily used in the last decades 
and have made an important contribution to 
reducing the number of deaths and infections 
from malaria: insecticide-treated bed nets and 
indoor residual spraying (Bhatt et al., 2015). The 
cumulative impact of those tools on non-target 
organisms is not well known (Junges et al., 2017). 
Insecticides may have impacts on non-target 
species and some formulations, such as those 
containing DDT, have raised particular concerns 
in terms of toxicity (Burton, 2009). Despite efforts 
to end the use of DDT because of its adverse 
environmental impacts, WHO re-endorsed its 
use for malaria control in 2006, reversing 30 
years of policy (WHO Global Malaria, 2011). 
In the past few years, alarming signs of resistance 
against insecticides have been identified in 
a number of African countries (http://www.
irmapper.com). Research on new molecules is 
underway to counteract the impact of this growing 
resistance. Vector control methods need to 
become more sustainable and more cost-efficient 
to overcome resistance and advance malaria 
elimination (WHO, 2015; Killeen et al., 2017). 
Current vector control tools also face 
important challenges in terms of social and 
cultural acceptance. For instance, there is 
still a discrepancy between the proportion of 
bed net ownership and proportion of people 
Case study 6:
Gene drive approach for malaria 
suppression in Africa   
Delphine Thizy, Luke Alphey
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reporting to have slept under a bed net 
during the previous night (WHO, 2017). 
Description of the gene drive approach
Researchers are exploring the possibility of using 
engineered gene drive mechanisms to suppress 
the population of Anopheles gambiae complex 
– one of the primary vectors of malaria in Africa 
– to a point where, in conjunction with other 
malaria interventions, the cycle of transmission 
of the parasite could be interrupted and thus 
contribute to the elimination of malaria. Other 
engineered gene drive approaches are also being 
researched to alter the mosquitoes to stop the 
malaria parasite transmission (Gantz et al., 2015).
The objective is to insert a modification in malaria 
mosquitoes that would affect the mosquito’s 
ability to reproduce. This could be achieved in two 
different ways (Burt et al., 2018): by biasing the 
sex ratio of mosquito populations to have mostly 
males (only females bite and transmit malaria); 
or by reducing female fertility (see Appendix 2 
(www.iucn.org/synbio) for an in-depth overview 
of engineered gene drive elements). When 
introduced in the malaria mosquito, the nucleases 
work by identifying and cutting essential genes 
targeted by researchers, such as fertility genes. 
The interrupted gene will no longer function, and 
modified mosquitoes will be affected according 
to the nature and importance of the gene. While 
there may be some fitness costs in addition to 
the sterility of female homozygotes, as long as 
these are not too large the preferential inheritance 
resulting from the gene drive can ensure the 
modified gene still increases in frequency 
over successive generations (Burt, 2003).
The ultimate goal is to produce modified 
mosquitoes for the malaria vector species that can 
pass these genes on to a high percentage of their 
offspring, so the modification is spread throughout 
the specific target populations relatively quickly 
and is effectively “self-sustaining” (Burt & Crisanti, 
2018). Since malaria is transmitted by several 
Anopheles species, and genetic control tools are 
highly species specific, any engineered gene drive 
tool would likely still need to be complemented by 
other existing approaches (Eckhoff et al., 2017).
As costs and logistical challenges create 
important limitations on the use of current tools, 
engineered gene drive approaches, alongside 
other new tools, could help reach remote areas. 
They are being thought of in terms of ‘first mile’ 
or ‘last mile’ interventions, where they could 
help increase the efficiency of existing tools or 
help achieve elimination in countries that have 
already significantly progressed but where 
low-level transmission remains persistent. 
Despite progress in the laboratory, any field release 
for the purpose of evaluating a gene-drive-based 
construct for vector control is at least a few years 
away. It is not expected that a fully evaluated vector 
control technology will be available for another 10 
years. This is not only a function of progress in 
scientific research, which is progressing rapidly, 
but a function of the large body of knowledge that 
must be acquired to assess the technique’s safety 
and efficacy. Some remaining areas for technical 
research are around the emergence of resistance 
to the editing, which could greatly diminish 
the efficacy of the tool (Champer, Buchman 
&Akbari, 2016; Unckless, Clark & Messer, 2016; 
KaramiNejadRanjbar et al., 2018). This is not 
unique to gene drive mechanisms but is common 
for all vector control tools (Kleinschmidt et al., 
2018). Researchers working on this technology 
showed that resistance can arise due to changes 
in target site caused by the gene drive construct 
(Hammond et al., 2017). Two ways of retarding 
resistance have been proposed: (i) targeting 
multiple sites (Champer et al., 2018), and (ii) 
targeting conserved sites that cannot tolerate 
changes while maintaining function. The latter has 
been demonstrated in small cages (Kyrou et al., 
2018). More work is needed to optimise how the 
two strategies can be best combined to maintain 
efficacy levels. Additionally, more information 
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is needed about mosquito populations to feed 
the models about the dispersion of the genetic 
modification and to understand if this technology 
could effectively and safely be deployed for malaria 
control. For example, there is ongoing research 
to better characterise the genomic diversity of 
Anopheles gambiae s.l., which will be instrumental 
to model the dispersion and understand its 
potential limitations (Miles et al., 2017). 
While there is a societal interest in finding new 
vector control tools to reduce malaria transmission 
and to do so in a cost-effective way, as expressed 
for instance during the Commonwealth Heads 
of States and Government Meeting in 2018 
(CHOGM, 2018), socio-economic and cultural 
considerations need to be explored for this 
application of engineered gene drive systems. 
It is important to ensure that dialogue is taking 
place with communities, indigenous people and 
other relevant stakeholders (including research 
groups) so that their perspectives and values are 
taken into consideration (Kofler et al., 2018). 
Biodiversity and conservation concerns are 
often raised by stakeholders, as illustrated by 
the press coverage and as reflected in the call 
from some organisations for a moratorium 
on gene drive research. As is the case for all 
synthetic biology risk assessment (Section 
3.4.3), these risks and potential impacts need 
to be considered relative to the situation 
without the intervention, i.e. in this case, to the 
impacts of existing malaria control tools.
Potential opportunities resulting 
from the approach
The intended direct impact of this approach is 
clearly the reduction of human malaria (Eckhoff 
et al., 2017; WHO, 2017; African Union, 2018). 
However, as engineered gene drive systems 
would be complementary to other malaria 
control tools, additional potential conservation 
benefits could come from the interaction with 
other malaria reduction tools, for example, 
the reduction in the use of DDT, which was 
reintroduced for malaria control in 2006 under 
certain conditions (WHO Global Malaria, 2011). 
An additional indirect impact from the research 
on engineered gene drive for human malaria 
control could be to advance scientific knowledge, 
regulatory frameworks and public engagement 
for engineered gene drive in mosquitoes. This 
could in turn benefit other applications of 
engineered gene drive currently being investigated, 
notably the use of engineered gene drive for 
the control of avian malaria (Liao et al., 2017).
Potential adverse effects resulting 
from the approach
A number of initiatives have started exploring the 
plausible pathways to harm in order to identify 
classes of data and information that may be 
required in order to perform a risk assessment. In 
2016, the Foundation for the National Institutes 
of Health (FNIH) organised a problem formulation 
workshop to examine hypothetical examples of 
engineered gene drive applications, including 
both suppression and alteration strategies, 
and arrived at consensus points including the 
following two bullets (Roberts et al., 2017):
• For mosquito biodiversity: 
Although this approach aims to target An. gambiae 
in its native range, unlike other case studies 
where the target is an invasive population, the 
workshop concluded that An. gambiae is not a 
keystone species and therefore the ecosystem-level 
consequences of suppression of its populations 
were unlikely to be severe. Interactions with other 
species (by feeding on them, being consumed as 
prey or competing with them) need to be further 
explored. The toxicity of novel gene products 
needs to be tested for those interactions as well.
 
The question of gene flow was considered, and 
the paper concluded that hybridisation with other 
Anopheles species was likely for some species. 
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• For animal health: 
The potential harm was considered from “pathogen 
transmission dynamics to livestock.” No other 
relevant pathways were identified, though 
equivalent impacts on wildlife might be envisioned.
Further to this workshop and publication, the 
question of gene flow is being investigated by 
researchers. Anopheles gambiae s.l. is a complex 
of sibling species. Some of these species have 
on-going gene flow which has been documented 
(Coluzzi et al., 1979; Fontaine et al., 2015; Neafsey 
et al., 2015). Therefore, there is a possibility of the 
gene drive elements spreading by hybridisation 
and this needs to be considered when assessing 
risks and benefits. Most of these species from the 
complex are vectors of human malaria and could be 
a target for vector control (Bernardini et al., 2017). 
It is an active field of investigation to see to what 
extent it is possible to direct gene drive constructs 
to only one species, despite hybridisation.
Furthermore on the question of the role of 
Anopheles gambiae in the ecosystem, a recent 
literature review confirmed the statement that 
it is not a keystone species (Collins et al., 2018). 
The suppression of An. gambiae using engineered 
gene drive systems may have an indirect effect 
on conservation through niche replacement – the 
possibility that another species will fill the now-empty 
ecological niche previously filled by An. gambiae even 
if those effects could be transient as the aim of those 
interventions is not extinction but suppression. While 
this does not seem to have been noted as a problem 
in control programmes so far, niche replacement 
may be more feasible in the context of engineered 
gene drive systems, as their species-specific nature 
may mean that they do not exclude other species 
as much as broad-spectrum interventions, such 
as insecticides, may do. In the specific case of An. 
gambiae it is not obvious that any significant ecological 
disruption might arise through this mechanism
(Collins et al., 2018).
The reduction or elimination of human malaria 
might lead to demographic and land-use changes, 
potentially impacting conservation and so should also 
be considered, although it is of course not specific 
to engineered gene drive systems and would apply 
to any successful vectorcontrol intervention. 
Issue
Pollinators are essential to food and nutritional 
security, with about three-quarters of all food 
crops benefiting from pollination, with the value 
to global production estimated at approximately 
US$ 351 billion annually (Lautenbach et al., 
2012). Honeybees are critical pollinators of plants, 
but they are increasingly threatened by pests, 
pathogens, neonicotinoids and other pesticides 
(Pisa et al., 2017), and other stressors such as 
anthropogenic habitat fragmentation. Managed 
honeybee colonies can be used for honey 
production, crop pollination, or both. There has 
been a significant decline in managed honeybee 
colonies, particularly in Europe and North America 
(vanEngelsdorp et al., 2009; IPBES, 2016a). 
Case study 7:
Addressing honeybee colony 
collapse                     
Daniel Masiga
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This phenomenon is known as Colony Collapse 
Disorder, because it is associated with large-scale 
loss of managed honeybee colonies. Experts 
believe that multiple factors are responsible for 
Colony Collapse Disorder, including parasites, like 
the Varroa destructor mite, bacterial diseases, 
viral infections and pesticides (van Engelsdorp 
et al., 2017). Although Colony Collapse Disorder 
has largely been considered in the context of crop 
pollination and hive products, significant loss of 
pollinators can have a large impact on biodiversity 
and ecosystem services in natural landscapes
(IPBES, 2016a).
Existing interventions
In response to the need to preserve honeybee 
health, the EU recently banned the use of 
neonicotinoid pesticides (Stokstad, 2018). There are 
clearly complex interactions between pathogens, 
pests, pesticides and habitat loss (IPBES, 2016a). 
Some studies have suggested an association of 
Colony Collapse Disorder and co-infection with 
fungi of the genus Nosema and invertebrate 
iridescent virus (Bromenshenk et al., 2010).
Synthetic biology proposed application
Al Dahhan and Westenberg have proposed 
using a synthetic biology approach, based on 
the hypothesis that removing either of these 
pathogens would reduce the occurrence of 
Colony Collapse Disorder (Foster & Pummill, 
2011). The approach proposed is based on 
the practice of farmers to control one of these 
pathogens, Nosema ceranae, with fumagillin, a 
compound produced by the fungus Aspergillus 
fumigatus. They propose to engineer a 
microbe to produce fumagillin, by scanning the 
fungus genome (Hagiwara et al., 2014) for the 
pathway responsible forfumagillin synthesis.
Potential adverse effects of the 
synthetic biology application
These authors concede that differential responses 
of Nosema species (N. apis and N. ceranae) 
could render the approach problematic if for 
example, the use of fumagillin favours the 
displacement of N. apis by N. ceranae. It has 
been demonstrated that N. ceranae (and not N. 
apis) weakens the immune system of honeybees, 
making them more vulnerable to other pathogens 
(Antúnez et al., 2009). Hence, a significant 
spread of N. ceranae could be damaging to 
honeybee populations. Such an approach could 
have negative effects on the natural resilience 
in honeybee populations. A study carried out 
in Kenya, where feral honeybee colonies are 
predominant, has shown that minimally managed 
honeybee colonies are resilient to stressors 
associated with colony collapse, such as Varroa 
mites and a range of pathogens (Muli et al., 2014). 
6.4 Synthetic biology 
applications for product 
replacement  
Synthetic biology has the potential to provide 
new production methods for new and existing, 
commercially available products (see: https://www.
futurebioengineeredproducts.org/) by changing 
the production methods and raw material inputs 
(e.g. petroleum to bio-based). These shifts in inputs 
could have important positive or negative impacts 
on conservation. For example, synthetic biology has 
the potential to replace existing products derived 
from threatened species (Case study 8) but shifts 
to a synthetic biology alternative could inadvertently 
increase the demand for the natural product (Section 
5.2.2). Different synthetic biology processes will also 
be utilised in order to derive these products, which 
could in turn exacerbate or minimise climate change, 
land-use change, nutrient cycles and biodiversity loss. 
Further, global commerce has the potential to translate 
the production of a synthetic biology application in 
one part of the world into land conversion in another, 
such that while beneficial at first glance, an application 
could generate increased ecological impact if viewed 
over time and at global scales (Melillo et al., 2009; 
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Liu et al., 2013, 2015). Analysis of synthetic biology 
applications may affect the socio-economic impacts on 
local communities that may be impacted by economic 
market shifts, which could drive changes in land use 
and livelihoods, potentially impacting indigenous 
peoples’ cultural heritage as well as conservation. For 
instance, rising demand for biofuel feedstocks has 
caused food prices to fluctuate (Westhoff, 2010;
Liu et al., 2015).
It is difficult to predict how the dynamics of complex 
economic systems change when substituting 
one product for another. The location and choice 
of organism used as the chassis to produce the 
new product might also affect the ecosystem 
dynamics. The following examples were chosen to 
illustrate how synthetic biology-derived products, 
at various stages of development, could at least 
partially replace current products on the market.
Issue
Three species of Asian horseshoe crab (Tachypleus 
tridentatus, Tachypleus gigas and Carcinoscorpius 
rotundicauda) and the North American species 
(Limulus polyphemus) are all facing global threats. 
While comprehensive data are difficult to obtain, 
populations of all four species are currently 
declining (Vestbo et al., 2018). While the three 
Asian species of horseshoe crab are considered 
Data Deficient, in 2016 the American horseshoe 
crab was re-assessed from Near Threatened to 
Vulnerable on the IUCN Red List of Threatened 
Species (Smith et al., 2016). Reduction in 
horseshoe crab populations have negative 
impacts on a number of wading bird species that 
depend on horseshoe crab eggs: six species of 
shorebirds synchronise their northward migration 
along the Atlantic flyway to gorge on the eggs of 
spawning horseshoe crabs in Delaware Bay, a 
critical food stop on their journey to Arctic nesting 
grounds (McGowan et al., 2011). The abundance 
of horseshoe crab eggs is a critical factor to 
the survival, physical condition and successful 
breeding of birds, particularly the red knot (Calidris 
canutus rufa), whose 9,500-mile migration from 
the tip of South America to the Arctic is among 
the longest of any bird in the world. From 1980 
to 2014, red knot populations decreased by as 
much as 75 per cent in some areas, largely due 
to the lack of horseshoe crab eggs in Delaware 
Bay (Mizrahi & Peters, 2009; US FWS, 2014). 
Fisheries managers now explicitly recognise 
the interdependence between the horseshoe 
crab and the migrant shorebirds and have 
designed a multi-species adaptive management 
framework to guide management (Atlantic 
States Marine Fisheries Commission, 2015).
The primary threat to horseshoe crabs stems 
from their unique role in biomedicine (Krisfalusi-
Gannon et al., 2018). Bacterial contamination 
in the production and delivery of injectable 
medications and medical devices can cause 
life-threatening fever or toxic shock if introduced 
intravenously (Ding & Ho, 2001). Horseshoe crab 
blood cells known as amebocytes are able to 
detect minute quantities of endotoxin (molecules 
present in gram-negative bacteria), and a lysate 
of horseshoe crab blood, known as the Limulus 
Amebocyte Lysate (LAL), has become the most 
Case study 8:
Horseshoe crab replacement for 
Limulus Amebocyte Lysate test            
Tom Maloney, Ryan Phelan
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commonly used endotoxin detection method 
worldwide (Federal Register, 1977). This test, and 
the necessary collection and bleeding of horseshoe 
crabs, has been integral to the safe production of 
vaccines and injectable medications for the past 
40 years (Abate et al., 2017), at the cost of severe 
declines in the species (Smith et al., 2016). 
Unlike in Asia, where horseshoe crabs are used 
for other purposes after being bled (Gauvry, 
2015), most crabs in North America are released 
after bleeding, although some are sold for 
bait in the whelk and American eel fisheries 
(Krisfalusi-Gannon et al., 2018). The mortality 
rate of released horseshoe crabs ranges from 
10 to 30 per cent in the US; however, these 
figures do not account for any further trauma 
and/or detrimental behavioural changes once 
the animals are returned to the ocean, nor the 
derivative population impact from the disruption of 
horseshoe crab spawning (Krisfalusi-Gannon et al., 
2018). The impact of biomedical bleeding on the 
fishery is compounded by the effects of shoreline 
development, climate change and rising sea 
levels, all of which are diminishing the availability 
of suitable spawning sites (Nelson et al., 2016). 
The IUCN Red List of Threatened Species 
predicts declines of at least 30 per cent in 
horseshoe crab populations over the next 
40 years, while global demand for vaccines, 
pharmaceuticals and medical devices over 
approximately the same period will require an 
increasing supply of LAL. These dynamics create 
significant uncertainties as to whether current 
harvesting levels can be sustained, much less 
meet projected demands (Krisfalusi-Gannon
et al., 2018).
Synthetic biology description
The invention of an effective synthetic alternative 
to the LAL test presents an opportunity for 
the conservation of horseshoe crabs and the 
birds that depend on them (Maloney, Phelan & 
Simmons, 2018). Crab-derived LAL undergoes 
a series of protein responses in the presence of 
endotoxin and the first reaction is known as factor 
C. In the late 1990s, scientists at the National 
University of Singapore engineered recombinant 
DNA to replicate the factor C reaction (Ding, 
Navas & Ho, 1995). This recombinant Factor C 
(rFC) endotoxin assay was patented and made 
commercially available in 2003 and eliminates 
the need to capture and bleed horseshoe crabs 
(Carmichael et al., 2015). However, whilst rFC 
has been commercially available for 15 years, a 
number of perceived factors such as uncertainty 
over efficacy, regulation, supply chain robustness 
and industry inertia have limited its adoption.
A recently-published paper summarised the results 
from 10 peer-reviewed studies that evaluated the 
efficacy of rFC in the detection of endotoxin in 
water or therapeutic samples (Maloney, Phelan 
and Simmons, 2018). Each study demonstrated 
that commercially available rFC tests detect 
endotoxins with equivalent or better efficacy 
when compared to the LAL test. These studies 
also demonstrate that the commercially available 
tests meet regulatory requirements (that require 
the assay to demonstrate as-good or better 
detection) for replacing LAL for the detection of 
endotoxins. Notably, pharmaceutical industry 
experts conservatively estimate that the adoption 
of rFC only in the testing of water and other 
commonly used manufacturing materials can result 
in an estimated 90-per cent reduction in the use 
of horseshoe crab-derived LAL (Bolden & Mozier, 
2018, personal communication, 1 April). This in turn 
will likely stimulate more widespread adoption of 
rFC. Patent restrictions have expired, meaning new 
manufacturers can now begin entering the market 
– Eli Lilly and Company has already converted 
to using rFC in three of its major manufacturing 
facilities – and are increasing the reliability of 
supply (Bolden, 2018, personal communication, 
9 May). It appears that widespread adoption of 
rFC in the biomedical industry is likely and will 
remove a significant source of annual mortality to
horseshoecrabs worldwide.
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6.4.1 Omega-3 oils
Commercial aquaculture has relied on wild-caught 
fish to provide essential fatty acids to captive stock 
– in particular docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA). Fishing for these forage 
fish can impact coastal fish nursery habitats, create 
local toxicological problems, and put pressure on wild 
fish stocks and marine food webs (Hites et al., 2004; 
Domergue, Abbadi & Heinz, 2005). As wild fish stocks 
decline, commercial aquaculture operators have been 
challenged by rising costs, responding by reducing their 
use of fish-sourced oils in feedstock and replacing it 
with plant oils, leading to a measurable reduction in the 
nutritional value of farmed fish (Sprague, Betancor & 
Tocher, 2017; Gasco et al., 2018). Transgenic varieties 
of DHA and EPA-producing terrestrially-grown crops 
and microalgae (Abbadi et al., 2004; Woessner, 2004; 
Adarme-Vega et al., 2012) have been proposed as 
means of maintaining the quality of fish feed, and 
reducing pressure on wild fish stocks (Domergue, 
Abbadi & Heinz, 2005), 70 per cent of which are now 
at or beyond exploitable limits (Winfield, 2012). 
In principal, aquaculture operations could benefit 
from the cost-effective production of locally-produced 
synthetic EPA and DHA (Sprague, Betancor and 
Tocher, 2017) and this could relieve pressure on wild 
forage fisheries. At the same time the availability of 
cheaper feedstocks could support an expansion of 
aquaculture by removing a limiting factor on growth 
and expanding current impacts on fish nurseries.
Synthetic biology-derived EPA and DHA could 
potentially impact conservation targets in other areas, 
depending on the method of production. As EPA and 
DHA can stimulate growth and reproduction in aquatic 
invertebrates that may associate with these ponds 
(Wacker et al., 2002; Arendt et al., 2005; Parrish, 
2009), the effects could similarly extend to terrestrial 
invertebrates, possibly pest species, if the oils are 
synthesised in transgenic crop fields (Colombo et al., 
2018). Insects can retain dietary fatty acids, and an 
experimentally high DHA and EPA has been shown 
to have developmental effects on insects (Hixson et 
al., 2016; Colombo et al., 2018). Even if measures 
are taken to ensure that the biosynthesis of bioactive 
compounds occurs only in organs of the plant that 
are not accessible, for instance the seed, this site-
specific production may not prevent a larger animal 
or indiscriminate feeders from accessing a bioactive 
compound if it is able to enter the field (Colombo et al., 
2018). Growing a synthetic biology product in a field 
that alters local insects could result in local expansion 
of the use of insecticides (Colombo et al., 2018). 
Current knowledge suggests the effects of synthetically-
derived compounds will be difficult to predict, be 
they at the social, economic or environmental level.
Given the challenge of exhaustively testing every 
possible interaction between a novel genetically 
engineered plant and a complex ecosystem, 
industries are considering production systems 
closed to the environment, potentially enabling less 
fishing from wild stock, and allowing environmental 
impact assessments of the transgenic production 
organism to be more reasonably completed 
(Sprague, Betancor & Tocher, 2017).
6.4.2 Squalene
Squalane is a cosmetic ingredient that functions 
as an emollient in lotions and moisturisers and has 
been used as a softener for more than 25 years, 
according to the Personal Care Council’s Cosmetic 
Ingredient Review (Personal Care Council, 2003). 
Squalane is the stable, saturated branched-chain 
hydrocarbon form of squalene that naturally occurs in 
large quantities in shark liver oil, other fish oils and in 
smaller amounts in plants (i.e. olive oil, wheat germ oil, 
rice bran oil, palm oil). Squalene also exists in humans 
as a component of sebum, an oily fluid produced 
by the sebaceous glands (Bergeson et al., 2015).
As shark liver oil contains the greatest yield potential 
for squalene, the manufacturing process to produce 
it often involves molecular distillation of shark liver 
oil and hydrogenation of the distillate, followed by 
a re-distillation step to produce a purity of about 
96 per cent squalene (Bergeson et al., 2015). 
The use of shark liver oil for cosmetic products 
is controversial, as a quarter of the world’s shark 
and ray species are listed as threatened (Dulvy, 
2014; IUCN, 2014) and shark liver harvest could be 
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having an impact on their populations. In 2008, the 
organisation Oceana led a campaign against the 
use of shark liver oil for the production of squalene, 
resulting in several cosmetic companies committing 
to stop or phase out the use of shark squalene in 
products (Oceana, 2008; McPhee et al., 2014). 
Squalene is also found in a variety of plant oils. While 
the amount of squalene in olive oil is typically less 
than 0.5 per cent, in 2010 BASF commercialised 
“plant squalene” derived from olive oil deodoriser 
distillate, the concentrated waste product from the 
final step of the olive oil refining process that contains 
up to 30 per cent squalene (McPhee et al., 2014). 
Manufacturing squalene using synthetic biology 
is an alternative option currently in practice at the 
biotechnology firm Amyris (Amyris, 2018). Amyris 
uses synthetic biology to develop synthetic yeast 
strains that convert sugar to produce β-Farnesene, 
the natural biosynthetic precursor of squalene 
(McPhee et al., 2014; Amyris, 2018). The yeast is then 
removed, followed by a chemical coupling process 
along with existing hydrogenation and purification 
technologies that extract and purify the squalane 
for commercial uses (McPhee et al., 2014). 
It is not clear whether sharks are being directly 
fished for squalene or if they are being harvested for 
other reasons (Dulvy, 2014). Therefore, the impact 
of a shift towards a synthetic biology alternative on 
shark population sizes is not known. Additional data 
related to market share of companies like Amyris are 
needed to determine the impacts from the production 
process (feedstocks), land-use change impacts, 
and whether there would be any other impacts on 
shark species by reducing the need for shark liver. 
6.4.3 Vanillin 
Natural vanilla flavour is obtained from the cured seed 
pods of the vanilla orchid (ETC Group, 2013). Vanilla is 
a complex blend of flavour and fragrance, with the most 
important ingredient being vanillin (Evolva, 2018). An 
estimated 200,000 people are involved in the production 
of cured vanilla beans per year, with Madagascar, 
the Union of the Comoros, and Réunion making up 
around three-quarters of the worldwide vanilla bean 
production (ETC Group, 2013). However, because of 
the cost and supply chain variability of natural vanilla, 
most products do not use natural vanilla but rather 
synthetic vanillin made primarily from petrochemicals 
or chemically derived from lignin (Evolva, 2018). Less 
than 1 per cent of all vanilla flavour comes from the 
vanilla bean (Bomgardner, 2016). The biotech company 
Evolva has developed a genetically engineered strain 
of yeast that produces vanillin glucoside when fed with 
glucose (Bomgardner, 2016). While the production of 
vanillin using synthetic biology techniques appears to 
be a replacement for the petrochemical production of 
vanillin, concerns have been raised about the socio-
economic impacts to local and indigenous communities 
who historically have been involved in the production 
of cured vanilla beans (ETC Group, 2013). Similar 
concerns have been raised around the production of 
stevia, in particular issues such as traditional knowledge 
and access and benefits sharing agreements 
both recognised under the CBD (Meienberg et al., 
2015). These issues are currently being deliberated 
inside the CBD and will likely impact how/if these 
synthetic biology applications enter the market. 
Other outstanding questions include the potential 
impact from the feedstocks needed to produce these 
synthetic biology alternatives, as well as the risks if 
the containment mechanisms for the production were 
to fail. Additional market share data on shifts towards 
vanillin and other flavourings produced using synthetic 
biology techniques versus petrochemical production 
will be key to evaluating conservation impacts. Further, 
the impact from national legislation regarding labelling 
of products, in particular whether they can be labelled 
natural or not (Meienberg et al., 2015), and quality 
of the product, may impact consumer preferences 
and thus affect the production of vanillin and other 
flavourings using synthetic biology techniques.
6.4.4 Leather 
The raw material used to produce leather is a by-
product of the meat industry. Tanners use the 
hides from slaughterhouses and process them into 
leather that is used in the manufacture of a wide 
range of products. The global leather industry uses 
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approximately 5.5 million tons of raw hides producing 
approximately 460,000 tons of heavy leather and 
about 940 million square metres of light leather, 
including split leather (Joseph & Nithya, 2009). The 
production process used during the tanning and 
finishing of leather requires considerable quantities 
of water and chemicals and can cause significant 
environmental impacts (Joseph & Nithya, 2009).
 
Synthetic biology may offer alternative pathways to 
reducing the biodiversity impacts of leather production. 
Modern Meadow and Zoa™ is a US-based company 
that “harnesses the power of design, biology, and 
engineering to produce the world’s first biofabricated 
leather materials” (Modern Meadow, 2017; ZOA, 
2018). Specifically, its technology platform uses 
DNA editing tools to engineer specialised collagen-
producing yeast cells. The cells are optimised to 
manufacture the type and quantity of collagen 
required. Once purified, the collagen is formulated and 
assembled into materials for consumer applications 
(Modern Meadow, 2017). The yeast fermentation 
technique requires bio-based feedstocks.
The impact of a synthetic biology alternative to 
leather, and its impact on conservation, has not been 
evaluated due to the nascence of the product and a 
lack of data on market impacts and other factors. A 
life-cycle assessment of the synthetic biology process 
will need to be conducted to understand the full 
impacts on conservation. Key questions include the 
environmental impacts of the synthetic biology process 
itself, whether the synthetic biology production method 
reduces the amount of chemicals currently used in 
the tanning process of leather goods, the potential 
impact on the use and disposal of unused animal 
hides, whether a synthetic alternative to leather will 
increase the desire and price for natural leather, and the 
impacts on animal welfare and ranching livelihoods.
6.4.5 Cultured meat 
Meat production is a major contributor to global 
environmental degradation. Currently, livestock 
raised for meat uses 30 per cent of global ice-free 
terrestrial land and 8 per cent of global freshwater, 
while producing 18 per cent of global greenhouse 
gas emissions (Tuomisto & Joost Teixeira de Mattos, 
2011; Alexandratos & Bruinsma, 2012). Livestock 
production is one of the main drivers of deforestation 
and degradation of wildlife habitats (Tuomisto and 
Joost Teixeira de Mattos, 2011) with 34 per cent of the 
global greenhouse gas emissions related to livestock 
production caused by deforestation: 25 per cent 
are methane emissions from enteric fermentation of 
ruminants, and 31 per cent of the emissions are related 
to manure management (Tuomisto & Joost Teixeira de 
Mattos, 2011; Alexandratos & Bruinsma, 2012). Global 
meat consumption is expected to double by 2050 
(Alexandratos & Bruinsma, 2012), potentially doubling 
the impacts of meat production on the environment 
(Tuomisto & Joost Teixeira de Mattos, 2011). 
Arguments have been made that shifting humans 
to a plant-based diet could lower the environmental 
burdens and greenhouse gas emission impacts 
associated with traditional meat production. One such 
study found that the substitution of 10 per cent, 25 
per cent and 50 per cent of ground beef with plant-
based replacements in the US results in substantial 
reductions in national annual dietary greenhouse gas 
emissions, water consumption and land occupation 
(Goldstein et al., 2017). However, increased demand 
for plant-based proteins also has the potential to 
increase land-use pressures (Goldstein et al., 2017) 
and could therefore increase environmental impacts 
from agriculture practices, depending on where 
these increased land-use pressures take place. 
Alternative sources to conventional and plant-based 
meat production have been proposed, including 
using biotechnology and synthetic biology (Servick, 
2018). Cultured meat, which is produced by growing 
animal muscle tissue in vitro, might reduce biodiversity 
conservation impacts relative to conventionally 
produced meat. Cultured meat can be produced 
using various genetic tools and techniques, including 
synthetic biology. Currently, small quantities of 
cultured meat are produced in laboratories, although 
large-scale production will require more research 
(Tuomisto & Joost Teixeira de Mattos, 2011). There 
are no cultured meat products currently on the market 
and at least one company is attempting to produce 
seafood (Carman, 2018; Finless Foods, 2018). Other 
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meat-alternative products produced, in part, with 
synthetic biology are available from companies such 
as Impossible Foods™ (Impossible Foods, 2018). 
A study in 2011 found that cultured meat production 
could potentially emit substantially less greenhouse 
gas and requires only a fraction of the land and 
water compared to conventionally produced meat. 
The study also found that cultured meat could have 
potential biodiversity conservation benefits by reducing 
pressure for converting natural habitats to agricultural 
land. However, the study also suggested that large-
scale replacement of conventional meat by cultured 
meat production may have negative impacts on rural 
biodiversity and livelihoods due to the reduction in 
need for – and incentive to maintain – grasslands and 
pastures (Tuomisto & Joost Teixeira de Mattos, 2011). A 
separate study which conducted a life cycle assessment 
for the cultivation of cultured meat found that cultured 
meat production could require smaller agricultural 
inputs and land compared to livestock, but those 
benefits could come at the expense of more intensive 
energy use (Mattick et al., 2015). The study concludes 
that “large-scale cultivation of in vitro meat and other 
bioengineered products could represent a new phase of 
industrialization with inherently complex and challenging 
trade-offs” (Mattick et al., 2015). This finding was 
complemented by Alexander et al. which found that 
“overall primary energy production was shown to be 46 
per cent lower than for beef production, but 38 per cent 
higher than for poultry meat” (Alexander et al., 2017). 
It’s not clear if consumers will accept cultured meat as 
an alternative. Several studies have examined consumer 
preferences towards cultured meat and found varying 
responses. A study by Siegrist et al. (2018) found that 
consumer acceptance could be a major barrier to the 
introduction of cultured meat because it is perceived as 
unnatural (Siegrist, Sutterlin & Hartmann, 2018). Indeed, 
as participants in the study learned more about cultured 
meat, it increased their acceptance of traditional meat 
(Siegrist, Sutterlin & Hartmann, 2018). An early study 
in 2015 found that 9 per cent of participants rejected 
outright the idea of trying cultured meat, with two-
thirds hesitant to try it, and about a quarter willing to 
try it (Verbeke, Sans & Van Loo, 2015). However, when 
informed of the potential environmental benefits of 
cultured meat compared to traditional meat, 43 per cent 
indicated they were willing to try it and 51 per cent were 
“maybe” willing to (Verbeke, Sans & Van Loo, 2015). 
6.5 Environmental engineering
Loss of habitat is a significant factor in biodiversity 
loss, affecting a quarter of the Earth’s land surface 
(Pacheco et al., 2018). Restoring ecological values 
to habitat is of global interest, as exemplified by the 
Bonn Challenge, with its effort to bring 150 million 
hectares of deforested and degraded land into 
restoration by 2020 (http://www.bonnchallenge.org/
content/challenge). Restoration efforts have been 
spotty (Nilsson et al., 2016) and there have been calls 
for relevant new tools, including those developed by 
the synthetic biology field (Piaggio et al., 2017). Two 
areas of environmental engineering that have received 
some attention are bioremediation and biomining.
6.5.1 Bioremediation 
Environmental contamination with inorganic and 
organic toxicants has increased over the years 
due to rapid industrialisation, urbanisation and 
anthropogenic activities. Organic contaminants such 
as petroleum hydrocarbons, pesticides, agrochemicals, 
pharmaceutical products and inorganic pollutants such 
as heavy metals resulting from mining are constantly 
added to the environment (Wong, 2012). Elimination 
or mitigation of the toxic effects of chemical waste 
released to the environment by industrial and urban 
activities relies largely on the catalytic activities of 
microorganisms, specifically bacteria (Dvořák et al., 
2017). Given their capacity to evolve rapidly, bacteria 
have the biochemical power to tackle a large number 
of molecules exposed through human action (e.g. 
hydrocarbons, heavy metals) or generated through 
chemical synthesis (e.g. xenobiotic compounds) 
(Das & Dash, 2017). The development of genetic 
engineering in the 1980s allowed the possibility of 
rational design of bacteria to catabolise specific 
compounds, which could eventually be released into 
the environment as bioremediation agents (Kellogg, 
Chatterjee and Chakrabarty, 1981). The complexity of 
this endeavour and the lack of fundamental knowledge, 
however, led to the virtual abandonment of such 
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recombinant DNA-based bioremediation methods 
only a decade later. Systemic biology, which merges 
systems biology, metabolic engineering and synthetic 
biology, now allows the same environmental pollution 
challenges to be revisited through the use of novel 
approaches (Dhir, 2017; Dvořák et al., 2017). The 
focus on contaminated sites and chemicals is now 
also broadened by the accumulation of plastic waste 
on a global scale. While plastics such as polyethylene 
terephthalate (PET) are highly versatile, their 
resistance to natural degradation presents a serious, 
growing risk to fauna and flora, particularly in marine 
environments (Thevenon, Carroll & Sousa, 2014). 
The remediation or treatment of contaminants by 
conventional methods (both physical and chemical) is a 
costly, time-consuming, invasive approach and causes 
environmental degradation (US EPA, 1999; Ghana 
EPA, 2003). For example, to abate acid mine drainage, 
companies often seal off the contaminated sites or erect 
barriers to contain the acidic fluids (Klein et al., 2013). 
In order to remediate acidic effluents in the polluted 
area, chemical treatments, such as the use of calcium 
oxide that neutralises the acid, are typically applied. 
To inhibit the acidophilic microorganisms responsible 
for the acid generation, certain organic acids – 
sodium benzoate, sodium lauryl sulfate or quaternary 
ammonium compounds – are used. Many of these 
treatments are complicated and expensive to apply
(Jerez, 2017). 
There is now a portfolio of systems-level metabolic 
engineering tools applicable for biodegradation 
purposes (Dvořák et al., 2017), providing an alternative 
to more conventional techniques. These tools are 
used to gain deeper insight into the genetic and 
physiological background of the target organisms, 
to model enzymatic reactions and to determine the 
constraints for efficient biocatalysis. For example, 
Austin et al. (Austin et al., 2018) have characterised 
the 3D structure of a newly discovered enzyme 
that can digest highly crystalline PET, the primary 
material used in the manufacture of single-use 
plastic beverage bottles, some clothing and carpets. 
They engineered this enzyme for improved PET 
degradation capacity and further demonstrated that 
it can also degrade an important PET replacement, 
polyethylene-2,5-furandicarboxylate, providing new 
opportunities for biobased plastics recycling.
Despite the clear progress of biochemical and biological 
engineering in the last decade, the vast complexity of 
the living cell remains the major hurdle for developing 
synthetic biology approaches (Dvořák et al., 2017). In 
the case of biosensing, biodegradation pathway design 
and the prospective applications of the genetically-
modified microbes, the complexity of intercellular and 
interspecific interactions, and the interplay between 
the biotic and abiotic factors that govern contaminant 
biodegradation in polluted ecosystems, are still poorly 
understood (de Lorenzo, 2008; Meckenstock et al., 
2015). Basic events need to be understood just as 
much as the adverse effects, which also must be 
identified and assessed as the technology advances.
6.5.2 Biomining 
Mining activities have been carried out for thousands of 
years and currently supply important industrial metals, 
including copper, iron and gold. Although modern 
mining companies have sustainability programmes 
that include tailings management and external 
verifications, it is recognised that these industrial 
activities are responsible for significant damage to the 
environment (Jerez, 2017). In particular, technologies 
such as smelting and roasting generate toxic 
emissions, including the release of solid particles into 
the air (Jerez, 2017). Mining operations can produce 
large tailings which can generate acid mine drainage 
(AMD) that affects both environmental and human 
health (Jerez, 2017). Consequently, and due in part to 
environmental laws and regulations, these methods 
are being replaced, in countries such as Chile, Brazil, 
South Africa and Australia, by less contaminating 
processes, such as biomining (Harrison, 2016). 
Biomining is a generic term used to describe the 
utilisation of microorganisms to process metal-
containing ores and concentrates by bioleaching 
and biooxidation (Brune & Bayer, 2012). Bioleaching 
is typically used in the extraction of base metals, 
where the metals of interest are solubilised through 
microbial action and are recovered from solution. 
Biooxidation is generally used for the pre-treatment 
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of recalcitrant gold and silver bearing minerals, where 
the microorganisms are used to oxidise the mineral 
sulfide matrix in which the metal of interest is located. 
After the undesirable sulfides are dissolved from the 
minerals, the gold or silver is typically leached with 
chemical lixiviants, such as cyanide. Both bioleaching 
and biooxidation utilise similar acidophilic iron and/
or sulfur-oxidising microorganisms to solubilise metal 
containing sulfides. Although biomining offers an 
economically viable and cleaner option, the acidophilic 
microorganisms mobilise metals and also generate 
AMD, potentially causing environmental harm. The same 
microbes and groups of microbes called consortia that 
are used in biomining operations are thus the major 
contributors to AMD generation (Brune & Bayer, 2012). 
There is also an increasing interest in applying 
biomining technology for leaching metals from 
low grade minerals and wastes. In such cases, 
however, bioprocessing is often hampered by the 
presence of inhibitory compounds that originate 
from complex ores (Gumulya et al., 2018). 
One company plans to use synthetic biology to 
develop microbes to extract copper more efficiently 
from the ore (Bergeson et al., 2015; Universal Bio 
Mining, 2018). These novel microorganisms will be 
designed to increase the solubility and extraction of 
copper from ore that, using current technology, either 
could not be extracted or could not be extracted in a 
cost-effective manner. The company plans to change 
the microbes by modifying the genetic material to 
increase the microbes’ efficiency in leaching specific 
types of low-grade ore and may seek to use the 
modified bacteria to recover additional copper 
from tailings. The leaching system occurs in a loop. 
Once the primary copper extraction is complete the 
remaining leachate is reinoculated with microbes and 
reintroduced at the top of an ore heap rather than being 
disposed and potentially contributing to environmental 
contamination. Because of the routine addition of 
new inoculant, the microbes are not engineered for 
maximum stability and fitness and indeed cannot 
survive at more neutral pH (>3) (Bergeson et al., 2015).
Gumulya et al. (2018) have reviewed the state-of-the-
art tools to genetically modify acidophilic biomining 
microorganisms. They also reviewed the limitations of 
these tools – both with regard to resilience pathways 
that can be engineered in acidophiles to enhance 
their robustness and tolerance in harsh environments 
that prevail in bioleaching, as well as with regard 
to the efforts that have been carried out towards 
engineering robust microorganisms and developing 
metabolic modelling tools. They explain that – despite 
a number of complete genome sequences being 
available for biomining species – only a handful of 
genetic modifications have been reported. They 
also show that at present, no genetically modified 
organisms are being used in commercial scale 
biomining, and that some heterologous expression 
vectors and markerless gene replacements have 
been developed for biomining organisms, albeit with
limited efficiency. 
6.6 Changing innovation 
frontiers in synthetic biology
Many new tools and processes from synthetic biology 
are under development or are on the horizon. Some 
could have clear relevance to conservation, even if 
they are still in the conceptual stage, while others will 
have less obvious consequences for conservation. 
In both cases, for the purposes of this assessment 
it is important to have as full an understanding as 
possible of the trajectory of research and innovation in 
synthetic biology that might impact conservation. This 
section provides a broad look at five developments 
in the field: digital sequence information; reverse 
engineering genomes for discovery; the International 
Genetically Engineered Machine Competition (iGEM); 
the Biodesign Challenge; and DIYBio. The first two 
showcase changing tools which may enable the 
collection, storage and sharing of data from the 
environment, and potentially enable more complex 
experiments in the laboratory. The last three examples 
describe a potential expansion of access and 
interest, especially among young people, in synthetic 
biology which could impact future innovations, or 
consequences, for conservation. While it’s unclear 
what those impacts may be, new collaborations from 
a diverse set of players in environments that nurture 
imagination have a potential to impact conservation. 
Whilst conservation has been a motivator for some 
of these new collaborations or actors it is difficult 
to assess the extent to which these collaborations 
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have fulfilled that potential and whether they will 
make a measurable impact on conservation goals.
6.6.1 Digital sequence information 
Digital sequence information (DSI) is the product of 
DNA, RNA and protein sequencing technologies. 
Generally these have become faster, cheaper and more 
accurate in recent years allowing for computational 
analyses and simulations (Wynberg & Laird, 2018) that 
previously were unavailable or required cumbersome 
laboratory experiments. The use of these technologies 
poses a governance challenge (Section 2.3.2).
Broadly, sequencing technologies used to produce 
DSI are designed to determine the order in which 
each of the four nucleotides in a DNA molecule are 
arranged (Wynberg & Laird, 2018). Sequencing 
technologies have evolved rapidly, giving rise to next 
generation sequencing, deep sequencing or high 
throughput sequencing, making it possible to sequence 
entire genomes or sample entire transcriptomes 
more efficiently and in greater depth (Wynberg & 
Laird, 2018). Sequencing technologies have led to 
vast amounts of data being produced giving rise to 
the need for bioinformatics – computational tools 
and software that enable the storage, analysis and 
manipulation of large biological datasets, leading 
to capabilities like metagenomics (Wynberg &
Laird, 2018). 
Metagenomics enables researchers to sequence and 
analyse gene sequences from environmental samples; 
for example, microorganisms and/or invertebrates 
present in a sample of soil or water. While whole 
genome sequencing describes the genome of one 
specific organism, metagenomic analysis produces data 
from millions of small fragments of the genome of each 
organism in the sample (Laird & Wynberg, 2018). DNA 
barcoding can act as a genetic fingerprint by focusing 
on genes that are present in most organisms, but are 
also unique to each species. While not applicable to 
all species, this technique can allow for rapid species 
identification if databases of sequences are available 
for comparison (Hebert, Cywinska & Ball, 2003; 
Conservation X Labs, 2017; Wynberg & Laird, 2018). 
Continuous innovation in DNA sequencing approaches 
has allowed a major increase in the scale, and 
decrease in cost of applying classical genetics to 
conservation, to fill gaps in biodiversity knowledge 
(DeSalle & Amato, 2004, 2017). The practice of 
working with whole genome datasets is likely to 
become routine in coming years (Fuentes‐Pardo 
& Ruzzante, 2017). As costs continue to drop 
and new affordable and accessible tools become 
available (Conservation X Labs, 2017), DSI and 
dematerialisation could greatly influence conservation 
practices and programs (Wynberg & Laird, 2018).
DSI presents conservationists with new capabilities 
for measuring and acting to minimise loss of 
genetic diversity (Ba et al., 2017; Hou et al., 2018), 
understanding population structures of endangered 
species (Miller et al., 2011; Niissalo et al., 2018), 
defining pedigrees and cryptic species as management 
units (Niissalo et al., 2018), and monitoring 
impacts from human development (McCartney-
Melstad, Vu & Shaffer, 2018) to name a few. 
Overall the hardware, software and wetware of 
modern DSI approaches is supporting acquisition of 
overwhelming volumes of data that can be used for 
conservation practice. Exemplifying this is an ambitious 
effort to sequence Earth’s Whole Genome (Lewin 
et al., 2018), which could provide conservationists 
with digital reference material to potentially make 
high resolution assessments of biodiversity. DSI’s 
expanded use could support direct measurement of 
the impact of policies and actions by governments, 
companies and organisations on biodiversity goals. 
Nonetheless, like other genomics technologies 
with the potential to make an impact on the field, 
conservationists must address many of the gaps in 
infrastructure, skills and funding to support routine use 
(Shafer et al., 2015), as well as the socio-economic, 
cultural and access and benefits sharing impacts of 
increased access/use of digital sequence information. 
113
Box 6.1
Earth Biogenome Project
In November 2015, a group of biologists proposed a plan 
to sequence all eukaryotic organisms (animals, plants, 
algae and fungi are all eukaryotes) on the planet (The 
Economist, 2018). This plan has since developed into the 
Earth Biogenome Project which was officially announced at 
the 2018 World Economic Forum in Davos. The goal of the 
project, estimated to cost US$ 4 billion, is to sequence within 
10 years the genomes of all known species of eukaryotes 
(The Economist, 2018; World Economic Forum’s System 
Initiative on Shaping the Future of Environment and Natural 
Resource Security, 2018). The scale and complexity of the 
project is not lost on its developers, and they state they 
will “rely on convening multi stakeholder collaborations 
that draw in science, research, technology and ethics 
communities, along with governments and the private 
sector” (World Economic Forum’s System Initiative on 
Shaping the Future of Environment and Natural Resource
Security, 2018).
The question this project is asking is: “Could genome 
sequencing be harnessed to unlock nature’s biological 
inheritance, honed by evolution over millennia?” (World 
Economic Forum’s System Initiative on Shaping the Future 
of Environment and Natural Resource Security, 2018). This 
is hugely ambitious, given that only 14 per cent of plant and 
animal species on land have been described to science 
(Mora et al., 2011), and less than 0.1 per cent of those 
have been sequenced (World Economic Forum’s System 
Initiative on Shaping the Future of Environment and Natural 
Resource Security, 2018), and access and benefit-sharing 
agreements codified in treaties like the Nagoya Protocol 
and ITPGRFA will need to be addressed (Section 2.2.4). 
Figure 6.1 The Earth Bank of Codes Platform Structure. Adapted from World Economic Forum’s System Initiative
on Shaping the Future of Environment and Natural Resource Security, 2018.
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The Earth Biogenome Project plans to utilise blockchain 
technologies in order to store and track the access to 
and subsequent usage of the digital information that will 
be generated in what they are calling the Earth Bank of 
Codes (Figure 6.1) (World Economic Forum’s System 
Initiative on Shaping the Future of Environment and Natural 
Resource Security, 2018). A blockchain is a digitised, 
decentralised, public ledger typically managed by a peer-
to-peer network that follows an agreed upon protocol. 
Both Nagoya and ITPGRFA are currently deliberating over 
whether digital sequence information meets the definition 
of genetic resources and this will need to be settled before 
blockchain could be implemented. Whether or not they 
will experiment with the use of blockchain technology to 
manage issues of access and benefits sharing is an
open question.
6.6.2 Reverse-engineering and 
understanding genomes  
Often the potential for forward engineering and 
“rationally-designed organisms” overshadows 
technical conversations about synthetic biology. 
But for such projects to exist, scientists must know 
exactly what genes to engineer, and how. This 
can be determined by systematically modifying 
an organism to build substantive knowledge of 
normal function, in a kind of reverse engineering, or 
functional genomics. Much of the biotechnology field 
has deployed tools and processes associated with 
synthetic biology to answer the question “how does 
an organism work,” often with humans and their 
mouse models in mind. However, the technology 
and the knowledge derived from its use could also 
answer important questions facing conservation. 
Genome perturbation is one such process that 
embodies a reverse engineering approach. By 
leveraging programmable nucleases, like CRISPR-Cas9, 
it is possible to modify genes methodically in order 
to discover their function. Edited experimental cells 
and organisms, contained to the laboratory, can be 
exposed to any number of chemicals or environmental 
stresses to understand how certain gene variants 
are relevant to a particular trait. Follow-up studies 
can then confirm the gene-trait relationship using a 
more deliberate forward engineering approach and 
experimental assay. A computational and automated 
approach to this process lends itself to screening many 
millions of variants simultaneously, supporting the rapid 
identification of potential interventions for conservation 
approaches (assuming the cell biology capabilities 
are also available for the organism in question). The 
true power of these genetic manipulation techniques, 
whether applied in small or large scales, is their potential 
to directly confirm causal relationships rather than 
using more limited computational methods to infer 
causation (Meinshausen et al., 2016). This is useful 
not only for identifying cause-effect relationships of a 
conservation-relevant problem, but also solutions. For 
instance: identifying potential treatments for diseases 
with no known cure like white-nose syndrome in bats 
(Cheng et al., 2017), identifying susceptibility and 
resistance traits to blights and their plant hosts (Lan et 
al., 2008), or directly confirming how disruptions in the 
microbiome affect amphibians (Bates et al., 2018). 
Reverse-engineering activities for discovering gene and 
genome function can produce impressive knowledge 
about biological systems, which could in turn inform 
conservation science and action. The technical capacity 
exists, as proven by the application of biotechnology 
to medicine, but for conservation applications, for 
discovery-for-conservation programmes to lift off, 
there will be a need for funding, personnel and 
technical infrastructure (Shafer et al., 2015). 
6.6.3 iGEM 
Synthetic biology is multidisciplinary, with the most 
represented disciplines including biochemistry, cell 
biology, genetics, computer science, engineering 
and computational biology (Shapira, Kwon & Youtie, 
2017). Many of these disciplines are themselves 
associated with open collaborative movements, which 
synthetic biology has been inspired by, and draws 
upon. Today, an active system of public laboratories, 
community projects, citizen science enterprises and 
public competitions use synthetic biology approaches. 
The capabilities of these groups are diverse, and 
the nature of their work lies along a spectrum of 
tinkering to engineering, depending on the degree 
to which a project has been planned (Keulartz & 
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van den Belt, 2016) and the nature of the tools and 
experience available to each individual or group. 
Generally speaking these groups have benefited from 
a combination of low-cost enabling technologies, 
the commoditisation of key reagents like synthesised 
DNA, and the culture of synthetic biology that is open 
to multidisciplinary projects (Redford et al., 2014). 
The International Genetically Engineered Machines 
competition (iGEM) is an annual synthetic biology 
event where undergraduates, graduates, high school 
students and community biotech labs (DIYbio) 
compete to build genetically engineered systems using 
standard biological parts called BioBricks. According 
to the Registry of Standard Biological Parts, which is 
maintained by the iGEM Foundation, a BioBrick or a 
biological part “is a sequence of DNA that encodes 
for a biological function, for example a promoters or 
protein coding sequences. At its simplest, a basic 
part is a single functional unit that cannot be divided 
further into smaller functional units. Basic parts can 
be assembled together to make longer, more complex 
composite parts, which in turn can be assembled 
together to make devices that will operate in living cells”
(IGEM, 2017). 
Teams are provided with an initial kit that contains about 
1,700 parts, and throughout the competition, they 
create new parts and improve other parts contained 
in the registry. All these parts are available for anyone 
to access, use and share. There are over 20,000 
documented genetic parts in the Registry and “teams 
and other researchers are encouraged to submit their 
own biological parts to the Registry to help this resource 
stay current and grow year to year” (IGEM, 2017). 
iGEM began in January 2003 as an independent study 
course at the Massachusetts Institute of Technology 
(MIT) where students developed biological devices 
to make cells wink on and off. This course became 
a summer competition with five teams in 2004 and 
continued to grow to 13 teams in 2005; it expanded 
to 340 teams in 2018, reaching 42 countries and over 
5,000 participants. Since 2004, over 40,000 students 
have participated in iGEM from across the globe (Figure 
1.6 and Figure 6.2). Team projects have ranged from 
simple biological circuits to developing solutions to 
local and global environmental conservation issues.
In 2016 the team from the University of Wageningen in 
the Netherlands designed a synthetic biology system 
Figure 6.2 Global participation in iGEM from 2004–2018. Adapted from iGEM, 2018. 
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to address bee colony collapse (Team Wageningen, 
2016). Also in 2016, the team from the Federal 
University of Amazonas and the Amazonas State 
University developed a project to address mercury 
contamination in the Amazon basin (UFAM-UEA_Brazil, 
2016). iGEM places as high a priority on students 
learning the technical skills of synthetic biology as 
it does on them understanding and contextualising 
how ‘human practices’ (IGEM, 2018) will influence 
the impacts of their technology, and how to best 
plan for potential consequences. Through the human 
practices component of iGEM, teams are required to 
study “how your work affects the world, and how the 
world affects your work” by imagining their projects 
in a social/environmental context and engaging with 
communities outside their lab to better understand 
issues that might influence the design and use of their 
technologies. To address safety and security issues 
associated with projects, iGEM has established a 
safety and security committee which evaluates every 
team’s project at various stages of development. 
Teams are required to submit check-in forms and 
subsequent approvals are needed depending on the 
type of project being proposed (iGEM, 2017). With 
tens of thousands of graduates from throughout 
the world iGEM could provide a ready-made pool of 
people with skills to help conservation if it decides it 
wants to develop new synthetic biology approaches.
6.6.4 The Biodesign Challenge 
The Biodesign Challenge (Biodesign Challenge, 2018) 
is an annual art and design competition that offers 
opportunities to university art and design students 
to develop projects around potential biotechnology 
applications, some of which directly or indirectly 
relate to conservation. Students are connected with 
a team of biologists and experts to guide them as 
they develop their ideas. At the end of the semester 
teams showcase their designs in front of members of 
the academic, industrial and design communities. The 
competition is based upon a theory that design plays 
an integral role in the development of any technology 
and that a designer’s vision can both anticipate and 
inspire new applications which in turn can drive 
the scientific community and influence society’s 
preferences around technologies (Biodesign Challenge, 
2018). These principles have expressed themselves 
in a number of Biodesign Challenge projects with 
implications for conservation. In 2017, the New York 
University team connected beekeeping, synthetic 
biology and conservation by using modified baker’s 
yeast to produce beta acids that target the parasitic 
bee mites that contribute to bee colony collapse 
(NYU Biodesign Challenge, 2017). Other teams have 
focused on developing biodegradable materials to 
replace non-biodegradable counterparts, or have 
worked on biosynthetic alternatives to animal-sourced 
textiles (Sullivan, 2018). The Biodesign challenge has 
notably received sponsorship from both People for 
the Ethical Treatment of Animals (PETA) and the Stella 
McCartney Foundation, which cite their desire to see 
a biofabricated wool as motivating their support for 
the competition (Sullivan, 2018). The involvement 
of fashion colleges in the Biodesign Challenge is 
noteworthy, and can be seen as a response to the 
fashion industry’s desire to source sustainable textiles 
and materials (Kerr & Landry, 2017), especially those 
that could replace wool, leather and silk, which have 
major environmental impacts on water scarcity, 
resource depletion and eutrophication (Higg Materials 
Sustainability Index, 2018), not to mention land use.
6.6.5 DIYbio 
Do-it-yourself biology, or DIYbio, is a global movement 
spreading the use of biotechnology and synthetic 
biology tools beyond traditional academic and 
industrial institutions to other publics (Grushkin et al., 
2013). Practitioners include a broad mix of citizen 
scientists, amateurs, enthusiasts, students and trained 
scientists, some of whom focus their efforts on using 
the technology and knowledge to create art, explore 
biology, create new companies or simply to tinker. 
Others believe DIYbio can inspire a generation of 
bioengineers to discover new medicines, customise 
crops to feed the world’s exploding population, harness 
microbes to sequester carbon, solve the energy crisis, 
or even grow our next building materials. Whether 
or how this growing community of biologists, and 
the expanding access to tools related to synthetic 
biology, will impact conservation is an open question. 
The concept of amateur biotechnologists – what 
eventually became DIYbio – began to take shape 
around 2000, after a working draft of the human 
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genome was completed by the Human Genome 
Project (Grushkin, Kuiken & Millet, 2013). People 
began setting up home labs (Carlson, 2005), which 
evolved into dedicated labs in commercial spaces. 
The organisers pooled resources to buy, or take 
donations of, equipment, and began what have 
become known as “community labs.” The first opened 
in the US in 2010. These labs sustain themselves 
on volunteers, membership donations and paid 
classes. DIYbio continues to grow rapidly. There 
are now community laboratories and other types of 
community biotech incubator spaces spread across 
six continents (Figure 6.3). They participate in iGEM, 
provide educational opportunities and are actively 
being sought after for innovation opportunities in the 
conservation arena (Conservation X Labs, 2018).
The Citizen Salmon project (SoundBioLab, 2018), for 
example, based at the Seattle community laboratory 
SoundBio, was set up to apply synthetic biology 
techniques to develop a database of salmon genotypes, 
and create a DIY genotyping kit for citizen scientists to 
determine the origin of their store-bought fish (Martin, 
2017). The project was notable as a DIYbio initiative 
that had the potential to advance conservation of king 
salmon without having conservation as an explicit goal 
(Martin, 2017). The project highlights the possibility of 
interactions between citizen scientists, the synthetic 
biology field, and the development of conservation tools; 
as costs in enabling technologies decline there is the 
potential for additional projects of this nature to emerge. 
The DIYbio community believes that wider access to 
the tools of biotechnology, particularly those related 
to the reading and writing of DNA, has the potential 
to spur global innovation and promote biology 
education and literacy that could have far-reaching 
impacts – and it raises valid questions about risk, 
ethics and environmental release for all scientists, 
policymakers and the public (Kuiken, 2016). For 
instance, Odin, a company that believes “the future 
is going to be dominated by genetic engineering and 
consumer genetic design” creates “kits and tools that 
allow anyone to make unique and usable organisms 
at home or in a lab or anywhere” (Odin, 2018). 
Some of these kits raise serious environmental and 
ethical issues regarding animal welfare (Bloomberg, 
2018), along with societal questions about who 
should be able to access these technologies.
The distributive and democratised nature of synthetic 
biology techniques presents both opportunities 
and challenges for the conservation community. 
Figure 6.3 Map of community biotech labs and community incubator spaces as of 2018. Adapted from http://sphere.diybio.org/ and 
personal communications.
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Summing up and looking 
forward  
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7.1 Synthesis  
This assessment provides an opportunity for IUCN 
Members to consider the evidence regarding the 
potential positive or adverse impacts of synthetic biology 
on the conservation and sustainable use of biological 
diversity. The assessment is rooted in the fundamental 
idea that decisions on the use of technology need 
to be informed by empirical studies examining their 
efficacy, potential benefits and risks. At the same time, 
the members of the Technical Subgroup responsible 
for the assessment were keenly aware that, given the 
nascent stages of most synthetic biology application 
for conservation, questions of how to address the issue 
of uncertainty are critically important (Figure 3.1). The 
assessment’s review of the tools of synthetic biology – 
which, as introduced in Chapter 1, include the concept 
of engineered gene drive systems – and their potential 
applications to conservation, and the accompanying 
case studies (Chapter 4–6) illustrate the broad range 
of scales at which synthetic biology and conservation 
may intersect, from small islands to all of sub-Saharan 
Africa. Such diverse potential both reinforces the need 
to ground any decisions about the future of synthetic 
biology and conservation on scientific evidence and 
offers important context for the debate. The assessment 
was done with a focus on scientific evidence and hence 
dictated the expertise of the Technical Subgroup, 
but this should not be taken as dismissing the role 
of traditional knowledge, religion and ethical values 
in decision making. These other types of evidence 
and other ways to examine risk and opportunity must 
be considered, and some communities, such as the 
Māori of New Zealand, are already proceeding with 
their own analysis (Mead, Hudson, & Chagne, 2017).
Conservation organisations and conservation scientists 
have long understood that the most significant 
threats to biological diversity relate to changes in 
the way humans use land, water and oceans, and 
also the species they contain. An analysis of the 
IUCN Red List of Threatened Species (Maxwell et 
al., 2016; IUCN, 2018) confirms that overexploitation 
of species and the expansion and intensification of 
agriculture inflict by far the most significant pressure 
on threatened or near-threatened species worldwide. 
Loss of intact ecosystems through destruction and 
degradation are also major threats and climate change 
exacerbates all these threats. Such loss also negatively 
affects the sustainable use of biological resources. 
The landscape of conservation threats is clear.
For many in conservation the tools to address those 
threats are clear as well. Decades worth of conservation 
work has produced some major successes – such as 
the recovery of whales and the conservation of species 
through well-designed and funded protected areas – 
yet there is a clear sense that the threats are getting 
worse and that current tools may not be able to address 
emerging threats. Therefore, some conservation 
scientists have a strong desire to explore the exploding 
field of synthetic biology, looking for ways that it might 
be able to help conservation address these intractable 
problems. There is also an incipient interest in engaging 
with the synthetic biology field to think of ways that new 
technologies might produce environmental benefits. 
At the same time there is deep concern in some parts 
of some societies that applying synthetic biology 
tools to environmental questions is an undertaking 
fraught with uncertainty and potential threat.
This assessment emerged, in part, from concern and 
from hope among broad segments of society and from 
a broad discussion that is taking place throughout 
the world on the proper place of synthetic biology in 
societies and in nature. It is based on the fact that the 
communities of conservation scientists and synthetic 
biologists have operated largely in isolation from one 
another but that that isolation will not remain. While 
investment in synthetic biology is expanding rapidly 
(Figure 1.7), little of that investment is directed at 
applications intended for specific conservation benefits. 
The bulk of effort remains on products and processes 
that may improve agriculture (i.e. more disease-resistant 
or productive crops or livestock) or human health 
(i.e. new medicines or approaches to diagnosing or 
treating diseases and preventing their transmission). 
So, a key question that emerges is where these areas 
of effort overlap with conservation and sustainable 
use, and what the intended and unintended impacts 
will be on biodiversity. As seen in Chapter 5, the tools 
and techniques of synthetic biology may be useful in 
addressing conservation challenges such as invasive 
alien species, wildlife trade and disease, although with 
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the potential for adverse effects as well. At the same 
time, as seen in Chapter 6, efforts are underway to 
change the production methods and raw materials 
needed for products like Omega-3 oils, vanillin and 
others. There is the potential for synthetic biology 
to develop new techniques to solve such problems 
as invasive species on islands or chytrid fungus, 
but at the same time to develop mechanisms that 
may change land-use patterns in ways that may be 
harmful or beneficial to biodiversity – or both. Each 
of these cases will need to be assessed on its own 
merits, as no technology can be applied universally. 
The evidence necessary to provide unequivocal 
answers to questions about the relationship between 
synthetic biology and conservation does not yet exist. 
Deeper collaboration between conservation scientists 
and synthetic biologists will be necessary to both 
develop evidence and to create the frameworks for 
understanding and using that evidence. Scientists are 
also not the only voices; society needs to be involved 
and may decide that some research should not 
proceed, in which case there will be no new evidence. It 
is already clear, however, that the opportunity to shape 
how these fields interact and to set the research agenda 
is here now and will require the engagement not just of 
scientists but also government at all levels, civil society 
and indigenous peoples’ organisations worldwide.
Key Messages
1. Synthetic biology and engineered gene 
drive have important implications for the 
conservation and sustainable use of biological 
diversity {1.1, 4.3} that are both direct {5} 
and indirect {6} (well established). While most 
synthetic biology and gene drive products are not 
designed as conservation applications {1.6} (well 
established), some of these will nonetheless have 
substantial impacts on conservation practices and 
outcomes {6.1} (established but incomplete).
2. New tools are needed for effective 
conservation and sustainable use of biological 
diversity {1.1} (well established). In recent 
years, global, regional and national measures 
promoting biodiversity conservation have resulted 
in some successes, but biodiversity continues to 
decline globally {4.3} (well established). Biodiversity 
conservation requires the continued application 
of proven approaches, but scaling these efforts 
up to the level necessary to reverse the declines 
will continue to be a major challenge, given the 
seemingly intractable nature of some of the 
threats {5.1} (well established). Some synthetic 
biology and engineered gene drive applications, 
if appropriately designed and targeted, could 
enhance biodiversity conservation, for example, 
by mitigating threats {5.2} and increasing 
species’ resilience to them {5.3} (speculative).
3. The practice of synthetic biology is increasing 
rapidly, with major developments being 
promised and some delivered across 
multiple sectors {1.6} (well established). 
Over the last 15 years there has been a five-fold 
growth in companies with public and private 
investment approaching US$ 10 billion over 
this period {1.6} (established but incomplete). 
Synthetic biology labs are found throughout 
the world in academic, corporate and non-
traditional spaces like community biotech labs; 
increasingly young people are being taught to 
use these technologies {6.6} (well established). 
The distributed nature of access to synthetic 
biology techniques (well established) presents both 
opportunities and challenges for the conservation 
community {1.6, 2.3, 6.6} (speculative).
4. Engineered gene drive systems can be a 
transformative tool for direct conservation 
applications {5.2.1, 5.3.1} (speculative) as 
well as in other sectors like public health 
{6.3} (speculative), where they could have an 
indirect impact on conservation {5.2.1, 5.3.1, 
6.3}.  Engineered gene drive systems are still years 
away from any deployment {5.2.1, 5.3.1, 6.3} 
(established but incomplete) despite the fast pace 
at which this technology is being developed {1.4} 
(competing explanations). The expertise of the 
conservation community is vital to the responsible 
development and deployment of engineered gene 
drive systems {5.2.1, 5.3.1, 6.3} (well established).
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5. Synthetic biology and engineered gene 
drive may be beneficial to conservation 
and sustainable use of biodiversity {4–6} 
(speculative). For example, by protecting 
threatened species against disease or climate 
threats {5.3.1} (speculative), eradicating invasive 
species {5.2.1} (speculative), increasing genetic 
diversity in small populations of threatened 
species {5.3.1} (speculative), restoring a proxy 
of an extinct species {5.3.2} (speculative), 
remediating degraded ecosystems {6.5} 
(speculative), or product replacement {5.2.2, 
6.4} (established but incomplete).
6. Synthetic biology and engineered gene 
drive may be detrimental to conservation 
and sustainable use of biodiversity {4–6} 
(speculative). Detrimental effects may stem from 
the movement of genes, or escape of engineered 
gene-drive-carrying organisms, impacting non-
target populations or species {5.2–5.3, 6.2-6.4} 
(speculative), changes to ecological roles played by 
target organisms {5.2, 6.3} (speculative), broader 
ecosystem effects {6.2} (speculative), product 
replacement that exacerbates a conservation 
problem {5.2.2} (competing explanations), socio-
economic effects of product replacement on 
livelihoods and on production and consumption 
patterns {6.4} (competing explanations), 
distracting funding from other conservation 
approaches {5.1, 5.4} (speculative), and moral 
hazard reducing the urgency and importance of 
biodiversity conservation {2.3, 5.1} (speculative).
7. Values, worldviews and lived experiences 
influence the development, assessment 
and governance of synthetic biology and 
engineered gene drive {2–3} (well established). 
Thus, to produce evidence for conservation-
relevant decision making, scientific methods 
and norms operate within contexts defined 
by the framing of problems and solutions, the 
integration of multiple perspectives and types 
of expertise, and who is trusted to produce 
credible knowledge {3} (well established). 
Community and stakeholder engagement have 
been proposed to help navigate this complexity 
{2.3, 3.4} (established but incomplete).
8. Indigenous and local communities are key 
actors in research, governance and decisions 
around synthetic biology and engineered 
gene drive for conservation (well established). 
Synthetic biology has potentially significant positive 
and negative impacts on local and indigenous 
communities, which manage, govern, reside in or 
depend on a large part of the world’s biodiversity 
{5-6} (well established). Historically there has 
been limited engagement with indigenous and 
local communities at both the project and global 
level (established but incomplete). Recently there 
have been calls for recognition of the rights of 
indigenous and local communities in decision 
making around synthetic biology and engineered 
gene drive {2.1} (well established). There have 
been some attempts to involve them in synthetic 
biology initiatives {2.3} (established but incomplete).
9. Multiple existing governance structures are 
relevant to synthetic biology (well established), 
but synthetic biology and engineered gene 
drive raise questions and challenges for these 
frameworks (competing explanations). Relevant 
governance frameworks include international, 
regional and national legal frameworks as well as 
religious, customary and indigenous governance 
systems, and scientific norms and practices (well 
established) {2.2}. Challenges relate to the extent 
to which current and future synthetic biology and 
gene drive applications are covered by existing 
regulations, norms and processes (competing 
explanations), implementation and enforcement 
in the context of accessibility of parts and tools 
(established but incomplete), different levels 
of governance capacity among jurisdictions 
(well established), mechanisms to address 
environmental harm, particularly transboundary 
impacts (established but incomplete), and 
the ability of governance frameworks to 
keep up with the rapid pace of technological 
innovation (competing explanations) {2.3}.
10. This “Assessment of Synthetic Biology 
and Biodiversity Conservation” is neither 
a risk assessment of individual synthetic 
biology and gene drive applications, nor 
of these technologies as a whole {3.4, 
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4.3} (well established). The diversity of these 
applications, of the mechanisms that can be 
used, and of the contexts in which these would 
take place, precludes an assessment of risks 
and benefits of this technology as a whole (well 
established). This assessment reviews existing and 
proposed applications of synthetic biology and 
engineered gene drive systems that are relevant 
to conservation and explores how they may be 
beneficial and detrimental to the conservation 
and sustainable use of biodiversity. Benefits 
and risks to conservation from synthetic biology 
applications vary on a case-by-case basis.
7.2 Looking forward: The 
IUCN process, interpreting 
evidence and reaching a 
policy recommendation
This assessment of synthetic biology and conservation 
takes places within a broader IUCN conservation 
policy process. At the 2016 World Conservation 
Congress in Hawai‘i, IUCN’s 1,303 government and 
civil society Members adopted Resolution WCC-
2016-Res-086 calling for the establishment of a Task 
Force to undertake a series of activities to develop an 
IUCN Synthetic Biology and Biodiversity Conservation 
Assessment. This assessment will serve as an input 
to the development of policy recommendations to be 
debated and voted on by the IUCN membership at 
the 2020 World Conservation Congress in Marseille. 
As directed by the Resolution, all six IUCN Commissions 
and the Director General appointed the Chair who 
in turn appointed the Task Force and its Technical 
Subgroup charged with developing this assessment. 
This assessment will be finalised based on an open peer 
review from a DG-appointed expert panel, the entire 
IUCN constituency and the general public. After revision, 
the assessment will then feed into policy guidelines that 
will be drafted by the Task Force and submitted to the 
IUCN Council (Figure 1.10). Once drafted the policy 
will receive input from the IUCN Regional Conservation 
Fora, as well as both online and in-person debate on 
the motion before being voted on by the full IUCN 
membership at the 2020 World Conservation Congress.
This assessment thus forms one part of IUCN’s 
decision-making process regarding policies to 
shape the role of synthetic biology in biodiversity 
conservation. The way IUCN will use the evidence 
assembled in this assessment to shape the 
decision will thus be of critical significance. 
One primary issue regarding the use of evidence 
in decision making concerns scientific uncertainty, 
an underlying issue in environmental governance. 
As discussed in Chapter 2, under various national 
and international environmental laws and policies, 
circumstances in which there is a potential for harm 
but incomplete or insufficient evidence trigger the 
precautionary principle [Rio Declaration, Principle 15] 
(Wiener & Rogers, 2002; Peterson, 2006), which states 
that where there are threats of serious or irreversible 
damage, lack of scientific certainty shall not be used 
as a reason for postponing cost-effective measures 
to prevent environmental degradation. This in effect 
places the burden of proof that the action is not 
unacceptably harmful onto those proposing the action. 
The precautionary principle is a legal obligation in some 
countries, and is also an internationally recognised 
tool for decision making, which may or may not be 
legally required. In the context of using synthetic 
biology for conservation the precautionary principle 
can, however, be utilised to support different positions. 
These dual interpretations of the precautionary principle 
are particularly important to surface and discuss 
given ongoing global biodiversity loss (Butchart et 
al., 2010) and the insufficiency of existing efforts 
and methods to prevent it (Maxwell et al., 2016). 
The third issue regarding the use of evidence has to 
do with recognising that subjective judgements and 
values are always part of any decision-making process, 
no matter how firmly based in empirical evidence it 
may be. It is better by far to acknowledge and engage 
with those values than to only privilege scientific 
expertise and silence other voices (Chapter 3).
Decision makers must pay attention to factors 
relating to both the production and use of evidence. 
Chapter 3 discusses evidence as it relates to 
assessing the potential impact of synthetic biology 
on the conservation of biodiversity. The next step 
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in the IUCN process requires seeing evidence in 
a slightly different light. This is a challenging topic 
because of the differing views that exist on what 
evidence is and how evidence should inform decision 
making. The frameworks, or ways of thinking about, 
this question of how to incorporate evidence into 
decision making vary based on the extent to which 
the framework recognises the interplay of scientific 
knowledge and public values and to what degree 
deliberative engagement processes are incorporated. 
There are three generally recognised frameworks to 
consider and the third of which is the one closest to 
the approach taken in creating this assessment.
The linear framework envisions the incorporation 
of evidence into decision making as a technical 
endeavour, outside of value judgements, that is best 
completed by experts (Sarewitz, 1996), without any 
deliberative processes and that scientific experts can 
accomplish in isolation. The multiple knowledges 
framework acknowledges that there are often 
tensions between scientific disciplines in terms of 
how they frame problems and the type of evidence 
they produce. Without concerted reflection, there is 
the potential for disciplinary assumptions to delimit 
both the types of evidence produced and how they 
are synthesised for a decision-making context. 
The deliberative-analytical framework highlights 
the potential for deliberative engagement to be 
fully incorporated into analytical processes (Sclove, 
2010; Delborne et al., 2013; Rask & Worthington, 
2015; Bertrand, Pirtle & Tomblin, 2017). One of 
the foundational assumptions of this model is that 
analysis and inclusive deliberation are both needed 
to achieve evidence-based decision making that 
is both rigorous and legitimate. More analysis and 
more evidence will not lead to better decision making 
without the inclusion of values in deliberations informing 
such analysis and helping to synthesise evidence 
and make sense of its relevance to a decision-
making context. In this approach to incorporating 
evidence into decision making, scientific experts, 
decision makers, and interested and affected parties 
all have a role to play in reviewing evidence and 
determining its relevance to a decision-making
context (NRC, 1996).
This model is best situated for conflictual issues 
that contain uncertainty – issues that need rigorous 
deliberative engagement to arrive at an appropriate 
understanding of the problem, the desired solution, 
the needed evidence, and how to incorporate existing 
evidence into a particular decision-making context. 
In keeping with this approach, IUCN’s process is 
intended to foster rigorous and trusted deliberation 
across a wide range of experts, affected communities, 
stakeholders and decision makers in order to 
successfully develop and deploy a policy on synthetic 
biology and biodiversity conservation. The review of 
this assessment, invited from over 15,000 people 
and organisations located throughout the world is an 
important facet of this deliberative engagement.
7.3 Technology, 
society and nature
Conservation and synthetic biology are situated in a 
landscape that is changing rapidly in at least three 
dimensions: the technologies underlying synthetic 
biology are changing at remarkable speed; society is 
changing in its views about technology and nature, 
particularly across generations; and nature is changing 
as well. The three are interlocking: technology changes, 
society changes in concert, and nature continues to 
change in response to both. These shifting dynamics 
provide the broadest context for this assessment.
For decades, the most often cited benchmark for rapid 
progress in information technology has been Moore’s 
Law, which roughly states that the number of transistors 
on an integrated circuit doubles every two years (https://
www.intel.com/content/www/us/en/silicon-innovations/
moores-law-technology.html ). That doubling reflects 
the explosion in computing power that lies at the 
heart of the revolution in information technology. 
The technology underlying synthetic biology is now 
accelerating at an even faster pace. The speed at 
which scientists can sequence DNA began to outpace 
Moore’s Law in 2008 (Bioeconomy Capital, 2018). 
Information technology has transformed the way people 
live and work, and there are good reasons to believe 
that the changes that will be wrought by synthetic 
biology will be equally profound and perhaps even
more rapid. 
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Synthetic biology applications are already changing 
business, industry and medicine. In 2017 the global 
synthetic biology market was valued at US$ 4.4 
billion and is expected to grow to US$ 13.9 billion 
by 2022 (Globe Newswire, 2018). Private investment 
appears to be growing rapidly (Figure 1.7). In 2016, 
investors poured over US$ 1 billion into synthetic 
biology companies, fuelling their rapid growth. But 
synthetic biology does not exist in a vacuum; it can 
interact with nanotechnology, artificial intelligence, 
robotics and a myriad of biological innovations to yield 
breakthroughs in smart materials, material structures, 
energy generation, pollution remediation and more. 
There is a constant, fluid, and potentially extremely 
broad interaction and innovation frontier between 
the Fourth Industrial Revolution and biodiversity.
Scientists are exploring new ways to make changes 
to the genetic makeup of any species at a speed, 
specificity and scale unimagined just a few years ago. 
While the potential future applications appear to be 
limited only by the imagination, only a relative handful 
have emerged from laboratory settings (Chapter 5). 
There remains a great deal of hype for synthetic biology 
applications and many are speculative or still in early 
stages of development and testing. Nevertheless, 
the very existence of the knowledge of how to 
approach tinkering with the machinery of life raises 
profound and complex moral, ethical, legal, cultural, 
spiritual and scientific questions. The breadth and 
complexity of these questions have resulted in often 
divergent opinions on the advisability of developing 
and applying synthetic biology to conservation.
Any new and powerful technology, particularly 
one with the potential to touch nearly any species 
and ecological system, anywhere in the world, is 
a challenge to existing views of what nature is and 
what should be considered worthy of conservation. 
Since synthetic biology is still in its early days, most 
applications have an uncertain future, and societies 
have not decided if they will support their application. 
Yet the powerful response to the idea of applying 
synthetic biology to problems of conservation and 
sustainable use, both from those wary of the impact 
and the ethical implication of the new science and 
those encouraged by the potential of new tools to 
solve tough challenges, suggests that the impact of 
synthetic biology on society could be significant. 
While synthetic biology may influence society 
in as yet uncertain ways, the reverse is true as 
well. As the general public learns more about 
synthetic biology their opinions will in turn help 
determine policy decisions about what kind of 
research receives government funding or regulatory 
approval, and ultimately which applications will 
be allowed to take place. Moreover, their demand 
or preferences as consumers for the products of 
synthetic biology – or not – will also influence the 
directions of corporate investment into the field.
Perhaps the most important cultural factor in the future 
relationship of synthetic biology to conservation will 
be the attitudes and experiences of young people 
growing up now with synthetic biology potentially as 
a fact of life, as well as future generations who will 
interact with it in ways we cannot predict. Raised 
in a world in which many technologies are already 
deployed, younger generations may not share the 
views of older people to whom these technologies 
are still novel. There is a generation being raised to 
consider synthetic biology as just one among many 
new technologies. For example, the International 
Genetically Engineered Machine Competition (iGEM) 
began in 2004 with five teams and 31 participants. In 
2018 there were 340 teams, from 42 countries, and 
5,806 participants. All told, over 40,000 young people 
in high school and college – most under the age of 
23 – have participated in synthetic biology experiments 
through iGEM. Many more have been exposed to the 
field through DIY biology labs now operating around 
the world or through classroom experience. The 
application of synthetic biology tools and technologies 
to conservation will no doubt remain contested, but the 
attitudes of people now learning about synthetic biology 
in college or high school biology classes will have an 
increasingly powerful say in the outcome of the debate.
The ongoing changes in technology and society 
regarding synthetic biology will presumably lead to 
changes in nature as well. As with so many of the 
questions about the intersection of synthetic biology 
and conservation, the precise contours of those 
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changes are still uncertain. That there will be changes, 
however, is beyond debate. Nature itself is changing, 
and human understanding of nature and natural is 
changing as well. This has always been the case; the 
relationship between people and nature has never 
been static. The pace of that change has accelerated 
dramatically, however, in tandem with the scale and 
pace of human transformation of the Earth’s biodiversity.
That transformation provides crucial context for 
assessing the potential impact of synthetic biology 
on conservation and sustainable use. Not only does 
the climate, altered by human activity, influence the 
entire planet, but other human impacts are just as 
pervasive, from microscopic plastic debris in the 
farthest reaches of the world’s oceans (Galloway, 
Cole & Lewis, 2017) to persistent organic pollutants in 
both the Arctic (De March et al., 1998) and Antarctica 
(Vecchiato et al., 2015). Species extinction caused 
by people is proceeding a thousand times faster than 
usual through Earth’s history (Pimm et al., 2014). 
Technology is an ever more pervasive aspect of the 
daily lives of people everywhere, including those most 
remote from urban centres and all the trappings of 
modernity. This may portend a fundamental shift in 
the relationship between technology and nature, and 
some observers argue that to a degree never before 
seen technology has become an obstacle that prevents 
humans, particularly children, from experiencing 
nature as they have through history (Louv, 2008). 
Just as powerful but less intuitive is the argument 
that there is no clear distinction between environment 
and technology, just that technology is – and always 
has been – the way humans experience the natural 
world (Reuss & Cutcliffe, 2010). The point here is not 
to try to resolve the differences between those ways 
of thinking about the human relationship with nature. 
The question, which this assessment is designed to 
help answer, is how diverse communities decide about 
the conservation uses of technology and whether the 
environment will benefit or not from these decisions. 
The way people will answer that question will depend 
to a large degree on the way they think about 
technology, science, society, risk, their perception of 
their own future and the future of the world around 
us. Those complex and emotional issues do not 
exist in isolation, but are tied together by powerful 
stories that help organise and make sense of the 
world. As the decision-making processes regarding 
synthetic biology move forward, the evidence 
presented in this assessment will become part of new 
narratives that will help all concerned understand the 
possibilities and the perils of this new technology. 
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